Rna Regulation During Gametogenesis And Triggers Of Egg Activation In Drosophila Melanogaster by Sartain, Caroline
  
RNA REGULATION DURING GAMETOGENESIS AND TRIGGERS OF EGG 
ACTIVATION IN DROSOPHILA MELANOGASTER 
 
 
 
 
 
 
 
 
A Dissertation 
Presented to the Faculty of the Graduate School 
of Cornell University 
In Partial Fulfillment of the Requirements for the Degree of  
Doctor of Philosophy 
 
 
by 
Caroline V. Sartain 
August 2013 
 
  
 
 
 
 
 
 
 
 
 
  2013 Caroline Sartain  
RNA REGULATION DURING GAMETOGENESIS AND TRIGGERS OF EGG 
ACTIVATION IN DROSOPHILA MELANOGASTER 
 
Caroline Sartain, Ph.D. 
Cornell University 2013 
 
One of the most critical transitory periods during development occurs when an 
oocyte prepares to undergo embryogenesis, in a process called “egg activation”. In many 
organisms, the oocyte has been at rest in the ovary, stored in a dormant state for a period 
ranging from a number of days (as in flies) to several decades (as in humans). Upon egg 
activation, this dormant egg must suddenly undergo several major cellular and molecular 
changes that prepare it for embryogenesis, including restructuring of the vitelline 
membrane, completion of meiosis, and changes to mRNA and protein pools. Where most 
organisms require a fertilizing sperm to set off these events, fruitflies are unique in that 
egg activation occurs prior to requirement of fertilization. I have used Drosophila 
melanogaster as a model system to dissect apart some key events of egg activation that 
are driven solely by the maternal components of the oocyte.  
In most animals, the initial trigger from the sperm sparks a calcium wave that 
traverses through the oocyte, acting as a message to kick off previously silenced 
biochemical pathways. For many years, it was unknown whether calcium played a role in 
egg activation in Drosophila. I have discovered that although Drosophila oocytes do not 
require a fertilizing sperm, a calcium wave does occur during egg activation. I have 
characterized the dynamics of this calcium influx using live imaging of Drosophila 
oocytes undergoing in vitro egg activation. Furthermore, I found that the calcium flux is 
not dependent upon internal stores but depends on extracellular calcium concentrations. 
Additionally, I have determined that the extracellular calcium likely enters the oocyte 
through mechanosensory TRP channels. 
Downstream of the calcium signal, there is major turnover of the maternally-
stored mRNAs within the oocyte. I have examined the phenotype and transcriptome 
changes in eggs from mothers carrying the prage mutation, an allele previously 
uncharacterized in egg activation. I have also performed microarray analysis of the global 
set of transcripts that undergo cytoplasmic polyadenylation by WISPY at egg activation. 
These data taken together give us a big-picture view of the global changes occurring in 
the mRNA pool during egg activation.   
BIOGRAPHICAL SKETCH 
Caroline grew up in a small town called Greers Ferry in northern Arkansas. Frustrated 
with the town’s public school system, she left Greers Ferry to finish high school at the 
Arkansas School for Math and Science (ASMS) in Hot Springs, Arkansas. During her 
time at ASMS, she focused on biological sciences and gained an appreciation for 
molecular biology and laboratory research. As an undergraduate at Rhodes College, she 
began regular research as a freshman in the labs of Drs. Terry Hill and Darlene Loprete, 
where she learned cell imaging, molecular biology, and biochemical techniques as they 
applied to gene mapping and discovery in Aspergillus nidulans. During the latter part of 
her undergraduate career, Caroline worked with Drs. Beatriz Sosa-Pineda and Guillermo 
Oliver at St. Jude Children’s Research Hospital, where she got her first taste of 
developmental biology studying homeobox transcription factors in mouse pancreatic 
development. She continued her passion for research and developmental biology at 
Cornell University in the lab of Dr. Mariana Wolfner, where she studied what she 
considers the most fascinating and most critical timepoint of organismal development: 
the egg-to-embryo transition, or those events which occur just prior to and just after 
fertilization that allow a fully functional multicellular organism to develop from just 
sperm and egg. After her time at Cornell, Caroline will join the lab of Dr. Patricia Hunt at 
Washington State University, where she will study the toxicity effects of bisphenol-A 
(BPA) on mammalian reproductive tracts. 
 iii 
ACKNOWLEDGEMENTS 
I have had a wonderful experience at Cornell, and there are many individuals I 
would like to thank for that. Mariana has been an exceptional mentor, concerned not only 
with the progress of the science but also with the personal well-being of her lab members. 
Many times I have walked into her office with some muddled and confusing scientific 
problem, and through our discussion always have left with a clear picture of what needs 
to be done next. I also thank her for creating a nurturing atmosphere in which to work. 
Having seen peers in some terrible lab environments, I do not take this for granted.  
I would also like to thank my committee members, Mike Goldberg and Kelly Liu, 
for so many helpful comments and ideas for new research directions. I enjoy that I can 
run into Mike in the hallway or in the break room and end up in a 45-minute conversation 
about the best way to perform a specific experiment. I must acknowledge Kelly for 
running the developmental biology journal club, which has kept me up to speed in the 
field when I don’t always have time to read the journals. 
There are many past and present lab members I must acknowledge. Jun Cui taught 
me the ropes in the Wolfner lab, and Norene Buehner and Amber Krauchunas have 
always been there to bounce ideas off of. Although I’ve never met Vanessa Horner, I 
must acknowledge her for laying the groundwork for the calcium project, and for keeping 
such well-organized lab notebooks and a well-written thesis. I’ve read them all cover-to-
cover at least twice. 
Finally, I must thank my friends and family for all their trust and support during 
my graduate career, without which I wouldn’t have been nearly as fruitful. 
 iv 
TABLE OF CONTENTS 
BIOGRAPHICAL SKETCH..............................................................................................iii 
ACKNOWLEDGEMENTS................................................................................................iv 
TABLE OF CONTENTS....................................................................................................v 
LIST OF FIGURES...........................................................................................................vii 
LIST OF TABLES.............................................................................................................ix 
 
CHAPTER 1. 
INTRODUCTION..............................................................................................................1 
1.1 Gametogenesis and early embryonic development in Drosophila……....…..3 
1.2 Calcium during egg activation…………………………….………………….5 
1.3 RNA regulation at egg activation……………………………….…………..13 
1.4 Dissertation outline………………………………………………………….17 
CHAPTER 2. A CONVERGENT CALCIUM RISE TRAVERSES THE DROSOPHILA 
OOCYTE DURING EGG ACTIVATION.......................................................................20 
 2.1 Introduction. ...................................................................................................20 
 2.2 Materials and Methods…................................................................................24 
 2.3 Results….........................................................................................................25 
 2.4 Discussion.......................................................................................................44 
CHAPTER 3. PHENOTYPIC AND TRANSCRIPTOMIC ANLAYSIS OF EGGS 
FROM PRAGE MUTANT MOTHERS DURING EGG ACTIVATION……….……...49 
 3.1 Introduction.....................................................................................................49 
 3.2 Materials and Methods...................................................................................51 
 v 
 3.3 Results..............................................................................................................53 
 3.4 Discussion.......................................................................................................67 
CHAPTER 4 CYTOPLASMIC POLYADENYLATION IS A MAJOR mRNA 
REGULATOR DURING OOGENESIS AND EGG ACTIVATION IN 
DROSOPHILA……………………………..…………………………………………....71  
4.1 Introduction......................................................................................................71 
 4.2 Materials and Methods ....................................................................................73 
 4.3 Results..............................................................................................................79 
 4.4 Discussion......................................................................................................102 
CHAPTER 5 THE POLY(A) POLYMERASE GLD2 IS REQUIRED FOR 
SPERMATOGENESIS IN DROSOPHILA MELANOGASTER……………………. 107 
 5.1 Introduction....................................................................................................107 
 5.2 Materials and Methods...................................................................................113 
 5.3 Results and Discussion .................................................................................116 
 5.4 Conclusions ...................................................................................................152 
CHAPTER 6. THESIS SUMMARY AND PERSPECTIVES........................................154 
REFERENCES................................................................................................................151 
APPENDIX A  SUMMARY AND RESULTS OF CALCIUM DRUGS TESTED…...165 
APPENDIX B  DAVID ANALYSIS OF WISPY MICROARRAYS………………....167 
REFERENCES………………………………………………………………………....201 
 vi 
LIST OF FIGURES 
Figure 1.1. Model of egg activation in Drosophila ………………………………….…..11 
Figure 2.1  Calcium dynamics during egg activation in Drosophila melanogaster……...28 
Figure 2.2  Wortmannin does not affect the Ca2+ wave at egg activation……………….30 
Figure 2.3  U-73122 does not affect the Ca2+ wave at egg activation…………….……..32 
Figure 2.4  Ruthenium red does not affect the Ca2+ wave at egg activation……………..34 
Figure 2.5 Chelation of ions using BAPTA inhibits the Ca2+ wave at egg activation…...37 
Figure 2.6  Moderate to high concentrations of gadolinium inhibit the Ca2+ wave at egg 
activation…………………………………………………………………………………39 
Figure 2.7 The TRP channel inhibitor ACA inhibits the Ca2+ wave at egg activation…41 
Figure 2.8  Low concentrations of gadolinium do not inhibit the Ca2+ wave at egg 
activation…………………………………………………………………………………43 
Figure 3.1  Schematic representation of prg alleles. . …………………………….….….55 
Supplementary Figure A.1  A map of P-element insertions relative to prg 
gene (CG42666) structure………………………………………………………….…….58 
Figure 3.2  Presence of insertion, P{XP}CG42666d10828, in CG42666………………… 60 
Figure 3.3  Expression patterns of prg transcripts. ……………….………………….….62 
Figure 3.4  Eggs from prg mutant mothers are defective for VM crosslinking and meiotic 
completion………………………………….…………………………….………….…...68 
Figure 4.S1 False-colored representation of (A) the raw oocyte poly(A)+ data, and (B) the 
same data after quantile normalization……………………………….………………….77 
Figure 4.1 Polyadenylated transcriptome is altered in the absence of WISP function…..84 
Figure 4.2 Poly(A) tails are shorter in the absence of WISP function……………….….90 
 vii 
Figure 4.3 Polyadenylated transcripts are depleted in the absence of WISP……………93 
Figure 4.4 WISP forms a complex with candidate target mRNAs…………...………...100 
Fig. 5.1  Overview of spermatogenesis in Drosophila melanogaster…..........................110 
Fig. 5.S1  The duplication giving rise to wispy/Gld2 occurred after the divergence of the 
Drosophila and mosquito lineages……………………………………………………...118 
Fig. 5.S2  The A. gambiae ortholog of wispy/Gld2 is in a region of the genome most 
resembling the D. melanogaster X chromosome………………………………….……121 
Fig. 5.S3  D. melanogaster Gld2 is missing introns that are conserved between wispy and 
the mosquito Gld-2 ortholog….……………………………….………………………..123 
Fig. 5.2  GLD2 is expressed in the testes, and is not detectable in the female……..….126 
Fig. 5.3  RNAi knockdown of GLD2 results in defective late spermatogenesis………132 
Fig. 5.4  Nuclei are scattered throughout spermatogenic cysts and individualization cones 
do not form in GLD2 knockdown testes………………………………….………….....134 
Fig. 5.5  Basal body docking is defective in GLD2-knockdown testes……….………..138 
Fig. 5.6  Protamines are transcribed, but not incorporated in GLD2-knockdown 
testes………………………………….………………………………….….….……….143 
Fig. 5.S4   g-tubulin staining shows centrosomal derivatives throughout many stages of 
spermatogenesis in whole wild-type testes……………………………….…………….145 
Fig. 5.S5  G-actin levels appear normal in GLD2 knockdown……………………...….147 
Fig. 5.7  Transition protein and dynamin transcripts are absent from GLD2-knockdown 
testes………………………………….………………………………….……………...149
 viii 
LIST OF TABLES 
Table 2.1  Expression of mechanosensitive channels in the adult ovary……………….46 
Table 3.1 Significant hits from comparison of unfertilized eggs from wild-type and prg 
mutant mothers 2-2.5 hours after egg laying………………………………….……...….67 
Table 4.1 SAM analysis of genes that show ≥2-fold significant change in abundance....82 
Table 4.2  PAT assay validation of selected candidate target mRNAs………………....87 
Table 5.1  Transcripts that tested negative for GLD2-dependent polyadenylation by PAT 
assay…………………………………………………………………………………….151 
Table A1. Pharmacological agents tested on activating oocytes……………………...166 
Table B1. Oocyte DAVID analysis, transcripts ≥2-fold higher in control than wisp…167 
Table B2. Oocyte DAVID analysis, transcripts ≥3-fold higher in control than wisp…172 
Table B3. Oocyte DAVID analysis, total RNA transcripts downregulated in wisp…..177 
Table B4. Embryo DAVID analysis, transcripts ≥2-fold higher in control than wisp...178 
Table B5. Embryo DAVID analysis, transcripts ≥3-fold higher in control than wisp...184 
Table B6. Embryo poly(A) downregulated minus embryo total RNA downregulated..186 
Table B7. Oocyte poly(A) downregulated minus oocyte total downregulated…….….192 
Table B8. Embryo poly(A) downregulated minus Embryo total downregulated……...194 
 
 
 
 
 ix 
CHAPTER 1 
 
INTRODUCTION1 
 
Through the process of egg activation, a single resting cell – the mature oocyte – 
suddenly is triggered to undergo several major changes that give it the capacity, once fertilized, 
to give rise to every type of tissue in the adult. Understanding the intricacies of egg activation is 
fruitful for understanding how cells can transition between differentiated and totipotent states, 
and also has relevance to our understanding of fertility and the development of assisted 
reproductive technologies. 
In many organisms, mature oocytes remain stalled in a species-specific stage of meiosis. 
Release from this arrest point occurs during egg activation. This process initiates a number of 
changes at the molecular and cellular levels in the oocyte that prepare it to undergo 
embryogenesis after fertilization (Horner and Wolfner, 2008b; Krauchunas and Wolfner, 2013; 
Raz and Shalgi, 1998). The molecular changes include modification of vitelline membrane 
structure, alterations in RNA and protein pools through translation or degradation of stored 
maternal RNAs, and post-translational modifications made to existing proteins. These molecular 
events drive major changes at the cell level, including release from meiotic arrest, pronuclear 
fusion, and finally progression to embryonic mitoses. 
Precise regulatory control of RNAs and proteins is critical for developmental processes to 
occur normally. Sperm and egg development in many organisms relies upon a decoupling of 
transcription and translation in addition to stage-specific modulation of protein activity; 
1 Part of this chapter has been published as: C.V. Sartain and M.F. Wolfner (2013). Cell Calcium 53(1), 10-15. This 
is reprinted here with permission. 
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therefore, gametogenesis and the transition from egg to embryo are particularly sensitive to such 
regulation. During oogenesis in Drosophila, the developing oocyte is stocked with many RNAs 
and proteins produced by the adjoining nurse cells. These materials are stored in a stable yet 
inactive state during egg development and become active during oocyte maturation and egg 
activation to facilitate these transitory states. If these mRNAs are prematurely translated, 
embryonic development could be compromised.  
The initiation of egg activation itself must also be tightly regulated to ensure that oocytes 
do not undergo spontaneous activation before they exit the ovary. In many animals, egg 
activation is triggered by components introduced to the egg by the sperm during fertilization. In 
each case, the sperm component initiates a rise in intracellular calcium (Ca2+) levels, which 
prompts signaling cascades leading to meiotic resumption, changes in RNA and protein pools, 
and polyspermy block (Saunders et al., 2002; Swann et al., 2006). Interestingly, Drosophila egg 
activation does not require fertilization, though previous studies indicate that increased internal 
Ca2+ is necessary for the process to begin (Horner and Wolfner, 2008a). The first part of this 
chapter focuses on the requirement of Ca2+ during egg activation and the mode of cytosolic Ca2+ 
increase. 
Many changes occur in the pool of maternally-produced stored RNAs downstream of the 
egg activation trigger in Drosophila. In contrast to de novo transcription, regulation of a large 
pool of existing RNAs can cause rapid, widespread change in cell state and function. RNA 
exonucleases and poly(A) polymerases contribute to the fate of stored RNAs through 
degradation or by promoting translation, respectively (Tadros and Lipshitz, 2005; Vardy and 
Orr-Weaver, 2007a). The second part of this chapter focuses on the mechanisms by which stored 
RNAs are degraded or translated. 
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1.1 Gametogenesis and early embryonic development in Drosophila 
Drosophila females produce oocytes throughout their lifetime. Here, oogenesis occurs 
within ovarioles in the ovary (Spradling, 1993). Each ovariole (of which there are 14-16 per 
ovary) is essentially an assembly line for oogenesis and consists of an asymmetrically dividing 
germline stem cell (GSC) and germarium with several developing egg chambers, such that each 
chamber further from the GSC contains an oocyte at a later stage of development. Each egg 
chamber eventually reaches 16 cells in number through four mitotic divisions: one of the first 
daughter cells of the initial divisions is determined to be the oocyte through inheritance of a 
unique germ cell component called the spectrosome, whereas the rest of the cells become nurse 
cells. The nurse cells within the egg chamber are connected to each other and to the oocyte 
through ring canals. The purpose of the nurse cells is to produce many nutrients, including 
mRNAs and proteins, which they deliver to the oocyte in a process called “dumping” or 
ooplasmic streaming to support early embryogenesis. After dumping, the nurse cells are no 
longer needed, and they apoptose. 
The somatic follicle cells that surround the egg chamber build a complex eggshell made 
up of a vitelline membrane and a chorion that will protect the developing embryo after egg 
laying. Built into the chorion on the anterior of the oocyte is a structure called the micropyle (an 
opening that serves as the single entry point for a fertilizing sperm) as well as dorsal appendages 
(tubes that serve as “breathing” appendages so that the developing embryo can exchange gases 
with the environment outside the eggshell). At the end of oogenesis, the oocyte is essentially a 
prolate spheroid approximately 0.5mm in length and 0.2mm in diameter at its waist (Markow et 
al., 2009). Thus, the Drosophila oocyte is particularly large among those of model organisms. 
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Within the mature oocyte, the cell cycle is stalled at metaphase I of meiosis, and many mRNAs 
and proteins are poised to undergo modification and activation in preparation for fertilization.  
Once oogenesis is complete, the oocyte exits the ovary and enters the oviduct for 
ovulation. Egg activation in Drosophila begins during passage through the oviduct, in contrast to 
many other species whose eggs activate at fertilization (Doane, 1960; Heifetz et al., 2001). In 
Drosophila, these events are sequential rather than simultaneous: just after ovulation, the oocyte 
will pass by the spermathecae (sperm storage organs), where sperm are released (if the female 
has mated) and a single sperm enters the oocyte through the micropyle. By the time the female 
deposits the oocyte on her substrate of choice, oftentimes fruit, embryogenesis is already 
underway, beginning with synchronous and very rapid (only 8 minutes per cycle) nuclear 
divisions that proceed without G-phases and without cytokinesis until the 14th cell cycle. 
In most organisms, transcription from the zygotic genome does not begin right away. 
Zygotic genome activation (ZGA) begins at the 2-cell stage in mice and at the 4-8 cell stage in 
humans, whereas in organisms with external development ZGA occurs much later (14th cleavage 
cycle in frogs, fish, and Drosophila) (Tadros and Lipshitz, 2009). Notably, eggs of this latter 
group are much larger than those of the former, reflecting the fact that embryogenesis depends 
on nutrients stored in the oocyte from the mother until ZGA is complete. Thus, there is a great 
requirement for proper timing of translation of those stored mRNAs and post-translational 
modifications of proteins prior to ZGA in Drosophila so that embryogenesis can run smoothly 
until the embryo can produce these essential macromolecules for itself. The activation of 
maternal RNA and protein stores, which were previously quiescent during oogenesis, occurs 
during egg activation in the oviduct, and must be maintained until ZGA. 
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Due to the large size of Drosophila oocytes, ease of genetic manipulation in Drosophila 
in general, short generation time of the organism, and the fact that egg activation and fertilization 
are separable events, Drosophila is an excellent model organism for studying egg activation. We 
and others have already successfully used Drosophila to identify genes and mechanisms involved 
in this complex cellular transition. Some notable work in this area includes sarah (sra) and 
calcineurin (Cn), involved in calcium signaling upon the trigger for egg activation (Horner et al., 
2006; Takeo et al., 2006; Takeo et al., 2010; Takeo et al., 2012); Young Arrest (Ya), required for 
maintenance of nuclear organization (Lin and Wolfner, 1991; Sackton et al., 2009); cortex (cort), 
a Cdc20 ortholog required for meiosis (Pesin and Orr-Weaver, 2007; Swan and Schupbach, 
2007); wispy (wisp), a poly(A) polymerase required for translational activation of stored 
transcripts ((Benoit et al., 2008; Brent et al., 2000; Cui et al., 2008) and Chapter 4); the Pan Gu 
Kinase (PNG) complex [including giant nuclei (gnu) and plutonium (plu)], which also regulates 
translation of stored mRNAs (Tadros et al., 2003); smaug (smg), which degrades stored mRNAs 
that will not be needed (Tadros et al., 2007); and prage (prg), which may be involved in 
degradation of unneeded mRNAs at egg activation ((Tadros et al., 2003) and Chapter 3). 
1.2  Calcium during egg activation 
In the vertebrate and invertebrate organisms studied, egg activation requires an increase 
in intracellular calcium levels within the oocyte (reviewed in (Malcuit et al., 2006; Miyazaki and 
Ito, 2006; Townley et al., 2006; Whitaker, 2008)). In most cases, the calcium increase is 
triggered through the fertilizing sperm, commonly through activation of an intracellular calcium 
signaling pathway. For example, in mice the sperm introduces a specific isoform of 
phospholipase C, which activates the inositol triphosphate pathway in the fertilized egg, 
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ultimately causing release of calcium stores from the endoplasmic reticulum (ER) (Rice et al., 
2000).  
However, the specific trigger for egg activation is different in at least some insects, 
including fruitflies and hymenoptera such as ants and bees (whose unfertilized eggs develop into 
males) (King and Rafai, 1970; Mahowald et al., 1983). Egg activation in these insects does not 
require fertilization (Doane, 1960). Instead, a mature oocyte begins to activate as it travels 
through the female reproductive tract. Activation is triggered by passage through the ovipositor 
in wasps (Went and Krause, 1974), or upon the oocyte’s release from the ovary into the oviduct 
in Drosophila (Heifetz et al., 2001).  
Calcium signals in many cell types are commonly transmitted through the calcium 
binding protein calmodulin (CaM), which may then interact with other proteins to activate 
downstream events. Studies in vertebrates had previously pointed to roles for CaM-mediated 
pathways in egg activation. In mouse, for example, activity of the calmodulin-dependent kinase 
CaMKII increases with the multiple calcium spikes in the oocyte, and each wave of CaMKII 
activity progressively promotes further landmarks of egg activation (Markoulaki et al., 2003). 
CaMKII and the calcium-dependent phosphatase calcineurin also play a role in activation of 
Xenopus oocytes, where much of the signaling network downstream of the calcium rise has been 
identified. In resting Xenopus oocytes, meiosis is held in an arrested state by inhibition of the 
anaphase promoting complex, APC/C, whose action is required to initiate anaphase. The APC/C 
acts as an E3 ligase when bound to its coactivator CDC20 to signal the degradation of cell cycle 
regulators at the spindle assembly checkpoint, thus promoting progression from metaphase to 
anaphase (reviewed in (Peters, 2006)). In the resting cell, anaphase progression is blocked by 
inhibitory phosphorylation of CDC20 and by active Emi2, a spindle checkpoint regulator 
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(Hansen et al., 2006). Upon fertilization (and thus egg activation), the resulting rise in cytosolic 
Ca2+ activates (1) CaMKII, which places an inhibitory phosphorylation on Emi2; and (2) the 
calcium-dependent phosphatase calcineurin, which removes CDC20 phosphorylation. These 
post-fertilization events release inhibition of APC/C and allow progression through anaphase 
(Hansen et al., 2006; Mochida and Hunt, 2007; Nishiyama et al., 2007). 
The first indication that calcium may play an important role in Drosophila egg activation 
came from genetic analysis: the gene for the calcineurin regulator sarah (Sra, calcipressin) was 
identified in a screen for mutations affecting early post-fertilization embryonic development. 
Embryos from sra mutant mothers arrest normally at metaphase I, but upon meiotic resumption 
at egg activation they are unable to proceed past anaphase I (Horner et al., 2006; Takeo et al., 
2006). Calcipressins typically regulate the activity of the Ca2+/CaM-dependent phosphatase 
calcineurin (CaN) through direct binding (Fuentes et al., 2000; Gorlach et al., 2000; Kingsbury 
and Cunningham, 2000). Recent evidence establishes that during egg activation in flies, the 
calcipressin Sra activates calcineurin. First, the phenotype of embryos derived from germline 
clones of a null allele of the CnB subunit gene of calcineurin is remarkably similar to that of sra 
mutants: meiosis arrests properly at metaphase I but is unable to continue past anaphase I upon 
release from meiotic arrest (Takeo et al., 2010). Second, a recent study confirms that Sra 
associates with calcineurin in vivo and further shows that phosphorylation of Sra at Ser215 is 
necessary for calcineurin activity (Takeo et al., 2012). This residue is phosphorylated only in 
activated eggs and not in mature oocytes, and this phosphorylation event is dependent upon 
activity of glycogen synthase kinase (GSK-3, shaggy) (Takeo et al., 2012); however, it is not 
known how GSK-3 activity is turned on specifically at egg activation. Taken together, these 
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results indicate the following scenario: upon egg activation, Sra becomes phosphorylated at a 
specific residue, which allows Sra to activate calcineurin. 
Interestingly, Sra is bound to calcineurin both in ovaries, where calciuneurin is not active, 
and in early embryos, where calcineurin is active (Takeo et al., 2012). In other organisms, 
calcipressin has been shown to bind groups of different targets for activating or repressive 
regulation depending on its phosphorylation status, and this association can be either repressive 
or activating (Takeo et al., 2012). The same may be true in Drosophila, where the association of 
Sra and calcineurin in the ovary may be inhibitory until Sra’s phosphorylation at egg activation. 
Roles for CaM and CaMKII in Drosophila egg activation have not yet been directly 
determined through genetics. We suspect that both proteins are important for signal transduction 
upon Ca2+ influx during egg activation. For example, the results just described indirectly point to 
at least one role for CaM through the calmodulin-dependent phosphatase calcineurin. In fact, 
CaM was identified in calcineurin-containing immunoprecipitates of Sra (Takeo et al., 2012), 
further suggesting that CaM is required to convey the calcium signal to effector proteins.  
Exogenous calcium is needed for Drosophila egg activation 
Early observations of Drosophila oocytes noted that laid eggs were already activated, 
even if they had not been fertilized (Doane, 1960; Mahowald et al., 1983). Oocytes in the ovaries 
were never activated, indicating that activation had to occur sometime between the release of 
eggs from the ovary and their being laid by the female. Subsequent detailed physiological studies 
indeed indicated that oocytes become activated as they pass into the oviduct (Heifetz et al., 
2001). Figure 1 demonstrates that transit through the oviducts promote activation: among 
oocytes that had just begun to exit the ovary, only a small percentage had undergone activation. 
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However, the percentage of activated oocytes increased progressively at positions further along 
the oviduct.  
The specific egg activation trigger that occurs in the Drosophila oviduct is still unknown, 
though the available evidence points toward a mechanical stimulus independent of sperm 
(Heifetz et al., 2001; Horner and Wolfner, 2008a). Mature oocytes in the ovary have a limp, 
deflated appearance; however, activated, laid eggs appear turgid and taut. Examination of the 
oviduct before and after egg laying indicates that fluid (possibly with any ions it contains) may 
be transferred from the oviduct epithelium to the egg during ovulation: the walls of the oviduct 
are swollen with fluid in female flies that have not yet ovulated an egg; after ovulation, the 
oviduct walls appear to have lost fluid (measured by the decrease in matrix space between the 
intima and the oviduct epithelium) and the laid egg to have gained fluid (Mahowald et al., 1983). 
Therefore, one model for egg activation in Drosophila posits that this passage of fluid from the 
walls of the oviduct into the oocyte is sufficient to activate the egg (Heifetz et al., 2001). Given 
the fact that females produce many eggs, this hypothesis would require a continual, net 
production of new fluid to flow into each subsequent oocyte. This transferred oviductal fluid 
could contain ions such as calcium that potentially could participate in egg activation. While 
Drosophila ovaries express RNAs for aquaporin water channels and, at low levels, for some 
other transporters such as the orthologs of NBC, NKCC1, and some potassium channels 
(Chintapalli et al., 2007; McQuilton et al., 2012), involvement of these molecules in egg 
activation has not been tested. Moreover, expression of aquaporins and ion transporters in the 
oviductal epithelium has not yet been examined. 
A second model suggests that exit from the ovary and passage through the oviduct exerts 
pressure on the oocyte, activating mechanosensitive ion channels that ultimately trigger egg  
 9 
  
 
Figure 1.1. Model of egg activation in Drosophila. The current model for egg activation posits 
that a mechanical tension force (FT) on the oocyte during its transit through the oviduct activates 
mechanosensitive Ca2+ channels. Ca2+ enters the cytoplasm where it binds and activates 
calmodulin (CaM; (transition from inactive CaMi to active CaMa), which can then act on 
downstream effectors like CaMKII and calcineurin (CaN) (dashed lines indicate that evidence 
has not yet been provided; subscripts “i” and “a” indicate inactive and active forms, 
respectively). Separately, calcipressin (Sra) is phosphorylated by GSK-3 upon egg activation, 
which allows Sra to positively regulate CaN. These phospho-modulatory proteins, as well as as-
yet unidentified kinases and phosphatases, are proposed to modulated the phosphorylation state, 
and thus activity, of over 300 proteins (Krauchunas et al., 2012), leading to the cellular changes 
of egg activation. 
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activation (Heifetz et al., 2001; Horner and Wolfner, 2008a). In accordance with this model, 
simply pulling on the dorsal appendages attached to the eggshell of a dissected Drosophila 
oocyte can induce egg activation (Endow and Komma, 1997), and external pressure on the 
oocyte can accelerate its activation in a buffer that contains calcium (Horner and Wolfner, 
2008a) (see below). These two models (fluid transfer, and mechanosensitive triggers) are not 
mutually exclusive. One can imagine, for example, that swelling of the egg due to hydration 
from oviductal fluid would cause mechanical stress in the oocyte membrane, which could 
activate mechanosensitive ion channels and initiate egg activation. 
It has been possible to analyze the trigger for egg activation by using an in vitro system.  
Oocytes dissected from the ovary are incubated in an “activation buffer” that is hypotonic to the 
egg and contains the appropriate ionic makeup (see below) (Mahowald et al., 1983; Page and 
Orr-Weaver, 1997). This method of hypoosmotic egg activation causes the oocyte to take up 
fluid and to become turgid, perhaps mimicking the hydration that occurs in the oviduct. These in 
vitro activated oocytes show all the signs of normal in vivo egg activation, including normal 
progression through meiotic stages (Page and Orr-Weaver, 1997), translation of stored mRNAs 
(Horner and Wolfner, 2008a), and vitelline membrane crosslinking (Page and Orr-Weaver, 
1997).  
In vitro experiments indicate that calcium plays a major role in Drosophila egg activation. 
The presence of calcium in the activation buffer is essential for hypoosmotic activation of 
Drosophila oocytes in vitro: oocytes dissected from the ovary cannot activate if incubated in 
calcium-depleted activation buffer (Horner and Wolfner, 2008a). Furthermore, in vitro activation 
of dissected Drosophila oocytes can be inhibited by treatment with gadolinium, which blocks 
some ion channels including mechanosensitive stretch-activated channels. The effects of 
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gadolinium and the buffer constitution suggest that calcium ions enter the oocyte from the 
external environment to trigger activation (Horner and Wolfner, 2008a). Taken together, the 
available data are most consistent with a model in which calcium from the oviductal fluid enters 
the oocyte from the outside due to a mechanical stimulus experienced by the oocyte as it passes 
through the oviduct, and this influx of calcium ultimately triggers egg activation. 
RNA regulation at egg activation 
Once activation is triggered in the oviduct and if fertilization occurs during passage 
through the lower reproductive tract, the egg will begin to undergo embryogenesis. Early 
embryogenesis in Drosophila is unique from that of some other model organisms in that ZGA 
does not begin to occur until the 11th cell cycle, and maternal-zygotic transition (MZT) is not 
completed until the 14th cell cycle. Therefore, the Drosophila embryo must drive early 
embryogenesis solely from the activity of maternally provided mRNAs and proteins. These first 
cell cycles prior to MZT occur extremely rapidly, with S phase moving directly into M phase 
without any interruption for G phases. 
After the initial trigger for egg activation during ovulation, the existing maternally-
deposited RNA and protein pools undergo major turnover. Many RNAs must either be translated 
or degraded, and a significant portion of the protein pool will experience post-translational 
modifications such as phosphomodulation, which can influence their activity and binding 
partners (Krauchunas et al., 2012). Altogether, these sweeping changes made to the oocyte RNA 
and protein populations are a major driving force for many events of egg activation. 
RNA degradation 
Perhaps the largest turnover in mRNA populations within the early embryo occurs at egg 
activation, with another significant wave of degradation occurring at MZT. The mature oocyte 
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contains an enormous pool of transcripts representing 55% of the entire genome (Tadros et al., 
2007). Approximately 20% (1600 of 7745) of these maternally deposited mRNAs are 
destabilized upon egg activation, and another 15% are degraded at MZT (Tadros et al., 2007). In 
some cases, these mRNAs exist throughout the cytoplasm of the oocyte; global degradation of 
such transcripts combined with regional protection results in specific localization, which can be 
critical for setting up the early embryonic axes and for embryonic patterning. Examples of 
mRNAs that are regulated in this way are Pgc, nanos, and Hsp83 (Bashirullah et al., 1999). 
Many other mRNAs that require posttranscriptional regulation at egg activation encode cell cycle 
components, such as cyclin B, which is important for proper timing of nuclear divisions [(Vardy 
and Orr-Weaver) and Chapter 4). 
Some of the mechanisms of transcript destabilization are known. Approximately two-
thirds of the transcripts that are destabilized at egg activation are dependent upon the activity of 
the posttranscriptional regulator SMAUG (SMG) (Tadros et al., 2007). SMG-regulated 
transcripts contain a SMG regulatory element (SRE) in the 3’ end of the transcript. Upon SMG 
binding, the CCR4/NOT deadenylation complex is recruited to the transcript, keeping the 
poly(A) tail short and inhibiting translation. Different regulatory mechanisms may be in place for 
transcripts not regulated by SMG, such as repression by PUMILIO (PUM), which also recruits 
the deadenylation machinery (Vardy and Orr-Weaver, 2007a). In addition, not all destabilized 
transcripts containing the SRE are necessarily regulated by SMG, indicating that other regulatory 
factors may be at play and may in fact bind the same element. The mechanism by which the 
transcript is actually degraded is unknown, but it is likely ultimately due to a short poly(A) tail 
on the transcript. 
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Cytoplasmic RNA polyadenylation 
Many maternally-deposited RNAs that exist within the cytoplasm are poised for 
translation. Here, the mRNA is bound within a regulatory complex that suppresses translation 
until the appropriate signal is received. Upon a signal to translate, phosphomodulation and other 
changes to proteins within the regulatory complex relieves translational suppression, and 
ribosomal subunits can then act on the transcript (Kim and Richter).  
There are several modes by which translational suppression can occur (Vardy and Orr-
Weaver, 2007a). In several cases, translation is regulated through controlling the length of the 
poly(A) tail. During RNA synthesis in the nucleus, a pre-mRNA undergoes processing before its 
exit into the cytoplasm. Processing includes removal of introns and splicing of exons, addition of 
a 7-methylguanosine cap to the 5’ end of the transcript, and addition of a poly(A) tail containing 
30-200 adenosine residues. The poly(A) tail serves two major purposes: 1) it protects the 
transcript from enzymes in the cytoplasm that may degrade the transcript, and 2) it recruits 
binding proteins and other factors that promote ribosome binding and translation. Thus, a 
transcript with a short poly(A) tail is more likely to be degraded and less likely to be translated, 
whereas a transcript with a long poly(A) tail will be more stable and more likely to be translated 
(reviewed in (Mendez and Richter). 
There are several different ways to achieve translational control through the poly(A) tail, 
depending on the specific sequence elements present in the 3’UTR of the transcript. Repressive 
elements have been identified as binding sites for SMAUG (SMG) and PUMILIO (PUM), which 
promote deadenylation, as well as BICOID (BCD), which prevents translation initiation factors 
from binding to the 5’ cap, and BRUNO (BRU), which represses translation in a poly(A)-
independent manner (Vardy and Orr-Weaver, 2007a).  
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Thus, translation of these repressed transcripts often necessitates polyadenylation not 
only in the nucleus, but again in the cytoplasm to act against the repressive deadenylation. 
Studies from Xenopus models have demonstrated that specific RNAs preferentially undergo 
poly(A) tail lengthening upon egg activation, and that this lengthening correlates with their 
translation. The mechanism by which this occurs has been well studied in this organism. Here, an 
mRNA that is destined for cytoplasmic poly(A) tail adjustment contains specific sequences in the 
3’ UTR: The CPE (cytoplasmic polyadenylation element) and hexamer sequence AAUAAA 
recruit binding factors that keep the mRNA in a stable, quiescent state. Included in this complex 
are a deadenylase as well as a cytoplasmic poly(A) polymerase (PAP). Upon a signal to translate 
the mRNA, phosphorylation of CPEB triggers the release of the deadenylase, and the poly(A) 
polymerase is free to lengthen the poly(A) tail of the transcript (Kim and Richter, 2006; Mendez 
et al., 2000). The long poly(A) tail recruits poly(A) binding factors, which ultimately recruit 
translation initiation factors and the ribosomal subunits.   
The particular family of poly(A) polymerase on which I focused on in my studies is the 
GLD2 (germline development) family of cytoplasmic PAPs. Members of this family have been 
identified in the oocytes of all species examined so far (Barnard et al., 2004; Benoit et al., 2008; 
Cui et al., 2008; Kadyk and Kimble, 1998; Wang et al., 2002). 
Poly(A) polymerases that act in the cytoplasm are different from those that act in the 
nucleus. Nuclear PAPs [such as hiiragi in Drosophila (Juge et al., 2002)] contain both an 
enzymatic domain as well as an RNA binding domain (Wang et al., 2002). GLD2 cytoplasmic 
PAPs, on the other hand, have an enzymatic domain but lack the RNA binding domain. Thus, in 
order to act on a particular transcript, a GLD2 protein must form a heterodimer with an RNA 
binding protein (Wang et al., 2002). In Drosophila, two GLD2 proteins exist, encoded by the 
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wispy and gld2 genes. At least one GLD2 binding protein has been also been identified in 
fruitflies, encoded by the GLD3 homolog BicC (Benoit et al., 2008; Cui et al., 2008). Other 
binding partners may exist for the Drosophila GLD2 proteins, but as of yet no others have been 
identified. Because the binding partner in the heterodimer contains the RNA binding domain, a 
GLD2 protein may have a different set of target transcripts depending on which RNA binding 
protein it is partnered with. In C. elegans, for example, the GLD2 homolog can pair either with 
GLD3 or with RNP8; binding to the former can induce a spermatogenesis developmental 
program, whereas GLD2 binding with the latter promotes oogenesis (Kim et al., 2009). Similar 
mechanisms may occur in Drosophila, but our data so far show an identical binding partner for 
both male and female gametogenic programs (Cui et al., 2008; Sartain et al., 2011).  
Drosophila has – unusually – two Gld-2 genes: the Drosophila genus has independently 
developed a duplication of the original gld2 locus. Though the binding partner may be identical, 
the GLD2 homologs active in the male and female germlines in Drosophila are not. The two 
genes now present in the genome may have undergone subfunctionalization to carry out male 
and female developmental programs independently. This hypothesis will be explored further in 
Chapter 5. 
1.4  Dissertation Outline 
 In this dissertation I present studies pertaining to several molecular and physiological 
aspects of egg activation and gametogenesis in Drosophila melanogaster.  My studies confirm 
the requirement of calcium during egg activation in this organism and further explore the source 
thereof. Furthermore, I show the extent to which the maternally stored mRNA pool is affected at 
egg activation, and investigate which gene classes are most affected during this time. Taken 
together, this work provides a comprehensive view of some of the large-scale changes that occur 
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within the egg on the physiological, cellular, and molecular levels, and demonstrates the power 
of Drosophila as an important emerging model organism for the study of egg activation. 
 In Chapter 2, I examine the dynamics of intracellular calcium concentrations within the 
oocyte during egg activation. Previous studies had suggested that cytosolic calcium levels likely 
increase within the egg during activation, but imaging studies had not been able to detect such an 
increase. I used a fluorescent calcium sensor to definitively detect an increase in intracellular 
calcium levels within the activating egg. Furthermore, I used pharmacological agents to test the 
requirement of particular calcium channels or pathway components. My results indicate that 
calcium enters the oocyte from the extracellular environment during egg activation through TRP 
ion channels. 
 In Chapter 3, I present mapping and classification of the prage gene and mutation. 
Although this gene encodes a predicted exonuclease and has previously been described as having 
roles in egg activation, my RNA-seq data and phenotypic analyses indicate that prage may play 
roles primarily in oogenesis, with little direct effects on the process of egg activation. 
 In Chapter 4, I present analysis of the cytoplasmic Gld-2 family PAP wispy in a large-
scale transcriptomics study initiated by Jun Cui (2008). Our microarray data indicate that 
cytoplasmic polyadenylation through WISP activates a very large portion of the extant 
maternally stored mRNAs both at egg maturation and at egg activation. 
 In Chapter 5, I examine the role of a second Gld-2 family PAP, Gld2. Interestingly, this is 
the only Gld-2 family member identified to date with roles exclusively in the male germline. I 
discovered that instead of having roles in oogenesis or egg activation, Gld2 is expressed in the 
testes and is required for post-meiotic spermatogenesis. Investigation into the evolutionary 
history of these genes revealed that Gld2 arose from a duplication of the wispy locus.  
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 Chapter 6 is a brief discussion of my thesis work with suggestions for future directions. 
 Appendix A contains a comprehensive list of all pharmacological reagents used in our lab 
to test the requirement of calcium during egg activation. This list summarizes the experiments 
and results spanning approximately 10 years of the project described in Chapter 2. 
 Appendix B contains all supplemental tables of gene ontology analysis from the 
microarray data described in Chapter 4. 
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CHAPTER 2 
 
A CONVERGENT CALCIUM RISE TRAVERSES THE DROSOPHILA OOCYTE DURING 
EGG ACTIVATION2 
 
2.1  Introduction 
The oocyte is, in many ways, unlike any cell type in the body. This highly specialized 
cell, once fertilized, will become totipotent, yet in many organisms the oocyte must remain 
quiescent for many years. The resting oocyte within the ovary is filled with maternally-provided 
stores of mRNAs and proteins that will drive embryogenesis and cell divisions prior to zygotic 
genome activation; its cell cycle is stalled in a species-specific stage of meiosis (typically 
metaphase I or II); its vitelline membrane is amenable to penetration by sperm and small 
molecules (Horner and Wolfner, 2008a; Raz and Shalgi, 1998). The mature oocyte remains in 
such a state until it is ready to be ovulated and fertilized; this quiescence period ranges from days 
in fruitflies to decades in humans.  
The series of events that leads to actualization of the oocyte’s developmental potential is 
collectively termed “egg activation”. In the vertebrates and marine invertebrates in which it has 
been studied activation is sparked by a rise in cytosolic Ca2+ levels that is triggered by the 
fertilizing sperm (Miao et al., 2012; Roux et al., 2006; Xu et al., 1994). Depending on the 
organism, this Ca2+ rise sweeps through the egg in a single wave or in multiple oscillations, but 
in all cases the results are the same: meiosis resumes, changes occur to the vitelline envelope, 
and mRNA and protein pools undergo modifications and turnover (Stricker, 1999; Whitaker, 
2 I acknowledge Professor Toshiro Aigaki, Taro Kaneuchi, and Misato Okajima (Tokyo Metropolitan University) 
for helpful collaborations on this project. GCaMP fly stocks used in these experiments were created by Taro 
Kaneuchi. 
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2006). Evidence from other organisms such as mice and frogs indicates that the rise in Ca2+ 
likely starts a signaling cascade through calcium-dependent kinases and phosphatases such as 
CamKII and calcineurin, which may have myriad effects on downstream events to produce all of 
the hallmarks of egg activation (Ducibella et al., 2006; Markoulaki et al., 2003). 
In nearly every organism studied, egg activation occurs at fertilization and requires a 
fertilizing sperm. In these cases, the sperm either introduces a specific isoform of phospholipase 
C (PLC) (as in mice (Saunders et al., 2002)), or sperm binding activates a Src-family kinase and 
in turn activates PLC (as in echinoderms (Giusti et al., 1999)); active PLC induces 
phosphoinositide signaling and ultimately results in release of Ca2+ from stores in the egg’s 
endoplasmic reticulum (ER) (Saunders et al., 2002; Swann et al., 2006). However, there are 
several examples of organisms whose eggs undergo activation in the absence of sperm: eggs of 
some insect species such as fruitflies activate during passage through the female reproductive 
tract, before the sperm is introduced (Heifetz et al., 2001). In addition, parthenogenetically-
reproducing organisms do not require sperm for egg activation to occur. I am interested to 
discover the requirement of Ca2+ during egg activation in such cases. 
Drosophila is a very useful and unique model for this egg activation since its egg 
activation is separable from fertilization (Doane, 1960). This allows a view of egg activation 
events driven solely by maternal processes, which will be of interest to the larger scientific 
community studying oocyte quality as well as fertility and infertility. Aside from this difference, 
we know that Drosophila egg activation is signaled through many of the same pathways and 
components as in other organisms: the requirement for calcineurin (Horner et al., 2006; Takeo et 
al., 2010; Takeo et al., 2006), likely involved in the initial transmission of the calcium signal, is 
conserved, as are the activities of CDC20 (Drosophila cortex) in meiotic resumption (Swan and 
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Schupbach, 2007), GLD-2 (Drosophila wispy) in cytoplasmic polyadenylation (Barnard et al.; 
Benoit et al., 2008; Cui et al., 2008; Kadyk and Kimble), and MAPK in signal transduction (Choi 
et al. 1996; Sackton et al., 2007). Furthermore, approximately 80% of proteins that undergo 
phosphomodulation at egg activation in Drosophila are conserved across species and may 
indicate a conserved function at egg activation (Krauchunas et al., 2012). Together with the 
sophistication of genetic tools and ease of manipulation of this organism, Drosophila is an 
excellent model system for the study of egg activation. 
Our lab has previously shown that activation of Drosophila oocytes occurs in the oviduct 
(Heifetz et al., 2001), likely involves some mechanosensitive component, and requires Ca2+ in 
the extracellular environment (Horner and Wolfner, 2008a). In this study, I further explore the 
dynamics of Ca2+ flux within the activating egg. Our lab has made previous attempts to image 
this phenomenon using a variety of fluorescent sensors, but those attempts were unsuccessful 
because the high autofluorescence of Drosophila oocytes resulted in a signal-to-noise ratio too 
low to reliably detect a true calcium flux (V.L. Horner thesis, 2008). Studies of calcium flux 
during egg activation in many other organisms use fluorescent sensors injected directly into the 
cytosol of the egg; however, injection poses a problem for Drosophila oocytes, since the pressure 
of a needle puncturing the egg or the liquid introduced during injection could itself induce 
activation. Therefore, monitoring Ca2+ at egg activation in Drosophila requires a diffusible or 
genetically encoded calcium sensor. Several lab members including myself have attempted use 
of diffusible sensors including Rhod-2, Fluo-4, and Calcium Orange (Invitrogen) (Vanessa 
Horner, Amber Krauchunas, unpublished data). However, in these studies we noticed that the 
fluorescent compounds were unable to diffuse into the egg, possibly because of Drosophila’s 
complex eggshell. Therefore, we explored genetically encoded sensors. Many fluorescent 
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calcium sensors are engineered from the calcium binding protein calmodulin, which undergoes 
conformational change when bound to calcium. Calmodulin-based calcium sensing tools 
typically encode a calmodulin protein linked to GFP or other fluorophore (Whitaker 2010). 
When calcium is not present, the fluorophore is weakly fluorescent. When calcium binds this 
chimera, the conformational change in calmodulin shifts the shape of the fluorophore such that 
fluorescent intensity increases. Vanessa Horner had previously attempted imaging using two 
such chimeras, GCaMP (Tian et al. 2009) and Cameleon (Miyawaki et al. 1997) (expressible in 
the GAL4-pUAS system), to visualize calcium dynamics in the activating egg. However, the 
UAS constructs that allow expression in the Drosophila soma work poorly in the female 
germline (Duffy, 2002; Rorth, 1998). The genetically encoded constructs we were working with 
were poorly expressible in the female germline. I later tried combining the same pUAST-
GCaMP with a stronger maternal germline GAL4 driver. Though I could sometimes see an 
increase in fluorescence upon egg activation, the signal was very low and difficult to reproduce. 
To overcome these issues, we collaborated with Toshiro Aigaki’s lab at Tokyo 
Metropolitan University. They created two GCaMP lines expressible at high levels in the female 
germline: pUASP-GCaMP and GCaMP driven directly behind the nanos promoter. Using these 
lines for live imaging of oocytes undergoing in vitro activation, my collaborators and I 
discovered two converging waves of Ca2+ increase that occur during egg activation. Incubation 
of activating oocytes in vitro in the absence of Ca2+ or with inhibitors of specific parts of the 
calcium release or uptake machinery indicate that this wave is not dependent upon release of 
internal Ca2+ stores, but instead requires external calcium, and the activity of channels in the 
egg’s plasma membrane. My data suggest that these channels are likely mechanosensitive 
channels of the TRP family. 
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2.2  Materials and Methods 
Live imaging of oocytes. Oocytes were imaged using a Zeiss 710 LSM in Cornell’s Core facility. 
The Zeiss 710 LSM is an inverted confocal microscope capable of holding a petri dish. Oocytes 
were dissected from females carrying two copies of GCaMP driven by the nanos promoter 
(developed by Toshiro Aigaki and Taro Kaneuchi) and induced to activate in vitro following 
methods similar to those previously described (Horner and Wolfner, 2008a; Page and Orr-
Weaver, 1997). For imaging, a single oocyte was placed in a drop of isolation buffer (IB) (Page 
and Orr-Weaver, 1997) in a glass-bottomed dish (MAT-TEK). Imaging parameters were then set 
on the scope using ZEN software. The gain on the 488 channel was set to 700, the pinhole was 
fully opened, and the laser power was set to 10% (laser power will need to be adjusted depending 
on the age of the laser). The experiment was programmed as a time series, obtaining one image 
every 20 seconds for approximately 100 cycles. Line averaging for each image was set to 4. 
Zoom was set to 0.6 so that an entire egg could fit within the imaging field. All imaging was 
done with a 25x objective. Once parameters were set and the egg was in focus, I flooded the dish 
with approximately 1mL of PIPES-based activation buffer (AB) (Horner and Wolfner, 2008a) 
and began imaging. Occasionally, if I was unable to see any increase in calcium signal in the egg 
with the controls, I added a few drops of ddH2O (thus increasing the osmotic pressure inside the 
egg). 
Drug and inhibitor treatment 
Removal of external Ca2+: BAPTA [1,2-bis(2-aminophenoxy)ethane-N,N,N’,N’-tetraacetic acid 
tetrapotassium salt] (Sigma-Aldrich) was used to chelate trace amounts of calcium from IB and 
AB. IB and AB were prepared without the addition of CaCl2, and sucrose was instead added to 
these buffers to match the osmolarity of control buffers, which were prepared normally. BAPTA 
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was added to IB and AB as previously described (Horner and Wolfner, 2008a) to buffer Ca2+ to 
levels below 50nM. 
Inhibitors of Ca2+ entry or release: Stock solutions of wortmannin (PI3K inhibitor), U73122 
(PLC inhibitor), N-(p-Amylcinnamoyl)anthranilic Acid (ACA) (broad TRP channel inhibitor), 
GdCl3 (stretch-activated channel inhibitor), and ruthenium red (ryanodine receptor and selective 
TRP blocker) were prepared and added to IB and AB on the day of the experiment. Oocytes were 
dissected and incubated in drug-treated IB or control IB for 30 minutes before beginning the 
experiment. Inhibitor-treated oocytes were then activated in AB also containing the inhibitor, and 
oocytes incubated in control IB were activated in control AB lacking the inhibitor. Final 
concentrations of inhibitors used are as follows: wortmannin, 1µM or 5µM (De Nadai et al., 
1998); U73122, 10µM or 20µM (Lee et al., 1998; Sato et al., 2000); ACA, 10µM or 20µM 
(Harteneck et al., 2007); GdCl3, 10µM, 100µM, 200µM, or 400µM (Hardie, 2007; Horner and 
Wolfner, 2008a); Ruthenium red, 10µM. Control solutions made in parallel were prepared 
normally. 
2.3  Results 
Ca2+ waves traverse the Drosophila oocyte during egg activation 
Using GCaMP as a fluorescent indicator of Ca2+ concentration, we observed an increase 
in cytosolic Ca2+ levels during egg activation in vitro in Drosophila oocytes. Oocytes were 
dissected in isolation buffer (IB), a solution hypertonic to the egg that maintains the egg in a 
dehydrated, inactivated state. For imaging, the dish was flooded with AB, a solution hypotonic to 
the egg, which causes egg hydration, swelling, and activation. We observed two converging 
waves of increased cytosolic Ca2+ concentrations after addition of AB, after the egg began to 
swell. In most cases, a wave initiated first from the anterior, followed shortly afterwards by a 
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secondary increase initiating from the posterior. Ca2+ increased in a wave moving toward the 
middle of the oocyte from either pole, creating a bidirectional wave of calcium flux through the 
cytosol. Fluorescence peaked, maintained a brief plateau, and then decreased in the same 
bidirectional manner (Figure 2.1). Total time from wave initiation to peak fluorescence was 
approximately 15 minutes, and waves typically began within 10 minutes of adding AB, though 
they occasionally took longer to begin. If I did not see a wave beginning within 30 minutes, I 
was usually able to initiate a wave by adding 1-5 drops of deionized H2O.  I hypothesize that the 
addition of water to the activating solution causes greater hypotonicity of the solution to the egg, 
resulting in further egg swelling, which may be critical for egg activation as further discussed 
below (Horner and Wolfner, 2008a). 
The Ca2+ wave is not dependent upon release from internal stores 
In most organisms studied to date, the first calcium wave that occurs at egg activation 
occurs through release of Ca2+ from ER stores within the egg through phosphoinositide 
signaling. To test whether this was also the case in Drosophila oocytes, I performed imaging of 
in vitro activation in oocytes treated with inhibitors of PI3K (wortmannin) (Figure 2.2) and PLC 
(U73122) (Figure 2.3), which diminishes the calcium wave at egg activation in mice and sea 
urchin (De Nadai et al., 1998; Deng et al., 1998) (for a review see (Whitaker, 2006)). Using 
either treatment, I did not observe an increase in cytosolic Ca2+ following the same dynamics as 
that observed in untreated control oocytes observed in parallel. Because the wave dynamics 
remain intact when phosphoinositide signaling is compromised, I conclude that the mode of 
cytosolic Ca2+ influx in Drosophila oocytes differs from that of other organisms during egg 
activation and is not sourced from internal ER Ca2+ stores.  
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Figure 2.1. Calcium dynamics during egg activation in Drosophila melanogaster.  Eggs of 
Drosophila melanogaster show a rise in cytosolic Ca2+ during in vitro activation, as indicated by 
GCaMP fluorescence. In control samples, the rise initiates at either pole and travels toward the 
center of the egg. Time is measured in minutes:seconds. 
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Figure 2.2. Wortmannin does not affect the Ca2+ wave at egg activation.  Oocytes treated 
with 1-5µM wortmannin show an intracellular Ca2+ flux similar to that seen in control oocytes 
during egg activation. Time is measured in minutes:seconds. 
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Figure 2.3. U-73122 does not affect the Ca2+ wave at egg activation.  Oocytes treated with 10-
20 µM concentrations of the PLC inhibitor U-73122 show an intracellular Ca2+ flux similar to 
that seen in control oocytes during egg activation. Time is measured in minutes:seconds. 
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Figure 2.4. Ruthenium red does not affect the Ca2+ wave at egg activation.  Oocytes treated 
with 10 µM concentrations of the ryanodine receptor inhibitor ruthenium red show an 
intracellular Ca2+ flux similar to that seen in control oocytes during egg activation. Time is 
measured in minutes:seconds. 
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Ca2+ can also be released from ER stores through activation of the ryanodine receptor on the ER 
plasma membrane. To test the possibility of this receptor in Drosophila egg activation, I 
performed in vitro egg activation with eggs treated with ruthenium red, an inhibitor of the 
ryanodine receptor. The Ca2+ flux was also unchanged when eggs were treated with ruthenium 
red, indicating that ryanodine receptor activity is not required for egg activation (Figure 2.4). 
Ca2+ influx requires extracellular calcium 
Since the Ca2+ rise is not dependent on internal calcium stores, I examined the possibility 
that calcium enters the oocyte from the external environment. Previous studies indicated that 
Drosophila oocytes cannot undergo in vitro activation in buffers depleted of Ca2+ (Horner and 
Wolfner, 2008a), suggesting that calcium from external sources was necessary to activate the 
eggs. This suggested that the source of calcium for the wave might be external. To test the 
requirement of extracellular calcium, I performed in vitro activation in buffers depleted of Ca2+ 
using the Ca2+ chelator BAPTA. Cytosolic Ca2+ levels did not increase in oocytes incubated in 
BAPTA-treated buffers, though egg swelling did occur (Figure 2.5). Control buffers prepared in 
parallel were able to elicit the Ca2+ rise. This result indicates that the Ca2+ rise requires calcium 
in the extracellular medium. 
Extracellular Ca2+ enters the oocyte through mechanosensitive channels 
Previous studies indicated that mechanical stress may be a trigger for egg activation in 
Drosophila and some other insects. For example, pressure and squeezing applied to Drosophila 
or wasp eggs can be sufficient for egg activation (Horner and Wolfner, 2008a; Went and Krause, 
1974). Horner et al. (2008) previously showed that the stretch-activated ion channel blocker and 
heavy metal gadolinium inhibits egg activation in Drosophila. To test whether this also interferes 
with the Ca2+ rise, I incubated dissected oocytes in concentrations of GdCl3 ranging from 10µM  
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Figure 2.5. Chelation of ions using BAPTA inhibits the Ca2+ wave at egg activation.  
Oocytes activated in Ca2+-depleted buffers containing BAPTA do not show an intracellular Ca2+ 
flux, though egg swelling does occur. Time is measured in minutes:seconds. 
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Figure 2.6. Moderate to high concentrations of gadolinium inhibit the Ca2+ wave at egg 
activation.  Oocytes treated with 100-400 µM concentrations of gadolinium do not show an 
intracellular Ca2+ flux, though egg swelling does occur. Time is measured in minutes:seconds. 
 38 
  
 
 
 
 
 39 
  
 
 
 
 
 
 
Figure 2.7. The TRP channel inhibitor ACA inhibits the Ca2+ wave at egg activation.  
Oocytes treated with 10-20 µM concentrations of ACA do not show an intracellular Ca2+ flux, 
though egg swelling does occur. Time is measured in minutes:seconds. 
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Figure 2.8. Low concentrations of gadolinium do not inhibit the Ca2+ wave at egg 
activation.  Oocytes treated with 10 µM concentrations of ACA show an intracellular Ca2+ flux 
similar to that of controls. Time is measured in minutes:seconds. 
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to 400µM in IB before imaging in AB also containing GdCl3. Oocytes treated with 100-400µM 
GdCl3 did not show an increase in cytosolic Ca2+ during egg activation (Figure 2.6), whereas 
control samples tested in parallel showed the stereotypical bidirectional Ca2+ flux. This result 
indicates that Ca2+ likely enters the oocyte through mechanosensitive ion channels. Interestingly, 
treatment of oocytes with 10µM GdCl3 was unable to inhibit the Ca2+ flux during egg activation 
(Figure 2.8). Some Ca2+ channels are more sensitive to gadolinium than others; for example, 
TRP-L channels are known to be insensitive to low concentrations (10µM) of gadolinium but 
sensitive to higher concentrations (100µM). 
Several mechanosensitive channels may be present in the Drosophila oocyte plasma 
membrane (for a review see (Sartain and Wolfner, 2013)). Some genes of the transient receptor 
potential (TRP) family encoding mechanosensitive ion channels are expressed in the ovary, but 
their role has not been assessed during Drosophila egg activation. I used a broad-spectrum 
blocker of TRP-type channels, ACA, to see if inhibition of TRP channels would affect the 
dynamics of the calcium wave during egg activation. I incubated oocytes with 10µM ACA in IB 
for 30 minutes before activating in AB containing ACA. ACA-treated oocytes could not produce 
the Ca2+ flux during in vitro egg activation, though egg swelling did occur (Figure 2.7), whereas 
untreated controls were able to produce the wave as previously observed. This strongly suggests 
that calcium enters the oocyte through mechanosensitive TRP channels during egg activation. 
2.4  Discussion 
Egg activation is a conserved set of events among animal species. This transition prepares 
an oocyte for successful embryogenesis through completion of meiosis, restructuring of the 
vitelline membrane, and changes to the existing protein and mRNA pools within the oocyte. 
Drosophila egg activation is different from the more commonly studied cases of vertebrate and 
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marine invertebrate egg activation in that it is decoupled from fertilization. Yet despite this 
critical difference, we have found that calcium remains a constant requirement, even in this 
species. Together with previous data (Horner and Wolfner, 2008a), we have demonstrated in this 
study that even though the mechanism of calcium rise differs, it is still a requirement for egg 
activation and a wave still occurs. Additionally, since many signaling pathways and events 
downstream of the calcium signal appear to be conserved between Drosophila and other species, 
we propose that Drosophila is an important model system for studying this process. Drosophila 
offers the unique perspective allowed by the ability to perform activation without fertilization as 
well as ease of genetic manipulation and larger-scale “omics” studies. 
This study has confirmed that a rise in cytosolic Ca2+ occurs during egg activation in 
Drosophila. In agreement with previous studies (Horner and Wolfner, 2008a), we found that 
calcium is required in the extracellular environment for the rise to occur, and that blocking or 
inhibiting mechanosensitive channels also blocks the calcium influx. Additionally, we and others 
have observed that eggs tend to swell during activation. The conditions in vivo may be such that 
the oocyte takes up fluid during its passage through the oviduct: mature oocytes in the ovary 
have a somewhat shriveled appearance, but laid eggs appear swollen and taut. In our in vitro 
experiments, we noticed that the calcium wave does not initiate until after the egg has begun to 
swell. Additionally, we were able to increase the speed of initiation by adding a few drops of 
water to the activating medium during imaging, thus increasing hypotonicity and causing faster 
egg swelling. We believe that swelling exerts a stretch tension force on the membrane, which 
triggers the opening of mechanosensitive Ca2+ channels. Our experiments indicate that this is 
likely a TRP family calcium channel, evidenced by inhibition of the calcium flux by ACA and 
gadolinium. Further experiments will be needed to determine the particular type of channel and  
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Table 2.1. Expression of mechanosensitive channels in the adult ovary.  
 
 
 
Expressed 
(high, moderate, low 
Not expressed 
TRP trpm, trpml, pain 
trp, trpg, trpl, nompc, nan, iav, 
trpa1, pkd2, trpml 
DEG/ENaC rpk, ppk28 
ppk, ppk4, ppk6, ppk7, 
ppk10, ppk11, ppk12, ppk13, 
ppk14, ppk16, ppk19, ppk20, 
ppk21, ppk23, ppk28 
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its localization on the egg cell surface, though we do know that at least three TRP family 
channels are expressed in the ovary [painless (TRPA1), trpm (TRPM3), and trpml 
(TRPP1/Pdk2)] (Table 2.1) . It is possible that the channels are localized only to the poles of the 
egg; this would allow the type of converging wave we observed in this study.  
Alternatively, it is possible that the egg cytoskeleton is less rigid on the poles of the egg, 
which might allow greater tension forces to be experienced there during egg swelling, thus 
opening those calcium channels first. During egg swelling, pressure on the egg membrane due to 
uptake of fluid would be experienced uniformly throughout the oocyte. However, because the 
egg is essentially a prolate spheroid, greater stretch tension would be experienced in the middle 
of the egg rather than at the ends of the egg, so if channels are uniformly localized in the plasma 
membrane we might expect stretch activated channels in the middle of the oocyte to open before 
those at the poles (Regen). However, different cytoskeletal makeup at the poles may cause 
tension to be experienced differently there, and in this way channels spread uniformly throughout 
the plasma membrane may open first at the poles. Further experiments will be required to 
determine why the wave initiates at the poles. 
Recent evidence from mice indicates that a requirement for external Ca2+ is not unique to 
insects like Drosophila. In fact, after the initial Ca2+ rise induced by sperm PLC in mice, further 
calcium oscillations require Ca2+ uptake from the extracellular environment through a store-
operated Ca2+ entry mechanism (Miao et al., 2012). Here, when intracellular ER Ca2+ stores are 
depleted, plasma membrane channels open to allow Ca2+ back into the cell. Though Drosophila 
egg activation does not appear to utilize intracellular Ca2+ stores, a similar Ca2+ entry mechanism 
may be at play. 
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 In other organisms in which the signaling pathway has been studied downstream of the 
Ca2+ influx, an increase in intracellular Ca2+ ultimately causes meiotic resumption and, if the egg 
has been fertilized, embryonic mitoses. Interestingly, the early embryonic mitoses in Drosophila 
occur in a convergent wave that initiates at either pole and moves inward (Parry et al., 2005), 
much like the Ca2+ flux demonstrated in this chapter. Although the downstream signaling 
pathway has yet to be completely understood in Drosophila, this supports the hypothesis that the 
Ca2+ influx triggers the events of egg activation including cell cycle resumption. Future work 
should aim to link the Ca2+ flux to downstream egg activation events.
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 CHAPTER 3 
PHENOTYPIC AND TRANSCRIPTOMIC ANLAYSIS OF EGGS FROM PRAGE MUTANT 
MOTHERS DURING EGG ACTIVATION3 
3.1  Introduction 
Mature oocytes undergo major cellular changes at fertilization. Oocytes within the ovary 
are stalled at a species-specific stage of meiosis and are stocked with many maternally-
contributed nutrients, RNAs, and proteins. At the egg-to-embryo transition (upon fertilization in 
most animals), the mature oocyte undergoes a series of changes collectively known as “egg 
activation”, including changes to vitelline membrane, meiotic resumption/completion, and 
modifications to the existing RNA and protein pools. These changes are critical for blocking 
polyspermy, for pronuclear formation, and for appropriate embryonic patterning and 
morphogenesis. 
Drosophila melanogaster affords a unique perspective on egg activation, notably because 
in this model, fertilization is not required for egg activation to occur. Instead, egg activation 
occurs during passage through the oviduct, prior to fertilization (Heifetz et al., 2001). Thus, we 
are able to study the events of egg activation decoupled from fertilization and embryogenesis. 
This has allowed for the identification of many genes required for regulation of this major 
cellular transition. Of importance to this study, several X-linked loci were identified in a screen 
for mutants that could not complete egg activation properly, using maternal transcript stability as 
a marker of proper activation (Tadros et al., 2003). From this screen, several conserved genes 
essential for egg activation were identified and have gone on for further study, including wispy 
3 This project was a collaboration between several members of the lab: Jun Cui mapped the prg mutations and Yun-
Wei Lai performed expression studies. 
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(wisp), a poly(A) polymerase required for translational activation of stored transcripts ((Benoit et 
al., 2008; Brent et al., 2000; Cui et al., 2008) and Chapter 4), and the Pan Gu Kinase (PNG) 
complex (Tadros et al., 2007; Vardy and Orr-Weaver, 2007) [including giant nuclei (gnu) and 
plutonium (plu)], which also regulates translation of stored mRNAs. 
Regulation, and specifically degradation, of maternally stored mRNAs is critical for 
several aspects of embryogenesis (reviewed in (Tadros and Lipshitz, 2005)). At egg activation, 
some cell cycle regulators must be eliminated in order for meiosis to resume and complete in 
preparation for pronuclear fusion and embryonic mitoses. In fact, many maternally-stored 
mRNAs that are degraded at egg activation have roles in cell cycle regulation, such as meiotic 
cyclins (Tadros et al., 2007). Without mechanisms to signal degradation of these cell cycle 
regulators, meiotic resumption at egg activation would not be possible. 
Regional degradation of transcripts within the mature oocyte or activating egg may be 
important for establishing patterning within the developing embryo. Precise localization of 
maternally-provided mRNAs is crucial for specifying embryonic axes. mRNA localization 
within the Drosophila oocyte can be accomplished in a number of ways. Some mRNAs, such as 
the transcript of the anterior determinant bicoid, are localized through tethering (Weil et al., 
2008). However, several transcripts that exhibit specific localization are initially present 
throughout the oocyte, and undergo massive destabilization during egg activation except in 
protected local areas. Transcripts that fall into this latter category include Hsp83, nanos, and Pgc 
(Bashirullah et al., 1999).  
A screen for X-linked female sterile mutations identified several loci that are required for 
maternal transcript destabilization in the early embryo (Tadros et al., 2003). We have 
characterized a new gene identified in this screen, prage (prg), whose mutant was reported to fail 
 50 
to degrade Hsp83 transcripts. We discovered that the prg gene encodes a protein with a predicted 
exonuclease domain. We performed RNA-seq to determine the extent of transcript 
destabilization in the absence of PRG function. However, this yielded only a modest number of 
hits. Further phenotypic analysis of egg activation events in eggs from prg mutant mothers 
indicate that PRG protein likely plays an important role in oogenesis rather than egg activation. 
3.2  Materials and Methods 
Fly stocks: Oregon-R P2 and w1118 were used as wild type stocks. prg16A/FM6 and prg32/FM6 
(Tadros et al., 2003) were kind gifts from W. Tadros and H. Lipshitz (Hospital for Sick Children, 
University of Toronto, Canada). Deficiency strains Df(1)BSC719/Binsinscy and three P-element 
insertion lines, P{Mae- UAS.6.11}CG42666GG01337, P{EPgy2}CG42666EY21466 and 
P{XP}CG42666d10828 (Bloomington Stock number CG14630, CG19337 and CG22483, 
respectively) were ordered from the Bloomington Stock Center (Indiana University). 
Df(1)BSC719/Binsinscy virgin females were crossed with FM7c males to get 
Df(1)BSC719/FM7c flies for maintaining the stock. Stocks were maintained on standard 
yeast/glucose medium at 25°C. 
Complementation test: Virgin females from each P-element insertion strain were crossed with 
prg males. Fertility of female progeny carrying P{Mae- UAS.6.11}CG42666GG01337/prg, 
P{EPgy2}CG42666EY21466/prg and P{XP}CG42666d10828/prg were scored for complementation. 
RNA extraction and RT-PCR: Total RNA was extracted from 3-5 day old adult 
males, adult females, and embryos collected 0-2, 2-4, or 4-6 hours after egg laying. cDNA was 
synthesized as described previously (Sartain et al., 2011). RT-PCR was performed to determine 
the expression patterns of prg transcripts. The primer sets for the PCR were: prg forward 5’- 
ATGGAGCAAATAACGAACTACTTCG -3’; prg reverse 5’-TCAGTCCGTCGTGGTAGTTG 
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-3’; 19337 forward 5’- GGGCGGGTAGTGGAGATA -3’; 19337 reverse upper 5’-
TCGGCTGTAAACGATGCT -3’; 19337 reverse lower 5’- AGCGAATGCTCTGCGTGT -3’; 
rp49 forward 5’- AGTATCTGATGCCCAACATCG -3’; rp49 reverse 5’-
TTCCGACCAGGTTACAAGAAC -3’. 
RNA-sequencing.  
Egg collection. Laid eggs were collected on grape plates as previously described. Briefly, 
approximately 100 control (prg32/FM6) or mutant (prg32/prg16A) females were placed in a bottle 
with 100 spermless males (sons of bw sp tud females (Boswell and Mahowald)) or normal fertile 
males (ORP2) in a reverse-cycle incubator overnight for mating. The following morning, females 
were allowed to lay eggs on grape plates for 1 hour, and then subsequent egg-lays were collected 
every 30 minutes. Eggs were placed in eppendorf tubes and frozen in liquid nitrogen at 0-30 
minutes or 2-2.5 hours after egg laying. 
RNA isolation. RNA from laid eggs was isolated using Trizol reagent (Invitrogen) as previously 
described (Sartain et al., 2011) and purified using RNeasy clean up kit according to the 
manufacturer's instructions. 
RNA-sequencing. RNA samples were sent to the Weill Cornell Medical College Epigenomics 
Core facility for library preparation and sequencing. Six samples (WT and mutant, three 
conditions each) were run in a single lane for HiSeq SR50 single read clustering. 
RNA-seq analysis. Sequencing data were aligned by WCMC Epigenomics Core using TOPHAT 
2.0. I ran the aligned reads through CuffDiff to get differential expression data using the default 
parameters (FDR=0.5). The command used was: 
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cuffdiff -o ./output -p 8 -L FM61,FM62,FM6fert,prg1,prg2,prgfert genes.gtf FM6_0-
30.bam FM6_2-230.bam FM6_FERT.bam PRG_0-30.bam PRG_2-230.bam 
PRG_FERT.bam 
 
3.3  Results 
The prage alleles carry nonsense mutations in CG42666 
Previously, two allelic mutations causing egg activation failure had been mapped to a 
relatively large region (1B4-1E2) of the X chromosome by Tadros and colleagues (Tadros et al., 
2003). We conducted deficiency mapping to determine the chromosomal locus of two mutation 
alleles, and sequenced these alleles to identify the molecular nature of the prg mutation. 
We first tested for complementation between the two prg mutant alleles, prg16A and prg32, 
and six deficiency lines in the 1B4-1E2 region available from the Bloomington Drosophila Stock 
Center. One line, Df(1)BSC719/Binsinscy, fails to complement both prg alleles, while another 
line, Df(1)A94/FM6, carrying a partially overlapping deficiency, complements both alleles. 
These results suggest that the prg mutation is in chromosome region 2B12-13. The ten genes that 
lie in this region were sequenced in both prg alleles. We found that both prg mutants have 
molecular lesions in the predicted ORF of CG42666, according to the latest annotation of the 
Drosophila genome (http://www.flybase.org). Both prg alleles have single base pair changes in 
the 3’ end of the transcript, shared by all six isoforms that exist in Drosophila. Interpro sequence 
analysis and classification identified a single conserved domain near the C terminal end of the 
CG42666 protein with terms “Exonuclease” (IPR006055), “Ribonuclease H-like domain” 
(IPR012337), and “Exonuclease, RNase T/DNA polymerase III” (IPR013520). In each prg 
mutation, a single coding codon changed to a stop codon resulted in a truncated protein of 72 
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amino acids (prg16A) and 373 amino acids (prg32) (Figure 3.1). Both truncated proteins lack the 
predicted exonuclease domain. 
To confirm that prg gene corresponds to CG42666, we carried out complementation tests 
of prg mutations with P-element insertions in CG42666. We tested for complementation between 
both prg mutant alleles (prg16A and prg32) and three P-element insertion lines available from 
Bloomington Stock Center. Two insertions, P{Mae UAS.6.11}CG42666GG01337 (Mae) and 
P{EPgy2}CG42666EY21466 (EPgy2), failed to complement either prg mutant allele. However, 
P{XP}CG42666d10828 (XP) unexpectedly complemented both prg alleles. We confirmed by RT-
PCR that this line had an insertion in CG42666 (Figure 3.2). Based on the gene structure 
described in Flybase, CG42666 contains six predicted isoforms (PE, PB, PD, PF, PC, PA). The 
insertions of Mae and EPyg2 are disrupted in all six isoforms, suggesting the universal effects of 
these two lines; however, XP is only inserted into regions found in one RNA isoform (PE). The 
simplest explanation is that XP insertion does not eliminate function of CG42666 gene, if some 
isoforms are still expressed normally and produce functional PRG protein. Whether functions of 
CG42666 isoforms can compensate for each other requires further study, but the results from 
Mae and EPgy2 insertion lines confirm that CG42666 is the prg gene. 
RT-PCR shows that prg (CG42666) is expressed in both males and females, and is 
present during early embryogenesis (Figure 3.3). High-throughput expression studies confirm 
this finding (Chintapalli et al., 2007). 
Oocytes from prg mutant mothers fail to undergo vitelline membrane reorganization 
Egg activation in laid eggs from prg mutant mothers was first studied in the Lipshitz lab 
(Tadros et al., 2003). There, embryos from prg mothers were observed to undergo proper 
vitelline membrane (VM) reorganization (crosslinking to create a hard, impenetrable eggshell)  
 54 
  
 
 
 
 
Figure 3.1  Schematic representation of prg alleles. Wild-type CG42666 gene (isoform A) 
encodes a protein of 761 a.a. prg16A and prg32 have nonsense mutations in the coding region that 
results in truncated protein of 72 a.a. and 373 a.a. respectively. 
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Supplementary Figure A.1 A map of P-element insertions relative to prg 
gene (CG42666) structure. Six isoforms (PE, PB, PD, PF, PC and PA) are shown in different 
lengths for both transcripts and cDNAs (CDS). The insertion sites of three P-element strains 
(P{XP}CG42666d10828, P{Mae-UAS.6.11}CG42666GG01337 and 
P{EPgy2}CG42666EY21466) are shown in a left to right order on the map (blue arrowhead). 
P{XP}CG42666d10828 only inserted into one gene isoform (PE) as described in the text. Map 
modified from Flybase (http://flybase.org/). 
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Figure 3.2  Presence of insertion, P{XP}CG42666d10828, in CG42666. (Yun-Wei Lai) 
Genomic DNA was extracted from ten 3-4 day old adult males and used for PCR analysis. 
RPL32 was used as an internal control for evaluating the relative amounts of cDNAs. Three 
different combinations of prg primers shown in the simplified diagram (upper) were used to 
detect prg transcripts: P1&P2 - test for the presence of CG42666 gene; P1&P3 - test for the 
presence of P-element insertion; P1&P3 - negative control. P{XP}CG42666d10828 is located in 
the predicted site, suggesting the presence of the insertion. 
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Figure 3.3  Expression patterns of prg transcripts. (Yun-Wei Lai) 
RT-PCR shows that prg is expressed in both whole males and females, and during early 
embryogenesis. RPL32 (rp49) is used as an internal control. 
 61 
  
 
 
 
 
 
 62 
and to resume and complete meiosis (Tadros et al., 2003). However, when we started working 
with the prg mutation, we observed that laid eggs from prg mothers do not behave the same as 
wild-type with regard to VM crosslinking events. To test eggs for activation, we and others use 
the “bleach resistance” test: incubate the eggs or embryos in a 50% bleach solution for two 
minutes; eggs that have activated should have undergone VM crosslinking, which makes them 
impenetrable to bleach, while eggs that have not activated will lyse in the bleach solution. I 
repeated these experiments with each mutant line (prg16A and prg32) separately and found that the 
eggs of females from neither mutant line were bleach resistant to wild-type levels. It is possible 
that each line gained some mutation over the last decade of maintenance in our lab, so I also 
tested laid eggs from transheterozygotic mutant mothers (prg16A/prg32) for bleach resistance. I 
found that while eggs from mutant mothers do not completely dissolve in a bleach solution like 
unactivated eggs, none of them appeared normal. After bleach treatment, 84 of 146 (57%) of the 
eggs from prg16A/prg32 mothers had not lysed completely, compared to 93 of 95 (98%) bleach 
resistance in wild-type samples.  
However, the “resistant” prg eggs did not appear normal. In wild-type, activated eggs that 
have undergone bleach treatment appear swollen and taut like oblong balloons. Furthermore, 
they are opaque white and have a distinct sheen on their surface. The prg eggs that did not 
dissolve after bleach treatment did not appear like wild-type: instead, they appeared deflated and 
translucent. Upon closer inspection with a dissecting scope, I noticed that some of the “eggs” 
appeared to have holes and tears in an otherwise intact but rough-looking membrane: they looked 
like ripped empty bags, as if the yolk had seeped out imperfections in the membrane (can be seen 
in confocal imaged in Fig 3.4C,D). I conclude that VM reorganization and possibly initial VM 
composition is not normal in eggs from prg mutant mothers. 
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Figure 3.4  Eggs from prg mutant mothers are defective for VM crosslinking and meiotic 
completion. Fertilized eggs collected 0-1 hour after egg laying normally show many dividing 
nuclei in wild type (A,B), indicating that egg activation has occurred normally and 
embryogenesis is underway. Eggs collected from prg mutant mothers 0-1 hour after egg laying 
do not contain mitotically dividing nuclei (C,D). Furthermore, many eggs have ripped or burst 
(asterisk in D), and the cell surface (vitelline membrane) appears rough and perforated. 
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Oocytes from prg mutant mothers fail to complete meiosis 
Tadros and colleagues (2003) previously observed that meiosis does not occur normally 
in eggs from prg mutant mothers, but did not provide any evidence to this point. I tested whether 
fertilized laid eggs from prg mutant mothers were able to being mitotic divisions. I bleached 
eggs from prg and ORP2 mated females 0-1 hour after egg laying, permeabilized and fixed them 
using heptane/methanol, and stained nuclei with DAPI. I was able to observe many mitotically 
dividing nuclei in eggs from wild-type mothers (Figure 4A,B), but was not able to detect nuclei 
in eggs from prg mothers (Figure 4C,D). I conclude that eggs from prg mutant mothers cannot 
enter mitotic divisions, and likely are defective for meiotic resumption. 
RNA-seq reveals putative targets of degradation by PRG 
Because prg encodes a putative exonuclease, we hypothesized that egg activation fails in 
prg mutants due to an inability to destabilize maternal transcripts at the appropriate time during 
development. To explore this hypothesis, we performed RNA-seq analysis to compare the 
presence of maternally deposited transcripts between mutant and wild-type samples. We sampled 
transcripts from freshly-laid unfertilized eggs (0-30 minutes after egg laying), aged unfertilized 
eggs prior to zygotic genome activation (ZGA) (2-2.5 hours after egg laying), and aged fertilized 
eggs prior to ZGA (2-2.5 hours after egg laying). While we did not observe great differences in 
transcript abundance in freshly laid unfertilized eggs, a modest number of genes showed excess 
transcripts in the prg mutant in aged unfertilized eggs (Table 3.1). Notably, among these was 
Hsp83. In the initial screen that first identified the prg mutation, Tadros and colleagues (2003) 
used Hsp83 maternal transcript degradation as a diagnostic marker of normal egg activation. 
They found that in prg mutants, Hsp83 transcripts are not properly destabilized at egg activation. 
Thus, the fact that Hsp83 is among the small number of genes identified in our RNA-seq  
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Table 3.1 Significant hits from comparison of unfertilized eggs from wild-type and prg 
mutant mothers 2-2.5 hours after egg laying. q-value is a representation of the p-value 
adjusted for multiple hypothesis testing. 
 
gene control prg fold change test_stat p_value q_value 
dhd 145.78 12997.2 6.47827 -5.73233 9.91E-09 0.000182838 
Hsp26 82.5635 3390.87 5.36001 -5.21289 1.86E-07 0.00147069 
26-29-p 19.5269 1294.82 6.05114 -5.1774 2.25E-07 0.00155735 
Hsp83 57.0172 1615.41 4.82436 -4.99563 5.86E-07 0.00249784 
CG6770 38.3399 3318.75 6.43565 -4.98725 6.12E-07 0.00251206 
osk 7.54558 374.58 5.6335 -4.3505 1.36E-05 0.0116145 
alphaTub67C 8.64095 692.788 6.32508 -4.24339 2.20E-05 0.0158069 
Hsp27 77.6815 1241.62 3.99851 -4.09153 4.29E-05 0.0246486 
Ahcy13 14.527 548.305 5.23817 -4.05857 4.94E-05 0.0269885 
RnrS 4.96371 650.018 7.03292 -4.02383 5.73E-05 0.0292221 
Gapdh2 18.6506 1868.32 6.64638 -4.01889 5.85E-05 0.0293002 
 
 67 
comparisons serves as an internal validation of our results. On the other hand, while comparisons 
between the aged fertilized groups also showed differences in mRNA levels for many genes, 
many of these results are not significant in the expected direction (i.e., greater abundance in prg 
than in controls) and are likely due to the possibility that prg embryogenesis has stalled before 
this timepoint while fertilized wild-type embryos are able to continue development. 
3.4  Discussion 
Egg activation in Drosophila is a complex set of events, the interdependency of which is 
not yet fully understood. At this critical period, the cell undergoes several major changes, 
including vitelline membrane restructuring, meiotic resumption, protein modification, and 
transcript turnover through degradation or polyadenylation/translation. While there is some 
evidence regarding the timing of the onset of each of these events, we do not yet know whether 
one event depends upon proper completion of any of the other events. In Drosophila, the initial 
trigger for egg activation is likely a mechanical stimulus that is exerted upon the oocyte during 
its passage through the oviduct (Heifetz et al., 2001; Horner and Wolfner, 2008a). The 
mechanical stimulus is believed to trigger the influx of calcium from the external environment,  
which then acts as the activating signal for all of the events of egg activation (Horner and 
Wolfner, 2008; Sartain et al., in prep). The incoming calcium signal may activate several 
pathways that independently result in each separate egg activation event, or the pathways may be 
linked such that a mutant that cannot properly reorganize the vitelline membrane will also not be 
able to complete meiosis. Alternatively, a mutant that has some fundamental flaw in the vitelline 
membrane may not be able to properly transmit the signal from the mechanical stimulation 
during passage through the oviduct, as proposed by Tadros and colleagues (2003). In the case of 
prg, there seems to be some fundamental problem with vitelline membrane reorganization during 
 68 
egg activation, but the flaw is not completely debilitating: While the activated egg does not 
appear “normal” like control samples (i.e., laid eggs from prg mutant mothers do not take on the 
sheen of wild-type eggs after bleach incubation), the egg does not completely lyse in bleach like 
unactivated eggs. It appears that eggs from prg mutant mothers can initiate some vitelline 
membrane crosslinking, but reorganization is not completely normal. 
Our RNA-seq data failed to return data that indicate that prg plays a major role in mRNA 
degradation during egg activation. According to previous studies, approximately 55% of the 
entire Drosophila genome is represented as mRNA in the mature oocyte (Tadros et al., 2007). 
Approximately 20% of maternally stored mRNA is degraded upon egg activation due to female 
components alone (i.e., occurs in unfertilized eggs without contribution from the sperm). We 
know that two-thirds of these destabilized transcripts are regulated through SMG and are 
enriched for elements critical for cell cycle regulation. The remainng one-third are enriched for 
genes required for oogenesis (Tadros et al., 2007). However, PRG targets identified by our RNA-
seq were not enriched for these categories. Interestingly, among the top hits in the RNA-seq data, 
some have previously been identified as SMG targets of degradation (deadhead, Hsp83), while 
others are cited as SMG-independent (oskar) (Tadros et al., 2007). Thus, it is possible that PRG 
acts independently of SMG, but the two are not mutually exclusive: for example, the exonuclease 
could act in concert with several different repressive elements to destabilize transcripts at egg 
activation. On the other hand, our RNA-seq data at may reflect secondary effects of prg loss-of-
function: If prg function is needed upstream of SMG machinery, then some of the hits are likely 
not direct targets of PRG (assuming PRG indeed acts as an exonuclease). Alternatively, we may 
consider the fact that smg mRNA must be translated upon egg activation, and this is regulated by 
PNG (and likely the PNG complex, which includes PLU and GNU) (Tadros et al., 2007); our 
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RNA-seq data indicate that GNU is present in greater amounts in eggs from prg mutant mothers. 
Therefore, smg mRNA may be translated to a greater extent in eggs from prg mothers, which 
may explain why SMG targets are identified in our RNA-seq. 
It is possible that the true requirement of prg is actually during oogenesis rather than egg 
activation. Our results indicate that prg is expressed in the female, in both the germline and the 
soma, and may be active in the ovary during oogenesis. If this is the case, prg might be required 
during the final stages of oogenesis, when the vitelline membrane and eggshell are synthesized 
around the oocyte. Here, the oocyte may still appear to have undergone normal development 
when observed in dissected ovaries, but any defects in eggshell composition may not become 
apparent until egg swelling and activation. Further analysis of timing of PRG function during 
development will be required to test this possibility. 
In conclusion, our study has further demonstrated that prg is necessary for egg activation. 
The vitelline membrane may not crosslink properly, meiosis fails to complete, and there are 
differences in the abundances of several mRNAs. Though the PRG protein contains an 
exonuclease domain, the extent to which PRG is required for degradation of maternal transcripts 
at egg activation is unclear. More experiments will be necessary to determine the precise role of 
PRG during egg activation.
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 CHAPTER 4 
 
CYTOPLASMIC POLYADENYLATION IS A MAJOR mRNA REGULATOR DURING 
OOGENESIS AND EGG ACTIVATION IN DROSOPHILA.4 
 
4.1 Introduction 
Most eukaryotic mRNAs are polyadenylated at their 3’ terminus in a nuclear process that 
is coupled to their transcription. The presence of a poly(A) tail on a transcript both enhances its 
cytoplasmic stability and promotes its translation. In some cell types, a subset of transcripts has 
been shown to undergo further poly(A) tail adjustment in the cytoplasm. Typically, these 
transcripts undergo poly(A) tail shortening, which attenuates their translation, yet they remain 
stably ‘stored’ in the cytoplasm. In response to the appropriate cellular signals, these transcripts 
can then be induced to undergo cytoplasmic poly(A) tail lengthening, enabling their subsequent 
translation. As such, cytoplasmic polyadenylation of stored transcripts allows for rapid protein 
production in the absence of de novo transcription, enabling a potent mechanism for regulating 
gene expression. 
The mechanism by which cytoplasmic polyadenylation is controlled has been studied in 
Xenopus oocytes (Mendez and Richter, 2001). Here, transcripts designated for poly(A) tail 
adjustments in the cytoplasm are marked by two cis-elements in the 3’UTR that interact with 
regulatory protein complexes, which include a poly(A) polymerase (PAP) as well as a 
ribonuclease that shortens the poly(A) tail. Upon a signal to activate translation, phosphorylation 
events within the protein complex cause the ribonuclease to be released (Kim and Richter, 2006). 
4 In revision as J. Cui, CV Sartain, JA Pleiss, MF Wolfner (2013) Developmental Biology. 
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The cytoplasmic PAP is then free to elongate the poly(A) tail of the transcript, thus promoting its 
translation. 
Important cellular and developmental transitions such as those during germline 
development rely on cytoplasmic poly(A) tail adjustments. For example, during late oogenesis 
and early embryogenesis prior to the maternal-zygotic transition, the transcriptional machinery of 
the cell is largely silent. Growing oocytes accumulate a large pool of maternal RNA molecules 
whose translation is repressed after their production and then activated post-transcriptionally 
through cytoplasmic polyadenylation for subsequent developmental progression during 
oogenesis and embryogenesis (Tadros and Lipshitz, 2005). Cytoplasmic polyadenylation that 
occurs in the germline is often mediated by the GLD-2 family of cytoplasmic PAPs. GLD-2 
homologs have been identified in many species, including worms, flies, mice and frogs (Benoit 
et al., 2008; Cui et al., 2008; Kwak et al., 2004; Nakanishi et al., 2006; Sartain et al., 2011). The 
GLD-2-type PAP in the Drosophila female germline is encoded by the wispy (wisp) gene (Benoit 
et al., 2008; Cui et al., 2008). In the absence of wisp function, several transcripts necessary for 
development do not undergo poly(A) tail lengthening and as a result these mRNAs fail to 
become translated in a wispy null mutant (Benoit et al., 2008). 
A candidate gene approach was previously used to identify specific maternal mRNAs that 
are subject to WISP-dependent cytoplasmic poly(A) regulation during Drosophila 
oocyte/embryo development (Benoit et al., 2008; Cui et al., 2008). Those studies focused on cell 
cycle regulators and maternal transcripts necessary for embryonic development as important 
WISP targets for cytoplasmic polyadenylation. However, the extent to which this process 
controls genome-wide regulation remained unknown. Here we describe a microarray-based 
approach designed to identify the full subset of maternal mRNAs that are targeted for WISP-
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dependent cytoplasmic polyadenylation. Our results indicate that WISP-dependent cytoplasmic 
polyadenylation is a major mechanism that regulates a wide spectrum of maternal mRNAs in the 
Drosophila female germline.  
4.2  Materials and Methods 
Drosophila stocks and sample collection: Male flies carrying the wisp null allele, wisp41 
(Cui et al., 2008) were crossed to Df(1)RA47/FM7c female flies. wisp41/FM7c (wild type control) 
or wisp41/Df (wisp-deficient) virgin female progeny were separated from males and aged on 
standard yeast/glucose medium until use. Stage 14 oocytes were hand dissected from 3- to 5-day-
old virgin females in hypertonic isolation buffer (Page and Orr-Weaver, 1997), which does not 
activate eggs. Virgin females that were 3 to 4 days old were mated to wild-type Oregon-R males 
and early embryos were collected 0- to 1-hr post egg deposition.  
Sample preparation and hybridizing of microarrays: For global transcript analysis, 
we prepared total RNA as well as polyA+-selected RNA for microarray analysis. For each 
sample, total RNA was extracted from ~2000 stage 14 oocytes or 0- to 1-hr embryos using the 
TRIzol reagent (Invitrogen, Carlsbad, CA).  Polyadenylated RNA was then isolated from total 
RNA using the Oligotex mRNA isolation kit (Qiagen, Valencia, CA) according to the 
manufacturer’s instruction. Sample preparation and hybridizing of microarrays was done as 
described (Pleiss et al., 2007), using 40 μg of total RNA or 800 ng of poly(A)-selected mRNA 
for cDNA synthesis. The purified cDNA was divided into halves. One half was conjugated to 
Cy3 and the other to the Cy5 fluorescent dye (GE Healthcare, Piscataway, NJ) to generate dye-
swap pairs. Dye conjugation was performed as described (Pleiss et al., 2007).  
Drosophila oligonucleotide microarrays (Agilent Design ID 18972, Agilent, Foster City, 
CA) were hybridized with labeled cDNA as described (Pleiss et al., 2007). Four groups of 
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comparisons were performed: WT vs. wisp total RNA from oocytes, WT vs. wisp total RNA 
from fertilized eggs, WT vs. wisp poly(A)-selected RNA from oocytes, WT vs. wisp poly(A)-
selected RNA from fertilized eggs. Each comparison consisted of three independent RNA 
extractions and each experiment was done with dye-swap pairs as two technical replicates.  
Image processing, data pre-processing and analysis: Microarray images were acquired 
and analyzed as described (Pleiss et al., 2007). The six different experimental replicates (three 
independent biological samples with dye-flipped technical replicates of each) comparing the total 
RNA samples of wild type and wisp mutant samples were processed largely according to 
standard procedures (Smyth and Speed, 2003). For each of the six microarrays, ‘within array’ 
normalization was accomplished using the LOESS implementation in the marray package in 
Bioconductor. No ‘between array’ processing was required to compare the six microarrays to one 
another. Processed data were then filtered according to expression level, excluding those features 
whose A-values were lower than 7.25 or greater than 15, and the remaining data were 
subsequently analyzed using Significance Analysis of Microarrays (SAM) to identify those 
genes whose expression was significantly changed in the mutant sample.  
Microarrays comparing poly(A)+ RNAs were processed differently. Our initial analyses 
of these data suggested that there was good correlation between each of the different 
experimental replicates, but that the dynamic range varied significantly between them (Figure 
S1). Because each of these samples was subject to poly(A)+ purification, the effectiveness of 
which cannot be easily assessed, the absolute level of ‘enrichment’ detected for any given 
transcript is likely to vary from one microarray to the next. To account for these different 
dynamic ranges, quantile normalization was used to adjust the data from each of the six 
experimental replicates (Smyth and Speed, 2003). Briefly, the data from each replicate 
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experiment were ranked from highest to lowest enrichment. From these lists, an average value 
was determined for each of the ranked positions. The average values were then re-assigned to the 
individual transcripts from each experiment according to their ranks (Figure S1). The validity of 
this approach was empirically confirmed using PCR-based polyA tail assays, as described below 
and in the Results section. After quantile normalization, we used SAM to identify genes that 
showed either enrichment or depletion within the poly(A)+ pool of wisp RNAs. Lists of enriched 
or depleted genes were tested by the DAVID Functional Annotation Bioinformatics Microarray 
Analysis (http://david.abcc.ncifcrf.gov/) to reveal over-represented Gene Ontology (GO) groups 
of annotated genes (Dennis et al., 2003).  
Quantitative PCR and poly(A) tail assay: Total RNA was prepared as described above. 
Synthesis of cDNA was done using the SuperScript II Reverse Transcriptase kit (Invitrogen) 
according to the manufacturer’s protocol. Quantitative real-time PCR was performed using an 
ABI Prism 7000 system (Applied Biosystems, Foster City, CA). Each reaction was prepared in a 
25 μl mixture containing 5 μl cDNA template, 0.2 μM of each primer and 1X SYBR Green 
Super Mix (Applied Biosystems). 
PCR-based polyA tail (PAT) assay was performed as previously described (Cui et al., 
2008).  PCR was performed on the PAT cDNAs using a gene-specific primer and the 
oligo(dT)12-anchor to assess the length of the poly(A) tail of a specific mRNA. PCR products 
from the PAT assay were separated on 8% acrylamide gels.  
Cross-linking and RNA immunoprecipitation: Early embryos (0- to 1-hr post 
deposition) were collected from Oregon-R P2 flies as previously described. These embryos were 
permeabilized and cross-linked by shaking at room temperature in a 1:3 mixture of 1.8% 
formaldehyde cross-linking solution [50 mM HEPES (pH 8.0), 100 mM NaCl, 1 mM EDTA, 0.5  
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Figure 4.S1 False-colored representation of (A) the raw oocyte poly(A)+ data, and (B) the 
same data after quantile normalization. In each case, the three biological replicates are 
indicated, along with their dye-flipped technical duplicates (labeled + and -). Our initial analyses 
of the raw data suggested a strong correlation between the six experiments, but also 
demonstrated the different range of enrichment values that were detected. In order to account for 
these between array variations we used a quantile normalization approach. 
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mM EGTA, 1.8% formaldehyde] and heptane. RNA immunoprecipitation was done using the 
method in (Keene et al., 2006) with modification. Cross-linked embryos were washed in 1 X 
PBST with 125 mM glycine and homogenized in the homogenization buffer [10 mM HEPES 
(pH 7.0), 100 mM KCl, 5 mM MgCl2, 0.5% Nonidet P-40 (NP-40, Sigma), 1 mM dithiothreitol 
(DTT), 100 U/ml RNasin RNase inhibitor (Promega), 2 mM vanadyl ribonucleoside complexes 
(VRC, Sigma), protease inhibitor cocktail (Roche)] at 4°C. Lysates were filtered using Miracloth 
(EMD Chemicals, Gibbstown, NJ) and then centrifuged at 1,500 g for 10 minutes at 4°C. Protein 
concentration of supernatants was adjusted to 2 mg/ml by diluting in the immunoprecipitation 
buffer as described (Keene et al., 2006). 
Protein A Sepharose beads (Sigma) were washed in the immunoprecipitation buffer with 
gentle shaking and centrifugation for 30 sec at 1,500 g. Egg extracts were pre-cleared with 50 μl 
of beads for 1 hr at 4°C, centrifuged at 1,500 g for 30 sec. The supernatant containing 5 mg of 
total proteins was incubated with 10 μg of anti-WISP antibody (Cui et al., 2008) or pre-immune 
serum (as control) and 50 μl of clean beads at 4°C with gentle rotating for 16 hr. The beads were 
collected with centrifugation and washed four times with the immunoprecipitation buffer and 
then four times with the immunoprecipitation buffer supplied with 1 M urea.  
Beads were incubated in the elution buffer [100 mM Tris-HCl (pH 8.0), 10 mM EDTA, 
1% sodium dodecyl sulfate (SDS), 40 U/ml RNasin RNase inhibitor] for 10 min with vortexing 
at 37°C and centrifuged at 1,500 g for 30 sec. The supernatants were treated with proteinase K 
(Roche) for 1 hr at 42°C and incubated for 1 hr at 65°C to reverse the cross-links. RNA was 
purified using TRIzol as described above. 
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4.3  Results 
The poly(A)+ transcriptome is altered in the absence of WISP function 
To determine the global changes in transcript polyadenylation status resulting from loss 
of WISP function, we used a microarray based approach to compare wild type and wisp null 
mutant samples at two different developmental stages: dissected stage 14 (mature) oocytes or 
fertilized activated eggs collected at 0- to 1-hr post egg deposition (hereafter referred to as “early 
embryos”). In an effort to distinguish between a change in the total level of a given transcript 
versus a change in its polyadenylation state, microarrays were performed that compared between 
the mutant and wild type flies either the total cellular RNA populations, or only those RNAs 
containing long poly(A) tails. Although conceptually similar to a previously described approach 
(Novoa et al., 2010), we undertook a different strategy to isolate these different populations (see 
Methods and/or SI for complete details). To compare levels of total RNA, independent of 
poly(A) state, between wild type and wispy strains, total cellular RNA was isolated and 
converted into cDNA using short, random oligonucleotides as primers for reverse transcriptase. 
Because these random primers initiate cDNA synthesis across the body of the transcript, 
conversion of RNA into cDNA occurs independent of the poly(A) status of the parent transcript. 
To address poly(A) state of these transcripts, portions of the same total cellular RNA preps were 
subjected to poly(A)+ purification using Oligotex mRNA isolation columns. Here we expect 
mRNAs with long poly(A) tails to bind the column more efficiently than those with short 
poly(A) tails. Notably, we previously observed that poly(A) tail lengths of WISP targets can 
become shorter in wisp null mutants (Cui et al., 2008). Therefore, we reason that the large 
difference in poly(A) tail length of a given target transcript between mutant and wild-type 
samples will result in differences in binding efficiencies between samples, such that the columns 
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will efficiently recover transcripts with long poly(A) tails in a wild-type sample, but will poorly 
recover the same targets with shorter tails in the wisp null mutant.  Multiple biological and 
technical microarray replicates were performed for each approach, and Significance Analysis of 
Microarrays (SAM) (Tusher et al., 2001)was used to identify RNAs whose total abundance was 
different between strains.  
Relatively few changes in transcript abundance were detected between the total RNA 
samples at either developmental point (Fig. 1A, C). In the stage 14 oocytes, only 5 probes, 
corresponding to 2 genes, were enriched by more than two-fold between mutant and control 
samples (and none was more than three-fold enriched). By contrast, 560 (9%) probes were 
downregulated by more than two-fold (including 206 which were more than three-fold) 
(summarized in Table 1). For the early embryos, the number of misregulated genes was lower 
still, with only 203 (4%) probes downregulated more than two-fold (only 32 of which were 
downregulated by more than three-fold) and no probes were significantly upregulated by more 
than two-fold. 
By contrast with our observations of the total RNA levels, the poly(A)+ RNA population 
from wild type was remarkably different from that of the wisp null mutant (Fig.1B, D). In stage 
14 oocytes, a total of 5849 probe sets (out of 14886, or 39%) detected on the microarrays were 
down regulated by at least two-fold, with 3298 of these showing down-regulation of at least 
three-fold. The 5849 probe sets further collapsed into 2613 unique genes (Table 1).  Remarkably, 
early embryos showed even larger changes with 11567 probe sets (out of 13208, or 88%) 
detected on the microarrays showing down-regulation of at least two-fold, and 9492 of these 
showing down-regulation of at least three-fold. The 11567 probe sets represented transcripts 
from 4171 genes (Table 1). 
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There was significant overlap between the probes downregulated among total RNA 
samples and the probes downregulated among poly(A)+ samples. In the oocyte dataset, where 
560 probes are downreglated by 2-fold or more, 87% are also decreased in abundance in the 
poly(A)+ dataset. In the embryo dataset, all 203 probes downregulated amongst total RNA are 
also downregulated in the poly(A)+ dataset. For these probes, we cannot distinguish between the 
possibility that their depletion in the poly(A)+ pools is a result of shortened poly(A) length 
leading to their degradation, versus a simple decrease in their overall abundance. Nevertheless, 
these results are consistent with our general expectation that difference in total mRNA 
expression between the mutant and wild type should be similarly reflected in the poly(A)+ 
samples. By contrast, the remainder of the probes that are downregulated in the poly(A)+ pool 
did not show a significant difference in total mRNA expression between the wild type and 
mutant strains, strongly suggesting that their behavior in these poly(A)+ microarrays reflects a 
shortening of their poly(A) tails.  
Among the 4171 putative WISP targets detected in early embryos, 2318 (56%) 
overlapped with the putative targets detected in stage 14 oocytes. These results are consistent 
with a model in which these RNAs have shorter poly(A) tails in wisp null mutants than controls 
during oogenesis, and the short poly(A) tails of these mRNAs are sustained in wisp mutants until 
after egg activation in the early embryos. However, we cannot rule out the possibility that they 
could be regulated by cytoplasmic polyadenylation during both oogenesis and egg activation. 
Some mRNAs such as the cyclin B transcript are known to undergo two rounds of 
polyadenylation (Benoit et al., 2005; Vardy and Orr-Weaver, 2007b). It is possible that other 
genes could be regulated in the same way as cyclin B mRNA. The remaining 1856 probe sets  
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Table 4.1 SAM analysis of genes that show ≥2-fold significant change in abundance.  
 
 
Higher in WT Higher in wisp- Array Total 
Probes Genes Probes Genes Probes Genes 
Oocyte 
Total 560 359 5 2 
14886 6359 
Oocyte 
polyA 5849 2613 2 2 
Embryo 
Total 203 133 0 0 
13208 5697 
Embryo 
polyA 11567 4171 0 0 
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Figure 4.1 Polyadenylated transcriptome is altered in the absence of WISP function. 
Histograms of global comparisons between wild type and mutant show that for the majority of 
transcripts analyzed, total RNA abundance is not affected by the absence of WISP in stage 14 
oocytes (A) or early embryos (C). However, within polyadenylated RNA populations, many 
transcripts are present in higher abundances in wild type than in wisp mutants in oocytes (B) and 
early embryos (D), indicating an overall downregulation of polyadenylated RNA in oocytes and 
embryos of wisp mutant mothers.
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were only detected as WISP regulated targets in early embryos, suggesting that their poly(A) 
tails undergo WISP-dependent elongation only upon egg activation.  
Poly(A) tail length assays confirm the microarray results 
Because of the challenges associated with analyzing the poly(A)+ microarray data (see 
Materials and Methods), we sought to examine directly the poly(A) tail lengths of putative 
targets from each group using a PCR-based poly(A)-tail (PAT) test (Salles et al., 1994). We 
chose to test target sets that represented the full range of positive hits predicted by the microarray 
data, according to rank order of statistical significance as determined with SAM, and use these 
data to help establish the subset of high-confidence targets of WISP. For stage 14 oocytes, we 
chose nineteen putative WISP egg maturation targets identified above, ranging in rank from 6 to 
4077 (Table 2): CG4880, CG11971, Klp10A, CG8180, klp67A, CDC6, sced, mei-S332, geminin, 
AurB, sse, cyclin A, HSF, sce, psq, mr, bifocal, eIF4G, and CG5316. Two previously known 
WISP-regulated RNAs, dmos and cyclin B (Benoit et al., 2008; Cui et al., 2008), appeared on our 
list (ranks 260 and 1083, respectively) and were included as positive controls. Similarly, in early 
embryos we chose twenty putative target mRNAs ranking in significance from 19 to 6551 (Table 
2): pimples, punt, spinster, CG8485, costa, Bj1, CG5262, CG2921, CG33298, Pp1a-96A, 
ubcE2h, tango11, Dsor1, CG8180, grapes, string, CG10209, mei-p26, CG8370, and CG34398. 
Two previously known WISP-regulated RNAs, bicoid and Toll (Benoit et al., 2008; Cui et al., 
2008), were also identified on our list (ranks 2293 and 3313, respectively) and included as 
positive controls. As shown in Figure 2 and Table 2, the poly(A) tail shortening of ~40 to ~120 
nts was seen for all positive controls and the vast majority of the test mRNAs in the absence of 
WISP. Remarkably, the top 16 candidates in oocytes, representing the top ~3000 target 
transcripts, all showed shortened poly(A) tail length in wisp mutants by the PAT assay, 
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suggesting a high true positive discovery rate for the microarray data. Similarly, 17 of the 20 
candidates tested in early embryos confirmed the shortened tail phenotype, demonstrating that 
upwards of ~6000 transcripts have shortened poly(A) tails in early embryos of the wisp null 
mutant. 
Due to the difficulty associated with amplifying the entire length of the poly(A) tail for a 
given transcript of interest, the PAT assay itself is subject to a high false negative discovery rate. 
For example, previously uncharacterized alternative 3’UTR isoforms have been discovered in C. 
elegans and likely exist in other model organisms (Jan et al., 2011). Such alternative isoforms 
could impede PCR amplification of 3’UTR and poly(A) tail regions, causing the transcript-
specific primers of the PAT assay to either not bind (shorter isoforms) or to be too far upstream 
for the allowed extension time (longer isoforms). As such, it remains unclear whether the few 
candidates that failed to show decreased poly(A)+ tail lengths in the absence of WISP by PAT 
assay are, in fact, false positive discoveries from the microarray, or whether their true 3’UTRs 
are simply misannotated in the sequence databases, leading to unclear PAT assay results. In the 
oocyte set, all 16 of the tested candidates within the top ~3000 most enriched showed clear 
poly(A) tail shortening in the absence of WISP, after which the success rate dropped off (Table 
2). For these data, we thus posit that the limit of the reliable microarray data is reached at or near 
the 3000 transcript mark. Interestingly, SAM revealed approximately 3000 transcripts that are 
upregulated by 3-fold or more among control poly(A)+ RNA populations, thus supporting 
inclusion of data within this limit. By contrast, three of the transcripts from the early embryo set 
failed to demonstrate poly(A) tail shortening in the absence of WISP by the PAT assay in spite 
of sometimes strong enrichment on the microarrays. However, there is a strong overall 
confirmation rate within the early embryo data set through the entire list of ~6000 transcripts.  
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Table 4.2. PAT assay validation of selected candidate target mRNAs. 
Oocyte 
 
Gene name Transcript ID Rank 
Score(d) PAT 
assay 
CG4880 CG4880-RA 6 4.76 + 
CG11971 CG11971-RA 23 4.15 + 
Klp10A CG1453-RE 38 4.02 + 
CG8180 CG8180-RA 39 4.01 + 
klp67A CG10923-RA 40 4.01 + 
CDC6 CG5971-RA 83 3.82 + 
sced CG3273-RA 103 3.76 + 
mei-S332 CG5303-RA 170 3.59 + 
dmos* CG8767-RA 260 3.45 + 
geminin CG3183-RA 369 3.31 + 
AurB CG6620-RA 540 3.16 + 
sse CG10583-RA 709 3.05 + 
cyclin B* CG3510-RA 1083 2.84 + 
cyclin A CG5940-RA 1247 2.77 + 
HSF CG5748-RD 1557 2.66 + 
sce CG5595-RA 1896 2.56 + 
psq CG2368-RI 2968 2.28 - 
mr CG3060-RA 3225 2.21 - 
bifocal CG1822-RB 3899 2.06 + 
eIF4G CG10811-RB 4013 2.03 + 
CG5316 CG5316-RB 4077 2.02 - 
Embryo 
 
Gene name Transcript ID Rank 
Score(d) PAT 
assay 
pimples CG5052-RA 19 4.18 + 
punt CG7904-RA 197 3.76 + 
spinster CG8428-RB 300 3.67 - 
CG8485 CG8485-RD 492 3.55 + 
costa CG1708-RA 600 3.48 - 
bj1 CG10480-RA 737 3.43 + 
CG5262 CG5262-RA 787 3.40 + 
CG2921 CG2921-RA 998 3.33 + 
CG33298 CG33298-RB 1087 3.30 - 
Pp1alpha-
96A CG6593-RA 1376 
3.21 
+ 
ubcE2h CG2257-RA 1569 3.16 + 
tango11 CG30404-RB 1674 3.13 + 
Dsor1 CG15793-RA 2146 3.03 + 
CG8180 CG8180-RA 2164 3.03 + 
bicoid* CG1034-RE 2293 3.00 + 
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grapes CG17161-RA 2346 2.99 + 
string CG1395-RA 2477 2.96 + 
Toll* CG5490-RA 3313 2.78 + 
CG10209 CG10209-RA 3738 2.69 + 
mei-p26 CG12218-RA 5702 2.29 + 
CG8370 CG8730-RA 6476 2.13 + 
CG34398 CG34398-RC 6551 2.11 - 
*previously identified WISP target 
+ Shift in electrophoretic mobility due to WISP 
- No shift in electrophoretic mobility due to WISP 
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Figure 4.2. Poly(A) tails are shorter in the absence of WISP function. Poly(A) tail length of 
mRNAs was assessed in stage 14 oocytes (A) or activated eggs (B) using gene-specific primers 
in PAT assays, including four ribosomal protein mRNAs and ten mRNAs. Bars indicate the 
longest products produced by PAT. “Predicted targets” are those predicted from our microarray 
data. “Known targets” and “non-targets” were identified previously as WISP targets or WISP 
independent (respectively) by Benoit et al. (2008) and Cui et al. (2008). 
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SAM revealed more than 8000 transcripts that are present at levels 3-fold more or higher in the 
poly(A)+ RNA population of controls compared to that of wisp mutants. 
We noticed that in wisp deficient oocytes all the tested mRNAs retain a short poly(A) tail 
of ~10 to ~40 nt, depending on the specific mRNA. This observation has been reported 
previously for bicoid mRNA in wisp mutants (Cui et al., 2008). The residual tail likely results 
from the function of the nuclear poly(A) polymerase, encoded by the hiiragi gene, which is 
active in early oogenesis (Benoit et al., 2008).  
qPCR also validates the shortened poly(A) tails in wisp mutants 
To further validate the microarray results, we used real-time quantitative PCR (qPCR) to 
quantify the RNA levels of selected candidates in both the total RNA and poly(A)+ pools. In 
stage 14 oocytes, seven mRNAs from the above list were chosen: CG4880, klp10A, mei-S232, 
CG11971, CG8180, klp67A, and geminin. CG12065 was used as a negative control. Two 
previously known WISP-dependent RNAs, dmos and cyclin B, were used as positive controls 
(Benoit et al., 2008; Cui et al., 2008). We used qPCR to assess the abundance of poly(A) RNA 
versus total RNA for these mRNAs in wild type and wisp oocytes and plotted the ratio of 
poly(A)+ RNA/total RNA for each transcript. As shown in Figure 3A, all seven putative targets 
and both positive controls, but not the negative control, showed a decreased ratio of poly(A)+ 
RNA/total RNA in the wisp mutant compared to wild type, suggesting that wisp null mutant 
affected the poly(A) tail length of these mRNAs. 
In early embryos, we tested seven candidates from the above list: cyclin A, string, grapes, 
Bj1, ubcE2h, CG8180, and pimples. CG3083 was used as a negative control. Two previously 
known WISP-regulated RNAs, bicoid and Toll were used as positive controls in the experiment. 
As shown in Figure 3B, all seven putative targets and two positive controls, but not the negative  
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Figure 4.3. Polyadenylated transcripts are depleted in the absence of WISP. qPCR analysis 
measures the poly(A)+ RNA abundance, shown as a proportion of the total RNA abundance in 
stage 14 oocytes (A) or activated eggs (B). Results from wild type oocytes (unfilled bars) and 
from wisp deficient oocytes (filled bars) are shown for two biological replicates and one 
technical replicate. Error bars indicate standard deviation. 
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control, showed a decreased ratio of poly(A)+ RNA/total RNA in the wisp null mutant compared 
to wild type, suggesting that wisp mutant affected the polyadenylation of these mRNAs. 
Functional relevance of genes regulated by WISP in stage 14 oocytes  
We performed Gene Ontology (GO) annotation analysis to determine which functional 
groups of genes are over-represented in putative WISP targets in mature oocytes using DAVID 
(http://david.abcc.ncifcrf.gov/) (Dennis et al., 2003). Only genes whose poly(A)+ transcript levels 
were greater by 2-fold or more in controls than in wisp mutants were included in this analysis. 
The total list of probes identified on the array for the mature oocyte poly(A)+ sample was used as 
the background sample. GO analysis revealed that “cell cycle” related genes made up the top 
category within Biological Process (P value=1.23E-22; Bonferroni-adjusted=2.84E-19) [for a 
full list of terms see Tables B1 (>2-fold) and B2 (>3-fold)]. These groups include genes that 
encode cell cycle regulators, such as cyclins (cyclin A, cyclin B, cyclin B3, cyclin D and cyclin 
E) and checkpoint regulators (wee and polo kinases). The enrichment of cell cycle related genes 
can be linked to the phenotypes observed in oocytes produced from wisp mutant mothers. One 
such example is klp3A, which encodes a kinesin-like protein that is required for pronuclear 
migration at the end of meiosis (Williams et al., 1997). Previously we observed that the female 
pronucleus does not migrate in wisp mutant (Cui et al., 2008). This phenotype could be due to 
the lack of translation of klp3A mRNA when its poly(A) tail fails to lengthen in the absence of 
WISP function. 
Top categories in Molecular Function are “DNA binding” (P value =3.71E-17; 
Bonferroni-adjusted 3.16E-14) and “zinc ion binding” (P value =2.75E-11; Bonferroni-adjusted 
2.35E-08) (Table B2). Emerging evidence suggests that zinc is critical for proper development of 
oocytes. During maturation, mouse oocytes accumulate over twenty billion zinc atoms, which 
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are exocytosed in up to five rapid release events during egg activation (Kim et al., 2011). Zinc 
function is critical for progression of oocytes through the meiosis I–meiosis II transition in 
mouse oocytes (Bernhardt et al., 2011). In Drosophila oocytes, zinc-binding proteins are also 
enriched and are modulated by phosphorylation or dephosphorylation during egg activation 
(Krauchunas et al., 2012).  
Using the KEGG pathway identifier in GO analysis, we found that members of the 
ubiquitination machinery were highly enriched among the WISP-regulated RNA groups in 
oocytes (P = 1.57E-07; Bonferroni-adjusted 1.38E-05) (Table B2). Among these are two E1 
ubiquitin-activating enzymes, 14 E2 ubiquitin-conjugating enzymes, and most subunits of the 
two major multi subunit E3 ubiqitin ligase complexes, Cullin-Rbx and Anaphase-promoting 
complex (APC/C) (annotations from KEGG PATHWAY Database, 
http://www.genome.jp/kegg/pathway.html). Regulatory protein degradation plays important roles 
in oocyte development. In Xenopus oocytes, the E3 ubiquitin ligase APC/C degrades XErp1 
protein, one component of the cytostatic factor, and this degradation causes the release of meiotic 
arrest (Wu and Kornbluth, 2008). The APC/C is also involved in the activation of meiotic 
progression in Drosophila oocytes. A mutation of the cortex gene, which encodes a female 
meiosis-specific activator of APC/C, results in the accumulation of Cyclin A protein and blocks 
meiotic progression (Pesin and Orr-Weaver, 2007). Polyadenylation of cortex mRNA occurs 
during oocyte maturation (Pesin and Orr-Weaver, 2007) and this polyadenylation depends on 
WISP function (Benoit et al., 2008). Our finding suggests that the ubiquitination machinery is 
probably activated as a consequence of cytoplasmic polyadenylation during late oogenesis, thus 
allowing cell cycle progression at egg maturation. 
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WISP-regulated RNAs are also associated with the “progesterone-mediated oocyte 
maturation” pathway (P = 1.16E-04; Bonferroni-adjusted 1.02E-2) (Table B2), a pathway that 
has been characterized previously in Xenopus (Belloc et al. 2008). In Xenopus, a signal from 
progesterone ultimately results in cytoplasmic polyadenylation and subsequent translation of 
stored mRNAs, which plays a central role in activating oocyte maturation in Xenopus (Belloc et 
al., 2008). Drosophila oocyte maturation does not involve progesterone, but the goal of oocyte 
maturation—release from one meiotic arrest point and progression to the next meiotic arrest 
point—remains conserved. Therefore, it is not surprising that some of the factors in the Xenopus 
progesterone-mediated oocyte maturation pathway, such as those that regulate cell cycle 
dynamics, would also be required during Drosophila egg maturation. Like the Xenopus oocyte 
maturation pathway involving MAPK and MOS, we have found that MAPK activity is high in 
Drosophila oocytes, and that mos mRNA is among WISP targets at egg maturation (Cui et al., 
2008), further confirming conservation of key signaling events at egg maturation between 
Drosophila and Xenopus. In contrast to Xenopus, however, Drosophila MOS is not required for 
completion of meiosis (Ivanovska et al., 2004). 
Genes that were identified as downregulated in the total RNA population (Table 1) are 
enriched for many of the same functional categories as those in the poly(A)+ population, 
including cell cycle and chromosome organization categories (Table B3); this is expected, since 
many transcripts that are downregulated in total RNA are shared in the poly(A)+ group. 
Functional relevance of genes regulated by WISP in early embryos 
We also searched for enriched functional groups among the genes that are WISP 
regulated in early embryos after egg activation. Enriched functional categories within Biological 
Process are indicative of cellular changes that occur during egg activation, including 
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“reproductive cellular process” (P value =4.32E-10; Bonferroni-adjusted 1.36E-06), “protein 
amino acid phosphorylation” (P value =6.36E-07; Bonferroni-adjusted 2.00E-3), and “pattern 
specification process” (P value =7.23E-06; Bonferroni-adjusted 2.25E-2) [for a full list of terms 
see Tables B4 (>2-fold) and B5 (>3-fold)]. Top-ranking categories in Cellular Compartment 
suggest that chromosome-related proteins are enriched in WISP targets (P value =1.36E-14; 
Bonferroni-adjusted 8.29E-12), which may reflect release from meiotic arrest and progression to 
embryonic mitotic cell cycles. Top categories in Molecular Function are “zinc ion binding 
proteins” (P value =7.16E-14; Bonferroni-adjusted 1.02E-10) and “protein kinase activity” (P 
value =2.41E-08; Bonferroni-adjusted 3.43E-05), which likely relate to the signaling events that 
initiate and coordinate the process of egg activation.  
GO analysis identified the functional group “pattern specification process” (Table B5). 
This group includes components that function in patterning the embryo, such as bicoid, Toll, 
torso, caudal, gurken, hunchback, nanos, oskar, pumilio, and trunk. Posttranscriptional 
regulation of axis patterning genes in Drosophila embryos has been documented, and some of 
these genes’ transcripts are already known to be regulated at the level of cytoplasmic 
polyadenylation. For example, translation of oskar mRNA in the embryo’s posterior is activated 
by cytoplasmic polyadenylation (Castagnetti and Ephrussi, 2003; Chang et al., 1999). 
Additionally, the maternally supplied hunchback mRNA poly(A) tail elongates to about 70 
nucleotides in early embryos; this correlates with the increase of its translation (Wreden et al., 
1997). Furthermore, changes in poly(A) tail length of bicoid has been described previously 
(Salles and Strickland, 1999) and attributed to WISP function (Benoit et al., 2008; Cui et al., 
2008). Although some of these pattern formation genes are already known to be targets of 
regulatory polyadenylation, it was not known that others are also regulated in a poly(A)-
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dependent manner. Our GO analysis reveals that transcripts of pattern specification genes 
comprise a major class among the total number of WISP targets at egg activation. 
Because some target transcripts identified in early embryos were also identified as WISP 
targets in mature oocytes, we additionally analyzed the subset of transcripts that are unique to the 
embryo array and were not identified as targets in the mature oocyte array. GO analysis indicates 
that transcripts from genes involved in embryogenesis and morphogenesis are enriched within 
this subset, but not to the level of our significance cut-off. 
Functional relevance of RNAs that are not regulated by WISP 
 We also performed GO analysis on the sets of genes whose transcripts were not affected 
by WISP in oocytes and early embryos. Genes involved in mitochondrial cellular respiration 
were highly represented in both oocyte and embryo sets (Table B6). The most highly enriched 
functional categories within Biological Process include “oxidation reduction” for oocytes (P 
value =2.98E-9; Bonferroni-adjusted 8.51E-6) and “oxidative phosphorylation” for early 
embryos (P value =7.68E-21; Bonferroni-adjusted 7.19E-18) (Table B6). Similarly, enriched 
functional categories within Cellular Compartment included “mitochondrial respiratory chain” 
for both oocyte (P value =2.16E-5; Bonferroni-adjusted 1.21E-2) and embryo (P value =1.62E-
17; Bonferroni-adjusted 3.99E-15). Genes within these groups for both data sets include subunits 
of cytochrome C oxidase (CoIV, CoVa, CoVb, CoVIb, and CoVIIc) as well as energy metabolism 
enzymes such as aldehyde dehydrogenase (Aldh) and glutamate dehydrogenase (Gdh). These 
results indicate that while WISP regulates many cellular changes during egg maturation and egg 
activation, genes and transcripts governing basic cellular energy requirements are not affected in 
a WISP-dependent manner. The mitochondrially-encoded gene mt:ND2 was also found among 
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the genes that are not WISP-regulated, indicating that transcripts from the mitochondrial genome 
likely remain unaffected. 
Target RNAs can be co-immunoprecipitated with WISP 
With such a large part of the maternal transcriptome showing poly(A) tail shortening in 
the wisp mutant, the question arises whether these transcripts are direct targets of WISP. 
Although GLD-2-type poly(A) polymerases do not have RNA binding domains (Wang et al., 
2002) and they are believed not to bind RNA directly, GLD-2 proteins can be recruited to the 
target mRNA by forming complexes with certain RNA binding proteins (Barnard et al., 2004; 
Kim et al., 2009; Wang et al., 2002). It has also been shown that WISP protein and RNA are in 
the same ribonucleoprotein (RNP) complex in ovarian extracts (Benoit et al., 2008). It is likely 
that mRNAs directly regulated by WISP will also be found in such WISP-containing RNP 
complexes.  
We used RNA immunoprecipitation (Keene et al., 2006) to determine whether a subset of 
putative WISP targets were associated with WISP-containing RNPs. Cytoplasmic extracts were 
made from wild type early embryos, and WISP-containing RNPs were immunoprecipitated from 
these extracts using an immobilized polyclonal anti-WISP antibody (Cui et al., 2008); pre-
immune serum was used in parallel as a negative control. We used real-time quantitative RT-
PCR to examine the enrichment of RNA that was immunoprecipitated with WISP. Test mRNAs 
included seven known targets of WISP (Benoit et al., 2008; Cui et al., 2008) as well as three 
targets identified in this microarray study and confirmed with PAT assays in Figure 3C. All of 
the ten test mRNAs were enriched by >2-fold in the WISP IP compared with the mock IP (Fig. 
4). Neither of the two negative control mRNAs, rpA1 and CG3083, were significantly enriched  
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Figure 4.4. WISP forms a complex with candidate target mRNAs. Embryos collected at 0- to 
1-hr post deposition from wild type flies were fixed and cross-linked in formaldehyde for RNA 
immunoprecipitation. Cytoplasmic extracts from these embryos were incubated with an 
immobilized polyclonal anti-WISP antibody or pre-immune serum (negative control). mRNAs 
enriched in the IPs were isolated and used to synthesize cDNA. RT-PCR was performed to test 
enrichment of mRNAs in the WISP IP vs. control IP. All data were normalized to RpL32. The 
average of two biological replicates and one technical replicate are shown. Error bars indicate 
standard deviation. 
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in WISP IP. This suggests that the ten WISP-targeted mRNAs and WISP protein are co-present 
in the same RNPs and they are likely to be directly regulated by WISP. 
4.4  Discussion 
Our study demonstrates that cytoplasmic polyadenylation is a powerful mechanism for 
facilitating cellular change. Post-transcriptional control through poly(A) tail elongation has been 
observed previously on several maternal mRNAs in the cytoplasm of Drosophila oocytes and 
early embryos. Importantly, experimental evidence demonstrates that this polyadenylation is 
necessary for protein production: the test-case mRNAs that fail to get polyadenylated in wisp 
null mutants also fail to get translated in these mutants (Benoit et al., 2008).  Previous studies of 
cytoplasmic polyadenylation in oocytes and embryos had tested a very limited number of 
candidate genes encoding transcripts that were expected to be WISP-regulated at these stage (e.g. 
cell cycle and patterning genes). In the study described here, we show that rather than being 
limited to a small group of specific maternal mRNAs, cytoplasmic polyadenylation is a major 
regulatory mechanism widely used on many maternal mRNAs at two distinct developmental 
stages in Drosophila. These mRNAs fail to elongate their poly(A) tails when the GLD-2 class 
cytoplasmic poly(A) polymerase WISP is not functional, suggesting these maternal mRNAs are 
putative targets of the cytoplasmic polyadenylation machinery during normal development.  
During oogenesis, large amounts of gene products are packed into the developing oocyte, 
where they must remain quiescent until activation of embryonic development. However, there 
are changes that occur in the developing oocyte during late oogenesis that may require the 
activation of some of these gene products for completion of egg development. Prior to oocyte 
maturation in Drosophila, the oocyte arrests in prophase I of meiosis, and can remain arrested for 
several days. At maturation during late oogenesis, this arrest is relieved and the oocyte 
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progresses to metaphase I, where it will arrest once more until the mature oocyte is ovulated. It 
has been shown that oocyte maturation involves the polyadenylation and translational activation 
of some transcripts involved in cell cycle control: PAN GU kinase activates both 
polyadenylation and translation of cyclin A mRNA, which promotes cell cycle progression into 
prometaphase (Vardy et al., 2009). Poly(A) tail elongation of cyclin B mRNA also occurs during 
oocyte maturation. About 100 to 120 adenosine residues are added to its mRNA (Benoit et al., 
2005; Vardy and Orr-Weaver, 2007b). This polyadenylation is mediated by the Drosophila 
homologs of known cytoplasmic polyadenylation machinery including WISP, and is believed to 
activate the translation of cyclin B for the exit from prophase I arrest. In the current study, we 
show that transcripts from over 2000 genes are likely regulated in a similar manner by WISP 
during late oogenesis. A substantial subset of these genes is involved in cell cycle control and 
chromosome organization, consistent with the cellular events that take place during oocyte 
maturation. Our validation studies confirm that most of the targets identified in our microarray, 
such as separase and CDC6, are indeed polyadenylated in a WISP-dependent manner during 
oogenesis. Interestingly, heat shock factor and the translation initiation factor eIF4G were also 
identified and confirmed as targets of WISP-dependent polyadenylation, indicating that 
activation of the more general regulators of cellular activity may also be critical while major 
cellular changes like maturation are underway. 
 After maturation, the Drosophila oocyte remains arrested at metaphase I of meiosis until 
the egg is ovulated. Ovulation induces a set of events collectively known as egg activation 
(Heifetz et al., 2001), which includes meiotic resumption, changes in stored proteins’ 
phosphorylation states, and transcript degradation or translation. These events prepare an oocyte 
to begin embryogenesis. Using a candidate-based approach, previous studies have found that 
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transcripts of several genes involved in embryonic patterning are regulated by cytoplasmic 
polyadenylation, including bicoid, torso, Toll, and hunchback (Salles et al., 1994; Wreden et al., 
1997). Our data suggest that over 4000 maternally-supplied transcripts undergo WISP-dependent 
polyadenylation in the cytoplasm of activating eggs, and translation of these transcripts likely 
facilitates the varied events of egg activation. In addition to embryonic patterning genes, mRNAs 
encoding cell cycle components such as grapes (Chk1 homolog), string (CDC25 homolog) and 
Bj1 (Rcc1 homolog) also undergo poly(A) tail extension during this period, and likely participate 
in meiotic resumption or subsequent embryonic mitoses. A striking finding from our early 
embryo data is the prevalence of targets involved in signal transduction. In many species, egg 
activation is triggered by a rise in intracellular calcium, often induced by factors in the fertilizing 
sperm. This calcium rise sets off a signaling cascade that ultimately results in the events of egg 
activation. In Drosophila, fertilization is not necessary for egg activation (Doane, 1960; Heifetz 
et al., 2001), though calcium signaling is still required for most events including meiotic 
resumption (Horner and Wolfner, 2008a). It is plausible that cell signaling factors are 
translationally activated by WISP in order to carry out downstream signaling events. Our GO 
analysis identified enrichment of genes with functions relating to ion binding and 
phosphorylation, which may indicate changes in enzymatic function leading to signal 
transduction. In our validation tests, we positively identified the kinases Dsor1 (MEK) and 
Mekk1 as well as the phosphatase Pp1α-96A as WISP targets at egg activation. Activation of 
these classes of proteins could be responsible for signaling events at egg activation, as well as the 
wide range of changes in proteins’ phosphorylation states following egg activation (Krauchunas 
et al., 2012). 
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Our microarray study has revealed that cytoplasmic polyadenylation can be a major 
regulator of cellular change. The regulation of oogenesis and egg activation by a GLD-2-
dependent mechanism is not restricted to Drosophila, nor is the phenomenon of cytoplasmic 
polyadenylation in general unique to the female gametes. However, the number of WISP targets 
identified in our microarray—well into the thousands at two different developmental periods—is 
greater than any group of GLD-2 targets identified to date. The cytoplasmic polyadenylation 
machinery has been well dissected using Xenopus oocytes, where xGLD2 has been studied 
during oocyte maturation (Barnard et al., 2004). Here, similar to the case in Drosophila, xGLD2 
is known to elongate the poly(A) tails of several mRNAs, such as those encoding Cyclin B and 
Mos, thus activating their translation (Barkoff et al., 2000; Stebbins-Boaz et al., 1996). Studies of 
the mouse GLD-2 homolog have also been performed. While mouse GLD-2 is present in the 
female germline during meiosis, knockout of mouse GLD-2 has no effect on egg maturation, 
suggesting that there may be a functionally redundant protein at play if cytoplasmic 
polyadenylation is a major regulator at this time (Nakanishi et al., 2006). As in Drosophila, C. 
elegans GLD-2 is involved in meiotic progression and embryogenesis (Kadyk and Kimble, 1998; 
Wang et al., 2002). Interestingly, C. elegans GLD-2 targets a different set of transcripts 
depending on the RNA-binding protein with which it is partnered (Kim et al., 2009; Kim et al., 
2010). RIP-chip studies indicate that the C. elegans GLD-2 homolog has approximately 550 
targets in whole adults, but the enzyme acts only on 335 of these when bound to the binding 
partner RNP-8 (Kim et al., 2010). Previous studies have identified the GLD-3 homolog Bic-C as 
a WISP binding partner in the Drosophila female germline (Benoit et al., 2008; Cui et al., 2008). 
Given a different binding partner, or in a different tissue, a GLD-2 enzyme may activate 
distinctive sets of target transcripts beyond those identified by our microarray study. 
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GLD-2s and other families of cytoplasmic PAPs also act outside of the female germline. 
The Drosophila genome encodes a second GLD-2 homolog, a paralog of wispy, that acts during 
post-meiotic spermatogenesis (Sartain et al., 2011). The same paralog has a second function in 
the brain, where it is required for long-term memory storage (Kwak et al., 2008), and there are 
other examples of vertebrate cytoplasmic PAPs that are required for gene expression at axon 
synapses (Rouhana et al., 2005). Finally, non-GLD-2 PAPs have also been identified in the 
mouse male germline (Kashiwabara et al., 2000). These findings indicate that the cytoplasmic 
polyadenylation system is a widely used mechanism for generating a quick protein production 
response in cell types that must undergo rapid changes, such as a firing neuron or an activating 
oocyte. Our findings that WISP regulates thousands of genes in this way demonstrates that the 
effects of cytoplasmic polyadenylation in a single cell can be very large-scale; thus, control of 
cytosolic mRNAs through cytoplasmic polyadenylation is a crucial mechanism for allowing 
coordinated, synchronous cellular change. 
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CHAPTER 5 
THE POLY(A) POLYMERASE GLD2 IS REQUIRED FOR SPERMATOGENESIS IN 
DROSOPHILA MELANOGASTER5 
5.1  Introduction 
Spermatogenesis is a tightly controlled developmental process that requires stage-specific 
production of proteins.  In animals, spermatogenesis begins when a diploid cell produced from 
the testis stem cell niche undergoes differentiation and proliferation though mitosis and meiosis 
to form many haploid spermatocytes.  Post-meiotic development, called spermiogenesis, is a 
series of morphological changes that will determine the final shape and form of the mature 
sperm; the latter can vary greatly among taxa.  One important phenomenon that is seen in 
spermatogenesis in many species is that transcription is silenced for part of the process:  for 
example, transcription cannot occur after nuclear condensation in mice (Braun, 1998), and there 
is some evidence for transcriptional silencing during meiosis in Drosophila (Vibranovski et al., 
2009).  In such cases, any proteins that must be translated during the transcriptionally silent 
period must be synthesized from mRNAs that were transcribed earlier but remain untranslated 
until the appropriate stage of development.  Furthermore, some transcripts needed for late 
spermiogenesis, such as those for don juan (Santel et al., 1997) and Mst87F (Schafer et al., 
1990), are synthesized in spermatocytes, though they are not translated until much later. 
Spermatogenesis in Drosophila melanogaster is well described.  Testis gonial cells 
originating from germline stem cell divisions undergo synchronous mitosis and meiosis with 
incomplete cytokinesis, resulting in a cyst of 64 round haploid spermatids after the completion of 
meiosis (Fuller, 1993; Fuller, 1998) (Fig. 1).  The spermatids undergo morphological changes 
5 Published and reprinted with permission: CV Sartain, J Cui, RP Meisel, MF Wolfner (2011) Development 
138, 1619-1629. 
 107 
                                                        
including flagellum extension and nuclear reshaping within the syncytium, until spermatid 
individualization occurs.  The cells exit the testis as mature sperm. 
During the final stages of spermatogenesis in Drosophila, as in many other invertebrate 
and vertebrate species, chromatin reorganization events cause the spermatid nuclei to become 
tightly compacted (Lewis et al., 2003).  Histones associated with spermatocyte chromatin are 
ultimately exchanged for protamines, allowing the nucleus to condense up to 200-fold (Fuller, 
1993).  Two genes encoding protamines have been identified in Drosophila (Raja and 
Renkawitz-Pohl, 2006).  Additionally, the gene tpl94D demonstrates functional homology to 
mammalian transition proteins, which bind chromatin as an intermediate step between histone-
based and protamine-based chromatin organization (Rathke et al., 2007).  Therefore, nuclear 
compaction in Drosophila occurs as a two-step process:  histones are first displaced by transition 
proteins, and transition proteins are later exchanged for protamines. 
Soon after protamine incorporation, the spermatids in a cyst become separated from one 
another in a process called individualization.  During this process, a cone-like structure 
composed of cross-linked F-actin assembles around each nucleus in the cyst.  The 64 cones in 
the cyst move as a unit down the length of the sperm tails, simultaneously pushing out excess 
cytoplasm and wrapping each spermatid in an individual membrane (Fabrizio et al., 1998; 
Noguchi and Miller, 2003).  The separated, mature sperm then roll into coils and exit the testis to 
be stored in the seminal vesicle (Tokuyasu et al., 1972). 
In Drosophila, there are many examples of transcripts that are synthesized in 
spermatocytes, but are not translated until after meiosis, to such an extent that transcriptional 
activity in the developing Drosophila sperm cell was previously thought to be predominantly 
limited to early spermatocytes and spermatogonia (Barreau et al., 2008; Fuller, 1998; Olivieri  
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FIG. 5.1.  Overview of spermatogenesis in Drosophila melanogaster.  Asymmetric divisions 
from germline stem cells (GSC) produce a single primary spermatocyte.  Spermatocytes undergo 
four rounds of mitosis, resulting in a cyst of 16 cells.  After a period of growth, each mature 
primary spermatocyte in a cyst completes meiosis, resulting in a cyst of 64 round spermatids.  
Spermatids then undergo differentiation events: the centriole becomes the basal body, the 
axoneme is formed, and the cell undergoes morphological changes.  Finally, spermatid nuclei 
become very compact and needle-shaped, and spermatids separate from one another through 
individualization. 
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and Olivieri, 1965; Rathke et al., 2007; Schafer et al., 1990).  However, recent evidence 
demonstrates that transcriptional activity occurs post-meiotically as well (Barreau et al., 2008; 
Vibranovski et al., 2010).  For those transcripts that remain quiescent until post-meiotic stages, a 
translational control mechanism must be in place. 
Many cell types including oocytes and neurons achieve translational regulation through 
adjusting the length of a transcript’s poly(A) tail in the cytoplasm (Benoit et al., 2008; Cui et al., 
2008; Galili et al., 1988; Kwak et al., 2008; Preiss et al., 1998).  A long poly(A) tail promotes 
translation of the transcript through recruitment of translation initiation factors, while a transcript 
with a short poly(A) tail remains untranslated or is degraded.  Most mRNAs are extensively 
polyadenylated in the nucleus; however, for some transcripts that will be held in an untranslated 
state for a period of time, poly(A) tail modifications occur outside the nucleus (Kim and Richter, 
2006).  In Xenopus, transcripts destined for post-transcriptional poly(A) tail adjustment contain 
two consensus sequences in their 3’UTR:  a cytoplasmic polyadenylation element (CPE) and the 
hexamer AAUAAA, which will recruit a complex of proteins to alter poly(A) tail length 
(Mendez and Richter, 2001; Pique et al., 2008).  In Xenopus, CPE is bound by CPE binding 
protein (CPEB) (Hake and Richter, 1994; Stebbins-Boaz et al., 1996).  The cleavage and 
polyadenylation specificity factor (CPSF) binds to the hexamer (Dickson et al., 1999; Mendez et 
al., 2000).  CPEB and CPSF recruit a cytoplasmic poly(A) polymerase (PAP) as well as a 
deadenylase, both of which work on the transcript simultaneously (Kim and Richter, 2007).  
However, the deadenylase is slightly more efficient than the PAP, so the net effect is a poly(A) 
tail that remains short.  Upon a signal to activate translation, CPEB is phosphorylated, causing 
the deadenylase to dissociate from the complex; the PAP is then free to elongate the poly(A) tail 
(Kim and Richter, 2007). 
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PAPs that act in the cytoplasmic complex differ from nuclear PAPs.  One family of 
cytoplasmic PAPs called Gld-2 (germline development 2) has been described in C. elegans, 
Xenopus, and Drosophila (Barnard et al., 2004; Benoit et al., 2008; Cui et al., 2008; Wang et al., 
2002). While nuclear PAPs contain a catalytic domain and a RNA binding domain, Gld-2 family 
members have only a catalytic domain (Bard et al., 2000; Martin et al., 2000).  For RNA 
specificity, Gld-2 associates with an RNA-binding protein, typically a Gld-3, to form a 
heterodimer which acts as a cytoplasmic PAP (Wang et al., 2002). 
Gld-2 family members have been shown to play roles in oogenesis in several organisms. 
In worms, a Gld-2 homolog is involved in the mitosis/meiosis decision to make both male and 
female germ cells (Kadyk and Kimble, 1998).  In Drosophila, the X-linked Gld-2 homolog wispy 
(wisp) is necessary for oogenesis and egg activation (Benoit et al., 2008; Cui et al., 2008). WISP 
is present in ovaries but not in testes, and is necessary for completion of meiosis in oocytes. 
WISP has been shown to polyadenylate transcripts of cortex, which is required for proper 
meiotic progression (Benoit et al., 2008).  WISP also polyadenylates several developmental 
transcripts whose protein products are needed for early embryogenesis such as bicoid, Toll, and 
torso (Benoit et al., 2008; Cui et al., 2008).   
The Drosophila genome contains an autosomal paralog of wispy called Gld2.   Previous 
studies of Gld2 have demonstrated a role in long-term memory and show that GLD2 acts as a 
poly(A) polymerase in vitro (Kwak et al., 2008).  Here, we show that Gld2 is expressed in the 
male, but not female, germline.  It is required for completion of spermatogenesis, specifically for 
elongation and individualization stages.  In GLD2-knockdown testes, the first disruption 
observed is post-meiotic, at the onset of spermatocyst elongation.  In these testes, the nuclei in 
developing cysts scatter, and basal bodies are not observed near nuclei.  F-actin-containing 
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individualization complexes do not assemble, and nuclear compaction does not complete.  
Additionally, protamines are not incorporated, and transcripts for both dynamin and the 
transition protein are undetectable.  Our findings indicate that Gld2 arose from duplication of the 
wispy locus, and that this derived paralog was likely maintained in the genome due to its 
necessary role in spermatogenesis. 
5.2  Materials and Methods 
Evolutionary analysis: Orthologs of wispy and Gld2 within the Drosophila genus were 
identified from sequences obtained from The Drosophila 12 Genomes Consortium (Clark et al., 
2007).  Orthologs in other insect species were identified via best reciprocal BLASTp hits between 
non-redundant protein databases at the NCBI BLAST server 
(http://blast.ncbi.nlm.nih.gov/Blast.cgi), using either GLD2 or WISPY protein sequence as the 
query. 
Drosophila stocks:  All strains were raised on standard yeast-glucose media at 22°C.  OregonR 
P2 was used as the wild-type stock.  The stock bam-GAL4-VP16 (Chen and McKearin, 2003), 
which expresses a GAL4 driver by the bag-of-marbles (bam) promoter, was kindly provided by 
C. Baker and M.T. Fuller (Stanford University, Palo Alto, CA).  The stock carrying an X-linked 
transgenic protamine-B-eGFP transgene (Manier et al., 2010) was kindly provided by J. Belote 
(Syracuse University, Syracuse, NY).  Lines carrying UAS-driven snapback RNA against Gld2 
(CG5732) transcripts were obtained from the Vienna Drosophila RNAi Center (VDRC 
ID#52042 and VDRC ID#51605) (Dietzl et al., 2007).  Both lines carry the same construct, and 
prediction programs detect no off-targets.  We crossed virgin females from the VDRC line to 
males carrying bam-GAL4-VP16 to achieve knockdown of GLD2 specifically in the gonads of 
the progeny.   To observe protamine B in knockdown and control flies, we crossed protamine-B-
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eGFP; P{tubP-GAL4}LL7/TM3,Sb virgin females to males from the VDRC line using methods 
described by Avila and Wolfner (2009); the Sb+ progeny were the knockdown group, and their 
Sb siblings were the control group.  Expression of the protamineB-GFP construct was confirmed 
by RT-PCR. 
Fertility tests:  To assess fertility, 3-5 day old GLD2 knockdown males and females created by 
the cross described above were singly mated to 3-5 day old wild-type males or females.  In vials, 
single pairs were observed until completion of mating, and the male of each couple was then 
removed.  The females from each mating were transferred to new vials for three consecutive 24-
hour periods.  The number of eggs laid during each period was recorded, and the number of 
progeny resulting from those eggs was also recorded.   
Phase-contrast microscopy:  Testes were dissected in cold Ringer’s solution (Ashburner, 1989) 
and squashed in a drop of solution on a slide under the weight of a cover slip.  Squashes were 
examined under phase-contrast using a Zeiss Axioskop compound microscope.  Images were 
captured using Hamamatsu ORCA-ER camera equipment and software. 
Fluorescence microscopy:  To detect actin individualization cones and nuclei, testes of 3-5 day 
old males were prepared for phalloidin staining as described by Fabrizio et al. (1998).  For 
immunostaining of GLD2, an affinity-purified polyclonal antibody was generated against GLD2 
by using a 329 amino acid region (residues 480-808) of the protein as antigen, using methods 
previously described (Cui et al., 2008).  Testes were dissected in cold PBS (10 mM Na 
phosphate buffer pH 7.4, 150 mM NaCl).  Dissected testes were then squashed and fixed in 4% 
paraformaldehyde in PBS as described by Fabrizio et al. (1998).  Squash preparations were then 
washed with PBS, blocked, and stained as described by Hurst et al. (2003).  A 1:1000 dilution of 
primary GLD2 antibody or a 1:500 dilution of primary γ-tubulin (#GTU88, Sigma, St. Louis, 
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MO, USA) was used, and a 1:1000 dilution of AlexaFluor 488 anti-rabbit or anti-mouse 
secondary antibody (Invitrogen, Carlsbad, CA, USA) was used.  Squashes were incubated with 
propidium iodide for 30 minutes or DAPI for 5 minutes at room temperature following 
secondary antibody incubation.   
To detect monomeric G-actin, squashes were fixed and washed as described above.  
Squashes were incubated with Alexa-488 conjugated DNase I (Invitrogen) for 1 hour at room 
temperature and then washed with PBS. 
Coverslips with a drop of anti-fade mounting solution (10 mM N-propyl gallate in 75% 
glycerol) were placed on stained squash preparations.  Preparations were examined using a Leica 
TCS SP2 confocal microscope or Zeiss Axioscop compound microscope.   
RNA extraction and RT-PCR:  Total RNA was extracted from hand-dissected testes of 3-5 day 
old males using TRIzol (Invitrogen) and reverse transcribed using SuperScript II reverse 
transcriptase (Invitrogen) according to the manufacturer’s instructions.  The GoTaq PCR system 
(Promega, Madison, WI, USA) was used for PCR analysis of cDNA. 
Western blot:  For each sample prepared for Western blot analysis, testes from five 3-day-old  
males or ovaries from two 3-day-old females were dissected in cold PBS and homogenized by 
rapid pipetting in sample buffer.  Samples were boiled for 5 minutes and run on a 7.5% SDS 
polyacrylamide gel, and proteins were transferred to a Millipore Immobilon membrane.  The 
membrane was then blocked with 5% milk in TBST for 1 hour before adding primary GLD2 
antibody (1:1000) overnight at 4°C.  The membrane was then washed 4 times in TBST and 
incubated with secondary HRP antibody (Jackson Laboratories, Bar Harbor, ME, USA) for 1 
hour at room temperature.  ECL-Plus (Amersham) was added to the membrane per the 
manufacturer’s instructions to expose the film.  
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Poly(A) Tail assay:  Poly(A) tail (PAT) assays were performed as described by Salles and 
Strickland (1999).  For PAT assay of low-abundance transcripts, nested PAT PCR experiments 
were performed.  Here, the first PCR was run using a gene-specific primer 500-600 base pairs 
upstream of the 3’ end of the transcript of interest, plus the anchor primer.  Product from this 
reaction was used as template in a second PAT PCR using a primer 200-400 base pairs upstream 
of the 3’ end of the transcript of interest, plus the anchor primer.  Products were resolved on a 
2% agarose gel or 8% polyacrylamide gel.  Primer sequences are available upon request. 
Yeast two-hybrid analysis:  Yeast two-hybrid analysis was performed as described by Cui et al. 
(2008).  Briefly, we cloned full length coding sequences from Gld2 and Bic-C into vectors of the 
Matchmaker yeast two-hybrid system (Clontech, Mountain View, CA, USA). In-frame fusions 
of each coding region were generated in both the DNA-binding domain vector pGBKT7 and the 
activation domain vector pGADT7. Yeast cells co-transformed with pGBKT7 and pGADT7 
derivatives were grown on -Trp -Leu synthetic medium and tested for growth on -Trp -Leu -His 
and -Trp -Leu -His -Ade synthetic media. 
5.3  Results and Discussion 
Evolutionary history of Gld2 and wispy:  The Drosophila genus can be divided into subgenera, 
and genome sequences are available from two subgenera: Sophophora (containing D. 
melanogaster) and Drosophila (containing species that diverged from D. melanogaster ~63 
million years ago (Tamura et al., 2004)). We identified wispy and Gld2 orthologs in species from 
both subgenera. The wispy orthologs in D. melanogaster, D. mojavensis and D. virilis have 
female-biased expression, while the Gld2 orthologs from D. melanogaster, D. simulans, D. 
secchelia, D. yakuba, D. pseudoobscura, and D. mojavensis are male-biased (Zhang et al., 2007).  
This is consistent with the conservation of the oogenesis and spermatogenesis functions of WISP 
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and GLD2, respectively, across the entire genus. All other insect species with sequenced 
genomes (including Anopheles gambiae and Aedes aegypti, the closest relatives to Drosophila 
with completely sequenced genomes) possess only a single ortholog of wispy/Gld2, based on 
best reciprocal BLAST searches. Therefore, a duplication event occurred after the most recent 
common ancestor (MRCA) of Drosophila and mosquitoes—but prior to the MRCA of the genus 
Drosophila—to give rise to either wispy or Gld2 (depending on which locus is ancestral and 
which is derived). A phylogenetic reconstruction of the evolutionary relationships of the insect 
protein coding sequences supports this hypothesis (Fig. 5.S1). Furthermore, the wispy/Gld2 
ortholog in A. gambiae has female-biased expression, based on microarray data from whole 
males and females (Marinotti et al., 2005). We hypothesize that the ancestral germline function 
of this gene family is in ovaries, and the testis-specific function of GLD2 (see below) is derived. 
 We examined the conservation of flanking genes on both local and global scales to 
determine whether wispy or Gld2 is the ancestral locus. On the local scale, wispy is in close 
proximity to Upf1, and the A. gambiae ortholog is in close proximity to the ortholog of Upf1. 
Assuming conserved synteny, this suggests that wispy is the ancestral copy. On a more global 
scale, the A. gambiae ortholog is located on chromosome 2R. This arm has homology to both the 
X chromosome and 3R of D. melanogaster (Fig. 5.S2A).  wispy is X-linked and Gld2 is found on 
3R.  However, the local region of A. gambiae 2R that contains the wispy/Gld2 ortholog is 
enriched for genes that are X-linked in D. melanogaster (Fig. 5.S2B). This provides further 
evidence that wispy is the ancestral copy. Additionally, Gld2 is missing introns found in both 
wispy and the other insect orthologs (Fig. 5.S3), suggesting that Gld2 may have arisen via the 
retrotransposition of wispy from the X to the autosome.  
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FIG. 5.S1.  The duplication giving rise to wispy/Gld2 occurred after the divergence of the 
Drosophila and mosquito lineages. Phylogenetic trees show the relationship between the D. 
melanogaster WISP and GLD2  protein sequences and orthologous genes from other insects. We 
constructed phylogenies using the neighbor joining algorithm (Saitou and Nei, 1987) 
implemented in MEGA 4.0 (Tamura et al., 2007). Divergence was estimated using Poisson 
corrected amino acid differences and alignment gaps were excluded from all comparisons. 
Bootstrap percentages (estimated with 1000 replicates) are given at the nodes. Scale bars indicate 
the number of substitutions per site along the branches. The A. gambiae gene is incompletely 
annotated, and phylogenies were constructed both with (A) and without (B) this sequence; the 
same evolutionary relationships are recovered regardless of whether the A. gambiae gene is 
included. 
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FIG. 5.S2. The A. gambiae ortholog of wispy/Gld2 is in a region of the genome most resembling 
the D. melanogaster X chromosome. We used reciprocal best protein blast hits to identify one-
to-one orthologs between D. melanogaster and A. gambiae. The x-axis represents chromosome 
2R in A. gambiae, and the red lines indicate the position of the A. gambiae ortholog of 
wispy/Gld2. Histograms show the number of genes mapping to each of the five major 
chromosome arms in D. melanogaster for windows along A. gambiae chromosome 2R (A). 
Looking closely at the proximal region of A. gambiae chromosome 2R (B), each circle represents 
a gene, with the y-axis indicating the chromosome arm in which the gene is located in D. 
melanogaster.  
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FIG. 5.S3.  D. melanogaster Gld2 is missing introns that are conserved between wispy and the 
mosquito Gld-2 ortholog. Rectangles represent protein-coding exons and lines represent introns 
in the annotated Gld2, wispy, A. aegypti, and A. gambiae genes (non-coding exons have been 
omitted). Diagonal lines between genes connect the end-points of homologous exonic sequences. 
The truncated A. gambiae gene is most likely an annotation error. Note that introns 5 and 6 of 
wispy are conserved in both mosquito genes but missing in Gld2. Introns 1 and 2 of wispy are 
near introns found in at least one mosquito gene. The gene structures of wispy and Gld2 are 
largely conserved within the Drosophila genus. 
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 The phenomenon of meiotic sex chromosome inactivation (MSCI) may have contributed 
to duplication of the wispy gene and subsequent retention of Gld2.  During spermatogenesis in 
Drosophila and other animals, the X chromosome is transcriptionally silenced prior to autosomal 
silencing (Hense et al., 2007; Turner, 2007; Vibranovski et al., 2009).  Therefore, genes located 
on the X chromosome have a limited capacity to encode proteins involved in spermatogenesis. 
Interestingly, an excess of genes has been retrotransposed from the X to the autosomes, and the 
autosomal derived copies are hypothesized to allow for the “escape” from X-inactivation (Betran 
et al., 2002; Meisel et al., 2009).  The testis biased expression (Chintapalli et al., 2007) and 
spermatogenic functions (see below) of Gld2 suggest that it was selectively retained because it 
performs a function unavailable to wispy because of MSCI.   
D. melanogaster Gld2 is expressed in the testis and localizes to elongating 
spermatogenic cysts:  To determine the normal expression pattern of Gld2, we performed RT-PCR and immunoblots of RNA and protein from dissected tissues as well as from whole wild-type flies.  Gld2 transcripts were detected in larvae, pupae, and adults.  The signal was quite robust in males, whereas expression was barely detectable in whole females (Fig. 5.2A).  Western blotting with affinity-purified GLD2 antibody revealed GLD2 presence in the testes of the adult, and did not detect GLD2 in the remainder of the male or the female body (Fig. 2B).  Gld2 has previously been reported to be expressed and function in the 
Drosophila nervous system (Kwak et al., 2008); apparently this expression was below the detection limits of our western blots.  We believe it is the source of the low levels of expression we see in RT-PCR of whole females.  We did not detect GLD2 in the ovaries of wild-type females (Fig. 5.2C). 
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FIG. 5.2.  GLD2 is expressed in the testes, and is not detectable in the female.  RT-PCR for 
GLD2 shows expression in male larvae, pupae, and adult stages, while expression is not detected 
in the female (A).  RPL32 is used as a positive control.  Western blot with anti-GLD2 shows 
expression is robust in the testes, but is not detected in the remainder of the male (carcass) or in 
whole females (B).  Western blot with anti-GLD2 and anti-WISPY show that GLD2 is expressed 
in testis but not ovary, and WISPY is expressed in ovary but not testis (C).  Membranes were 
probed with anti-a-tubulin as a loading control.  Immunostaining of whole testis squashes using 
anti-GLD2 shows the breadth of GLD2 expression (D).  GLD2 first appears in primary 
spermatocytes (E) at the distal tip of the testis, and persists at the distal ends of spermatogenic 
cysts in late stages of spermiogenesis (F).  Arrowheads in E indicate the start of the region of the 
testis containing weakly labeled primary spermatocytes.  Arrows in F indicate the distal ends of 
elongated spermatogenic cysts.  Scale bars, 40mm. 
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 Immunostaining of adult testis shows that GLD2 localizes to the cytoplasm in primary 
spermatocytes, throughout meiosis, and in early round spermatids, consistent with its proposed 
action as a cytoplasmic PAP in the male germline (Fig. 5.2D).  GLD2 first appears in early 
spermatocytes, with robust expression in mid-primary spermatocytes (Fig. 5.2E).  In later stages 
of spermatogenesis, GLD2 is detectable in elongated spermatogenic cysts and is specifically 
localized to the distal end of the cysts (Fig. 5.2F).  This region of the cyst is where polarized 
growth of the cyst occurs in accordance with axoneme extension (Fuller, 1993; Tates, 1971); 
additionally, a group of mRNAs that are transcribed post-meiotically have been shown to 
localize to the distal end of the spermatogenic cyst (Barreau et al., 2008).  Interestingly, one of 
these late-transcribed genes is orb, which encodes the Drosophila ortholog of CPEB, the protein 
necessary for cytoplasmic polyadenylation in Xenopus (Barnard et al., 2004; Richter, 2007).  The 
presence of both the CPEB homolog ORB and the cytoplasmic poly(A) polymerase GLD2 at the 
end of the cyst where growth is occurring may indicate GLD2’s involvement in late 
spermatocyst growth.  Taken together, these data suggest that the distal end of the cyst may be a 
major production center for cyst growth, with necessary mRNAs regulated post-transcriptionally 
through cytoplasmic polyadenylation. 
GLD2 has the ability to bind the Drosophila Gld-3 homolog Bic-C:  GLD2, like its 
Drosophila homolog WISP and other Gld-2 family members (Kwak et al., 2004; Kwak and 
Wickens, 2007), does not contain any predicted RNA recognition motifs.  In C. elegans, binding 
of GLD-2 to mRNA is mediated by an RNA binding protein GLD-3 through formation of a 
heterodimer (Wang et al., 2002).  In Drosophila, the Gld-3 homolog is encoded by bicaudal-C 
(BicC).  Previous studies have shown that the Drosophila Gld-2 homolog WISP, a known 
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cytoplasmic poly(A) polymerase, can interact with Bic-C in yeast two-hybrid assays (Cui et al., 
2008),  though co-immunoprecipitation experiments suggest that this interaction is RNA-
dependent (Benoit et al., 2008; Cui et al., 2008).   
Using a yeast two-hybrid assay, we found that GLD2 can interact with Bic-C.  GLD2 in 
an activation domain (AD) fusion can interact with Bic-C in a binding domain (BD) fusion but 
not with the BD alone. We only observed interaction between GLD2 and Bic-C in this 
orientation. The two-hybrid interaction we observed between GLD2 and Bic-C suggests that 
GLD2 might function, analogous to WISP and other Gld-2 family members, by forming a 
protein complex with an RNA binding subunit.  Bic-C is expressed in the testis as well as in the 
ovary (Chintapalli et al., 2007), so GLD2 has the opportunity to associate with Bic-C, thus 
supporting the case for the role of GLD2 as a PAP during spermatogenesis. 
GLD2 is necessary for late spermatogenesis:  To assess the function of GLD2 in the testes, we 
examined flies expressing dsRNA against GLD2 transcripts specifically in the germline.  
Efficiency of GLD2 knockdown was confirmed by RT-PCR (not shown) and Western blot (Fig. 
5.3A); we did not detect GLD2 in these animals.  We analyzed the GLD2-knockdown phenotype 
using two different RNAi lines (see Methods) as well as two different drivers, bam-VP16-GAL4 
and tubulin-VP16-GAL4.  All four RNAi-driver line combinations gave the same phenotype in 
our experiments (data not shown).  The results reported here are from RNAi progeny resulting 
from a cross between VDRC line #52042 and bam-GAL4-VP16, unless otherwise stated.  
The most striking effect of GLD2-knockdown in the germline is that knockdown males 
are completely sterile, whereas knockdown females display normal fertility in our fertility tests, 
even though the same RNAi is produced in their germlines (data not shown). Wild-type females 
mated to GLD2-knockdown males produced a normal number of eggs, but no eggs from these 
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matings hatched.  The reciprocal cross, in which GLD2-knockdown females were mated to wild-
type males, produced normal numbers of eggs and progeny, indicating that females do not 
require GLD2 for fertility.  The same fertility effect is observed when GLD2 RNAi is driven 
globally using a tubulin-GAL4 driver as when GLD2 RNAi is driven exclusively in the male and 
female reproductive tracts using a bam-GAL4 driver.   
  Because the fertility phenotype of GLD2-knockdown is male specific, we checked 
knockdown testes for proper sperm development. Phase-contrast images of GLD2-knockdown 
testis squashes show that in spermatozoa and spermatocytes, mitosis and meiosis proceed 
normally, producing spermatogenic cysts containing 64 spermatids after completion of meiosis II 
(Fig. 5.3B,C).  Each early spermatid contains one nucleus and one associated mitochondrial 
derivative, indicating no obvious morphological defects during meiosis and mitochondrial 
development.  However, spermatids within elongated cysts show several abnormalities.  Testes 
and seminal vesicles from GLD2 knockdown males are devoid of mature or motile sperm, thus 
resulting in male sterility.  Instead, fully elongated cysts in GLD2-knockdown males still contain 
syncytial spermatids, indicating that spermatogenic individualization did occur (Fig. 5.3D,E).  
Bulges of material that accumulate along the tails of the elongated spermatids can be seen in 
squash preparations of GLD2-knockdown testis to a considerably higher degree than is seen in 
control squashes prepared in the same way (panels 3D and 3E are typical of what we see in 
control and knockdown, respectively); bulges of similar appearance have been observed in testis 
squash preparations of mutants that fail to complete spermatogenic individualization (Fabrizio et 
al., 1998).  We speculate that these bulges are cytoplasmic aggregates freed from the cyst during 
the squash preparation, and because the GLD2-knockdown sperm tail is not contained within a 
membrane the droplet of cytoplasm can adhere to it. 
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 We stained testis squash preparations from knockdown and wild-type males with DAPI 
and rhodamine-conjugated phalloidin, in order to detect nuclear bundles and actin 
individualization complexes, respectively.  Individualization complexes appear as groups of 
cone-like structures composed of F-actin that assemble around bundled nuclei; each nucleus is 
associated with one actin cone.  During the individualization process, these actin cones move as 
a complex down the length of the cyst, wrapping each spermatid in an individual membrane 
(Noguchi and Miller, 2003; Tokuyasu et al., 1972).  In wild type, cysts isolated from ruptured 
testis tissue contain all 64 spermatid nuclei at their apical ends, and many of these nuclear 
bundles are closely associated with assembled individualization complexes (Fig. 5.4A).  Testes 
of GLD2-knockdown males show dramatic differences from the wild-type.  Their spermatogenic 
cysts never contain bundled nuclei or assembled F-actin-containing individualization complexes.  
Instead, nuclei of spermatogenic cysts from RNAi-treated flies are evenly scattered throughout 
the cyst, without a tendency for greater nuclear density at the apical end of any cyst (Fig. 5.4B).  
A scattered nuclear phenotype is common in many individualization mutants (Fabrizio et al., 
1998).  Such scattering has usually been attributed to malformation of the actin individualization 
complexes.  It has been proposed that in those mutants, a malformed individualization complex 
will drag nuclei along as the complex moves down the length of the cyst (Fabrizio et al., 1998).  
However, in such mutants, even in cysts containing scattered nuclei there is a higher density of 
nuclei at the apical end.   This pattern suggests that nuclear bundles may have been formed 
initially, but later became scattered by malformed individualization complexes.  The phenotype 
of GLD2 knockdown cysts differs from this:  since individualization complexes are apparently 
unassembled, nuclear scattering cannot be due to the previously-described dragging effect.  
Instead, because nuclei are scattered uniformly across the length of the spermatogenic cyst,  
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FIG. 5.3.  RNAi knockdown of GLD2 results in defective late spermatogenesis.  GLD2 
knockdown was achieved by driving UAS-snapback RNA against GLD2 transcripts specifically 
in the testes using a bam-GAL4 driver.  Reproductive tracts of GLD2-knockdown (KD) and 
control males were assayed for GLD2 expression using western blot (A).  Testis squashes under 
phase-contrast microscopy show that meiosis completes normally in spermatogenic cysts of 
knockdown (C) testes compared to those of wild-type controls (B), so that each cyst contains 64 
nuclei (light phase), and each nucleus is associated with one mitochondrial derivative (dark 
phase).  Late spermatogenesis becomes disrupted, resulting in lack of individualized spermatids 
in knockdown testes (E) compared to wild-type testes (D).  Arrowheads in E indicate 
cytoplasmic bulges.  Scale bars, 40mm. 
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FIG. 5.4.  Nuclei are scattered throughout spermatogenic cysts and individualization cones do not 
form in GLD2 knockdown testes.  Testes squashes were fixed and stained with DAPI and 
rhodamine-conjugated phalloidin to detect nuclei (blue) and F-actin individualization cones 
(red), respectively.  In wild-type controls (A), individualization cones assemble around bundled 
nuclei in late spermatogenic cysts.  In GLD2-knockdown testes, nuclei of late spermatogenic 
cysts are scattered uniformly throughout the cyst (its extent is visible with the phase-contrast 
overlay), and individualization cones are absent (B).  Furthermore, higher magnification of 
nuclei shows that nuclei in late spermatogenic cysts of the knockdown (D) are noticeably less 
condensed than those of wild-type (C).  Nuclei shown in (D) are representative of the most 
highly condensed nuclei that we see in knockdown testes.  Examination of pupal testes with 
propidium iodide staining shows that nuclei (red) begin to bundle at the onset of cyst elongation 
in wild-type (E); at early elongation stages in GLD2-knockdown, nuclei are already scattered 
(F).  Outlines denote early elongation cyst.  Scale bars, 10mm. 
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nuclei were likely not bundled in initial stages of spermiogenesis, and defects may be apparent 
even before onset of individualization complex assembly.  Therefore, we looked in preceding 
spermatogenic stages to search for earlier visible defects in the absence of GLD2. 
Many post-meiotic spermatogenic cysts within adult Drosophila testis have already 
undergone substantial flagellar extension and cyst elongation, making the smaller, early post-
meiotic cysts difficult to identify.  In order to observe cysts that are just beginning to elongate, 
we examined testes of wild-type and GLD2-deficient pupae.  Tissues were dissected 3-4 days 
after pupation and stained for nuclei and GLD2 localization as was done with adult tissues.  In 
wild-type preparations, nuclear bundling at one end of elongating cysts was observed at the onset 
of elongation (Fig. 5.4E); however, such nuclear bundles are never observed in GLD2 
knockdown preparations from the pupae.  GLD2-knockdown pupal testes showed nuclear 
scattering within cysts even in the earliest stages of spermatocyst elongation (Fig 5.4F).  This 
indicates that GLD2 is necessary for some aspect of post-meiotic nuclear localization.  Previous 
studies have indicated a requirement for dynein and dynactin at apical ends of elongating cysts 
for nuclear retention and bundling (Ghosh-Roy et al., 2004).  Additionally, interfering with 
phosphoinositide signaling can affect cyst polarity (Fabian et al., 2010).  It is possible that GLD2 
is required for proper nuclear localization by mediating dynein-dynactin dependent anchoring 
and/or phosphoinositide-dependent cyst polarity. 
Basal body docking is defective in GLD2-deficient spermatogenesis:  After completion of 
meiosis, haploid round spermatids undergo differentiation events before entering the spermatid 
elongation period.  One important event is the formation of the basal body derived from the 
centriole.  During meiosis II, the centrosome undergoes reductive division so that each post-
meiotic spermatid nucleus is associated with only one centriole.  Upon spermatid differentiation 
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soon after meiosis, the centriole inserts into a groove in the nuclear membrane at the base of the 
nucleus (a process called basal body docking), where it becomes the spermatid basal body 
(Fuller, 1993; Tokuyasu, 1974).  Nuclear scattering has previously been described in mutants 
affecting basal body docking (Anderson et al., 2009; Texada et al., 2008). 
 To assess whether the basal body could form and dock properly in the absence of GLD2, 
we compared staining patterns of g-tubulin in adult testes of GLD2-deficient and control males.  
In wild-type testes, g-tubulin stains centrosomes throughout meiotic phases, and stains basal 
bodies associated with nuclei in elongated spermatids (Fig. 5.5A).  In GLD2-knockdown testes, 
centrosomal g-tubulin staining can be seen in meiotic spermatocytes (data not shown); however, 
g-tubulin is not consistently detected at or near the nuclei of elongated spermatids (Fig. 5.5B).  
This result indicates that centrioles were unable to attach to the nuclear membrane after meiosis, 
resulting in post-meiotic spermatids that lack basal bodies at the nucleus.  In examining the full 
length of the testis, some intermittent staining can be detected, but staining does not appear to be 
associated with nuclei, nor does it appear as succinct puncta as in the wild-type.  It is unclear 
what happens to centrosomal derivatives in elongated cysts.  The presence of axonemes raises 
the possibility that centrosome-derived structures are intact at least in early spermatids, since the 
basal body is required for axoneme assembly (Fuller, 1993).  However, our confocal microscopy 
scans of late spermatogenic cysts of knockdown testes failed to detect distinct g-tubulin staining, 
which would have indicated the presence of properly-formed basal bodies; we did detect such 
basal body staining in wild-type (Fig. 5.S4). 
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FIG. 5.5.  Basal body docking is defective in GLD2-knockdown testes.  Basal body formation 
was examined by immunostaining for γ-tubulin.  In wild-type control testes (A), γ-tubulin 
staining (green) can be seen at the base of each nucleus (stained with propidium iodide, red), 
indicating proper differentiation of basal bodies.  In GLD2-knockdown testes (B), concentrated 
γ-tubulin staining cannot be observed near nuclei.  Scale bars, 10mm. 
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 Nuclear compaction is disrupted in GLD2-deficient spermatogenesis:  DAPI staining 
indicated that, in addition to the nuclear scattering phenotype, nuclei in elongated spermatocysts 
of GLD2-knockdown testes were less condensed than those of wild-type testes (Fig.5. 4C,D), 
suggesting a nuclear compaction defect.  We found that the nuclei that were the most condensed 
in GLD2-knockdown testes had not progressed past the canoe stage (Fig. 5.4D).  One possible 
explanation is that the translation of nuclear compaction proteins requires GLD2.  To investigate 
whether spermatids in GLD2-knockdown flies are able to exchange histones for protamines, we 
examined spermatid nuclei of GLD2-knockdown males carrying a protamineB-eGFP construct.  
In this cross, snapback RNA against GLD2 was driven by tubulin-GAL4, which yields a 
knockdown testis phenotype identical to RNAi achieved by bam-GAL4 (data not shown).  While 
many spermatid nuclear bundles and all nuclei of free-swimming sperm in control testis showed 
clear GFP signal (Fig. 5.6A,B), there was no GFP signal detectable anywhere in knockdown 
testis (Fig. 5.6C,D).   However, RT-PCR shows the presence of protamineB-eGFP transcripts, 
indicating that the construct is present and transcribed in these flies (Fig. 5.6E).  Therefore, we 
performed PAT assays for protamine A and protamine B on control and knockdown flies, and we 
found no difference in poly(A) tail length of protamine transcripts between the two groups (Fig. 
5.6F). 
To further investigate why nuclei fail to condense fully in the GLD2-knockdown, we 
tested for presence of transcripts of the Drosophila transition-protein tpl94D (CG31281) by RT-
PCR.  The gene encoding the Drosophila transition protein is transcribed in spermatocytes, and 
its protein appears only transiently during nuclear remodeling (Rathke et al., 2007).  Thus tpl94D 
is a candidate for post-transcriptional regulation at the transcript’s 3’ sequence.  Drosophila 
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tpl94D transcripts were detectable in wild-type testes, but were not detectable in GLD2-
knockdown testes (Fig. 5.7).  This result could indicate that the gene is not being transcribed, or 
that the transcript is synthesized but is unstable.  Such instability could arise from a poly(A) tail 
elongation defect; however, because the transcript is not detectable in GLD2-knockdown 
samples, we could not measure its poly(A) tail length or otherwise test these hypotheses.   
These data suggest that GLD2 acts upstream of protamine B translation.  Given that no 
effects of GLD2 on poly(A) tail length of protamine transcripts were detected, it seems likely 
that removing GLD2 causes a block in the spermatogenic developmental pathway at a stage 
before protamine transcripts would normally be translated.  Rathke and colleagues (2007) 
showed that protamines are incorporated into the spermatid chromatin after the onset of 
transition protein incorporation, so it is possible that lack of transition protein causes a 
developmental block in GLD2-knockdown testes, and the lack of protamine translation in these 
testes reflects that block.  There is evidence that protamine transcripts are translationally 
repressed for a few days after their transcription, and this repression is dependent upon elements 
in the 5’UTR (Raja and Renkawitz-Pohl, 2006).  GLD2 alternatively could be responsible for 
controlling translation of a critical element that affects the release of repressor binding at the 
protamine 5’UTR repression element, while not affecting poly(A) tail status of the protamine 
transcript itself.   
Although no effect of GLD2 on protamine transcripts was observed, we found an 
interesting result that has not been reported before in Drosophila spermatogenesis.  The poly(A) 
tail of the protamine A and protamine B transcripts is approximately 30 nucleotides longer in 
larval testes than in adult testes (Fig. 5.6F).  Larval testes are comprised mostly of primary 
spermatocytes and have not yet developed the protamine-based nuclear configurations that are 
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seen in adult testes (Fuller, 1993).  Therefore, the difference in protamine poly(A) tail length 
between larval and adult testes indicates that deadenylation accompanies spermatid 
differentiation, and may promote protamine translation.  While this seems contradictory to what 
is known about the role of the poly(A) tail in regulating translational efficiency, deadenylation 
has been known to accompany translation in some cases.  In mice, transition protein and 
protamine transcripts are synthesized in primary spermatocytes and are translationally repressed 
for several days.  The translationally inactive, non-polysome-bound forms of the mouse 
protamine transcripts are considerably longer than the active polysome-bound forms, and this 
difference in transcript length reflects differences in amount of poly(A) (Kleene et al., 1984).   
Absence of dynamin may contribute to F-actin assembly defect in GLD2-deficient 
spermatogenesis:  In wild-type adult testes, F-actin individualization complex formation follows 
protamine incorporation.  As described above, actin individualization complexes do not develop 
in the absence of GLD2.  Lack of F-actin at nuclear bundles could be due to a failure to regulate 
actin transcripts, a failure to stabilize G-actin, or a failure to assemble G-actin into 
individualization cones in GLD2-knockdown testes.  To distinguish between these possibilities, 
we performed tests at each level.   
We tested for expression of two actin genes, act42a and act87e, that are reported to be 
highly expressed in testis tissue (Chintapalli et al., 2007).  We were able to detect both 
transcripts in wild-type and GLD2-knockdown testes; however, poly(A) tail (PAT) assays 
indicated no change in polyadenylation state in the absence of GLD2 (Fig. S5A).  To test 
whether actin transcripts were being translated, we stained adult testes for monomeric G-actin 
using AlexaFluor-labeled DNase1.  DNase1 binds to G-actin and is an indicator of G-actin levels 
(Philip et al., 1992; Snabes et al., 1981).  There was no noticeable difference in the staining  
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FIG. 5.6.  Protamines are transcribed, but not incorporated in GLD2-knockdown testes.  We 
examined protamine incorporation by crossing in eGFP-tagged protamine B and staining for 
DNA using DAPI.  In control testes, many nuclear bundles of late spermatogenic cysts (A) 
contain protamine-based chromatin, visualized here as GFP (B).  Late-stage nuclei in GLD2- 
knockdown testes (C) are only partially condensed.  Lack of GFP signal in GLD2-knockdown 
testes (D) indicates that protamine B is not incorporated.  RT-PCR specifically for the 
protamineB-eGFP construct shows that the construct is expressed in knockdown and control 
testes (E).  PAT assay (F) shows that both protamines are expressed in wild-type male larvae (L), 
wild-type male adults (A+) and GLD2-knockdown male adults (A-).  The transcripts of both 
protamines are larger in larvae than in adults, and there is no difference in transcript length 
between wild-type and GLD2-knockdown adults.  Scale bars, 40mm. 
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FIG. 5.S4.   g-tubulin staining shows centrosomal derivatives throughout many stages of 
spermatogenesis in whole wild-type testes.  g-tubulin stains centrosomes throughout 
spermatocyte stages of spermatogenesis (distal testis), and stains basal bodies in post-meiotic 
spermatogenesis (basal testis).  Centrosomal staining is bright and can be seen at lower 
magnification; however, basal body staining is fainter and requires higher magnification (inset). 
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FIG. 5.S5.  G-actin levels appear normal in GLD2 knockdown.  PAT assay of Act42a and 
Act87e from testes cDNA samples indicates no difference in mRNA levels or length of these 
actin transcripts (A).  Cellular G-actin protein levels do not differ between control (B) and 
knockdown (C) testes, as indicated by intensity of Alexa 488-conjugated DNase1 staining 
(green).  Scale bars, 150mm. 
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FIG. 5.7.  Transition protein and dynamin transcripts are absent from GLD2-knockdown testes. 
RT-PCR shows that the dynamin (dyn) transcript is present in control adult testes, but absent 
from GLD2-knockdown testes; additionally, transition protein tpl94D transcript is present in 
control adult testes, but absent from GLD2-knockdown testes.  RPL32 is used as a positive 
control. 
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pattern detected between wild-type and GLD2-deficient testes, indicating that G-actin is present 
in apparently equal amounts (Fig. S5B,C).  These data indicate that the loss of F-actin in GLD2-
knockdown testes is likely not due to a deficit of available G-actin, but could possibly be 
attributed to missing F-actin assembly machinery in the GLD2-knockdown. 
Therefore, we tested for the presence of a number of factors known to be involved in F-
actin formation, including profilin and dynamin.  RT-PCR showed that dynamin was expressed 
in wild-type, but not in GLD2-deficient, testes (Fig. 5.7).  Dynamin has previously been shown 
to be necessary in late spermatogenesis for assembly of F-actin cones at spermatid nuclei 
(Ghosh-Roy et al., 2005).  The absence of dynamin in GLD2-deficient testes may account for the 
lack of F-actin individualization cones in late-stage spermatids; however, as with the transition 
protein transcript, we cannot determine whether the absence of the dynamin transcript is a direct 
result of lack of polyadenylation by GLD2, or rather a secondary result of a block to 
spermatogenesis occurring upstream of dynamin regulation. 
Candidate target testing:  We have tested candidate transcripts for changes in poly(A) tail 
length due to GLD2 by PAT assay, but thus far have not found a change in the polyadenylation 
status in GLD2 knockdowns for any mRNA tested (Table 5.1).  Candidates were chosen based 
on the phenotype of the GLD2 knockdown; specifically, gene transcripts known to be necessary 
for the affected late spermatogenesis events such as basal body formation, nuclear anchoring, 
nuclear compaction, or individualization were tested by PAT assay.  A change in poly(A) tail 
length due to amount of GLD2 would indicate a positive hit.  We did not identify any targets of 
GLD2 using this candidate approach.  All transcripts that were tested by PAT assay (with the 
exception of tpl94D and dynamin, see above) were present in GLD2-knockdown and control 
testes, and variation in transcript length between GLD2-knockdown and control samples was not 
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 detected.  However, it is conceivable that because some of the candidate genes have multiple 
transcript isoforms, a change in some minor isoform could have gone undetected.  Additionally, 
it is possible that tpl94D and dynamin transcripts, which are not detectable in GLD2 knockdown 
testes, are true targets of GLD2.  Without GLD2, target transcripts would have short poly(A) 
tails, which may cause increased susceptibility to degradation in the cytoplasm by exonucleases.  
Another possibility is that GLD2 is responsible for polyadenylation of a master regulator of 
spermiogenesis, such as a transcription factor, and the many aspects of the GLD2 phenotype 
occur as a result of one missing regulatory step. 
5.4  Conclusions 
We have shown that in the absence of GLD2, spermiogenesis is severely compromised in 
Drosophila.  The earliest defects are seen in early post-meiotic spermatids, when the basal body 
fails to attach and the nuclei begin to scatter.  Many downstream events are also affected, 
including protamine translation and F-actin cone formation, as well as stability of dynamin and 
transition protein transcripts.  However, without identifying the direct targets of GLD2, we 
cannot determine whether later defects are directly due to GLD2, or they are a result of improper 
nuclear positioning or malformed basal bodies.  
Based on results by Kwak and colleagues (2004) showing that GLD2 has poly(A) 
polymerase activity, it is very likely that GLD2 functions as a cytoplasmic poly(A) polymerase 
during spermatogenesis.  GLD2 could be responsible for turning on a single or small number of 
master regulators for post-meiotic spermatid development.  Alternatively, GLD2 could act on a 
suite of transcripts required in early spermatids, and perhaps even another subset of transcripts 
needed later at the distal end of the spermatogenic cyst.  The fact that there is a long period 
during which some transcripts must remain stable and untranslated in the cytoplasm, as well as 
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the fact that the CPEB homolog orb is turned expressed during late spermatogenesis (Barreau et 
al., 2008), supports the hypothesis that GLD2 is a cytoplasmic poly(A) polymerase important for 
spermatogenesis.   
It is interesting that Gld2 is critical for post-meiotic spermatogenesis in Drosophila, yet 
all Gld-2 family members analyzed so far in Drosophila and other species play roles specifically 
at meiosis. We hypothesize that GLD2’s male germline function reflects its evolutionary origin: 
duplication of the X-linked wispy locus allows for a testis-expressed derived autosomal copy that 
can be expressed during MSCI.   Although this is the first example of a Gld-2 family member 
with a role solely in spermatogenesis, other species may have developed similar mechanisms of 
translational control in the testes; for example, spermatogenesis in mice is regulated in part by a 
cytoplasmic poly(A) polymerase outside of the Gld-2 family called TPAP (Kashiwabara et al., 
2002).  Further investigation and identification of GLD2 targets in Drosophila testes will help to 
elucidate how spermatogenesis can be regulated through cytoplasmic polyadenylation. 
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 CHAPTER 6 
 
THESIS SUMMARY AND PERSPECTIVES 
 
 Egg activation is a highly conserved set of events among animals, yet Drosophila is just 
emerging as a viable model for studying this process. The results described in this dissertation 
show that like in other organisms, Drosophila oocytes experience an increase in cytosolic Ca2+ 
levels as a trigger for egg activation. Furthermore, high-throughput biochemical analysis, 
phenotypic analysis, and evolutionary analysis has demonstrated the versatility of this organism 
in approaching important questions of egg activation. In this chapter, I discuss the implications 
of the work presented in this dissertation and provide perspectives pertaining to future studies. 
A convergent Ca2+ influx as a trigger for egg activation 
Until relatively recently—only seven years ago—it was unknown whether calcium 
played a role in egg activation in Drosophila. Because the trigger for egg activation is quite 
different in fruitflies and some other insects, Drosophila has been somewhat overlooked as a 
model system for this process. However, some important discoveries have been made concerning 
the requirement for and source of the calcium, the relationship of calcium to the trigger of the 
release from the ovary into the oviduct, and the components of the subsequent signaling 
pathway. Taken together, calcium is absolutely required for egg activation in Drosophila, and 
many of the downstream signaling components are conserved among species. Furthermore, 
without the fertilizing sperm, their egg activation events are driven solely by maternal 
components within the oocyte, affording a different view of egg activation than can be observed 
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in other organisms. Thus, I posit that Drosophila is not only viable but also uniquely valuable as 
a model system for egg activation, especially given the availability of genetic tools and ease of 
rearing and manipulation in this organism.  
The work I have presented in Chapter 2 focuses on visualizing a calcium influx during 
egg activation in live Drosophila oocytes. In mice and other vertebrate species, the fertilizing 
sperm sparks a rise in cytosolic Ca2+ levels, and this event triggers egg activation events. In 
mice, several different types of calcium channels work together to propagate the influx that 
occurs upon egg activation (Malcuit et al., 2006). While the first calcium transient results from 
Ca2+ release from the ER following sperm-induced phosphoinositide signaling, further 
oscillations depend upon a number of different calcium channels and ion pumps. When Ca2+ 
levels are depleted from ER stores, sarco/endoplasmic reticulum Ca2+-ATPase (SERCA) pumps 
on the ER membrane must actively transport Ca2+ from the cytosol back into the ER. 
Furthermore, plasma membrane Ca2+-ATPase (PMCA) pumps on the cell surface move Ca2+ out 
of the cell to restore normal cytosolic Ca2+ levels. Thus, for each oscillation, the intracellular 
Ca2+ levels are elevated for several minutes. In organisms whose oocytes undergo multiple 
waves at fertilization, oscillations following the initial sperm-induced transient rely not only 
upon Ca2+ from the ER, but also Ca2+ influx from the external environment (Miao et al., 2012). 
On the other hand, not all organisms’ oocytes undergo multiple oscillations: in the large eggs of 
frogs and fish, for example, only a single large calcium transient is produced (Stricker, 1999).  
My work shows that the Ca2+ requirement for egg activation is conserved in Drosophila. 
However, the mode of Ca2+ elevation is different from that of most other organisms studied. 
Notably, I found that release of calcium from intracellular stores is not required for calcium wave 
propagation: inhibition of members of the phosphoinositide signaling pathway does not 
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compromise the cytosolic calcium increase during egg activation. Instead, Ca2+ from the 
extracellular environment enters the oocyte through TRP family mechanosensitive channels. 
However, it is unclear exactly which type of TRP channel mediates the Ca2+ influx, or which 
channels are present on the egg cell surface. Several members of the TRP family of calcium 
channels (reviewed in (Montell, 2005)) are activated by mechanical stress, including nompC 
(which is activated by cytoskeletal tension (Walker et al., 2000)), nanchung, and inactive (both 
activated by hypoosmolarity (Gong et al., 2004; Kim et al., 2003)). Although transcripts 
encoding these particular TRP channels are not detectable by RT-PCR in the adult ovary (Horner 
and Wolfner, 2008a), and thus cannot be the sensors for the egg activation trigger, a fourth TRP 
protein that may be responsive to mechanical stimuli, TRPA encoded by the painless gene, is 
expressed in the ovary (Horner and Wolfner, 2008a), but it has not yet been tested for a role in 
egg activation. In addition, mechanosensitive channels of a different class, the DEG/ENaC 
family are expressed in ovaries and thus are candidates for involvement in egg activation. Only 
one member of this family, ripped pocket (rpk), had been tested, and its mutant exhibited normal 
fertility (Horner and Wolfner, 2008a). However, that mutant is not null so it is not possible to 
conclusively rule out a role for rpk in egg activation. Additional mechanosensitive channels of 
the TRP and DEG/ENaC families are expressed in the ovary (Chintapalli et al., 2007; McQuilton 
et al., 2012). An important direction for future study is to assess the roles of these ovary-
expressed channels in egg activation and their localization, if any, to the egg cell surface. 
One surprising result that came from the study is the form of the influx itself. In most 
organisms, the calcium influx initiates from the point of sperm entry and traverses across the 
egg. However, Drosophila does not require sperm entry for egg activation. Therefore, before we 
began this study we could imagine several possible scenarios: (1) If the Drosophila oocyte opens 
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stretch-activated calcium channels as a result of fluid uptake in the oviduct, which likely exerts 
pressure across all parts of the egg membrane uniformly, we would expect an isometric rise in 
cytoplasmic calcium levels, instead of a wave initiating from a single point (as occurs in systems 
that require sperm entry for activation). (2) Since the posterior pole of the oocyte enters the 
oviduct first, and thus pressure is first exerted posteriorly, a calcium rise may initiate from the 
posterior and propagate anteriorly in vivo. (3) The calcium rise may initiate from the micropyle 
(the small opening through which the sperm enters) on the anterior end of the oocyte, which is 
analogous to the point of sperm entry in oocytes of other organisms, even though the Drosophila 
egg activation does not require fertilization. In this case, a calcium wave would propagate from 
the anterior to the posterior.  
However, none of these scenarios was observed in my in vitro studies. Instead, I observed 
an increase originating from either pole and moving inward to finally converge at the center of 
the egg. Typically, a rise in Ca2+ levels would be visible first at the anterior pole, followed by an 
increase at the posterior pole. The high Ca2+ regions would expand towards the interior and 
plateau for several minutes, after which time levels would then fall to baseline first from the 
poles and lastly in the interior. The question remains whether these particular dynamics are 
specific to in vitro egg activation or if the wave occurs in the same way in vivo. An in vivo 
imaging technique will need to be developed to answer this question. 
Perhaps the most interesting question is, what happens after the Ca2+ influx? What are the 
biochemical pathways involved in connecting the initial Ca2+ increase to all of the major egg 
activation events (meiosis resumption, transcript turnover, etc.)? The initial steps of this process 
are likely conserved in many species. I believe that the calcium-binding protein calmodulin 
(CaM) is involved as a first step and then interacts with downstream calcium-dependent kinases 
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(likely CaMKII) and phosphatases (calcineurin) to spark signaling pathways. However, studying 
the requirement for CaM and CaMKII has been difficult in Drosophila. One challenge for such 
genetic analysis is that global knockout of either CaM or CaMKII is lethal to the animal, so, 
tissue-specific knockdowns must be tested. CaM-deficient germline clones were generated to 
study CaM’s role in oogenesis and embryogenesis, but surprisingly, the germlines of these flies 
were not depleted of CaM protein. Though the germline cells were indeed CaM-null, it appeared 
that CaM protein was able to enter the germline cells from the surrounding somatic cells 
(Andruss et al., 2004). Thus, it was not possible to determine definitively whether CaM plays a 
role at egg activation. However, Andruss and colleagues observed that some mature oocytes 
absorbed less somatic CaM than others (anywhere between 28% and 76% that of heterozygous 
controls), and those that received relatively little somatic CaM show severe defects upon 
embryogenesis, though oogenesis occurs relatively normally (Andruss et al., 2004). These latter 
results support the idea that CaM plays a role in the egg-to-embryo transition, although further 
experiments are needed to fully prove this hypothesis. 
It has not yet been possible to test for a role for CaMKII in Drosophila egg activation 
because the location of the CaMKII gene, on Drosophila’s fourth chromosome, has precluded the 
generation of germline clones. However, a method to generate mitotic clones for fourth 
chromosome genes in the soma has just been reported (Sousa-Neves and Schinaman). Future 
tweaks to this system may make it possible to induce loss of CaMKII expression in the germline 
while maintaining normal expression in the soma. 
Because generating germline clones deficient for CaM or CaMKII has not yet been 
possible, attempts have been made to knock down the amount or activity of these proteins using 
other means. Interfering RNA (Harvard Medical School, TRiP) or inhibitory peptides targeted 
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against CaM (VanBerkum and Goodman, 1995) or CaMKII (Griffith et al., 1993) can be 
expressed in the germline. Preliminary experiments of this type have not produced an effect on 
egg activation or fertility (A. Krauchunas, K. Kumar, Y. Lai, K. Sackton, C. Sartain, and M. 
Wolfner, unpublished data), but it is possible that the abundant maternal stores of CaM or 
CaMKII in oocytes cannot be sufficiently inhibited by these methods. Thus, at present we cannot 
evaluate whether CaM and CaMKII are essential for egg activation. We expect that new genetic 
techniques for germline analysis will allow us to study these proteins’ roles in the future. 
Transcript regulation downstream of the activating signal 
Through as of yet unknown signaling pathways, the trigger for egg activation eventually 
results in major changes to the pool of maternal mRNAs stored within the cytoplasm. 
Approximately 55% of the entire Drosophila genome is represented among the stored transcript 
pool in mature oocytes (transcripts from an estimated 7745 genes), where they remain in a 
stored, quiescent state (Tadros et al., 2007). Upon egg activation, these transcripts must become 
active and are either translated or degraded as the egg transitions to embryogenesis. Previous 
studies have demonstrated that about 20% of the transcripts present in mature oocytes are 
degraded at egg activation in eggs from virgin females: this represents the degradation that 
occurs as a direct result of egg activation (Tadros et al., 2007). Our studies on the cytoplasmic 
poly(A) polymerase wispy indicate that approximately 73% of transcripts present at egg 
activation get polyadenylated in a wisp-dependent manner (Chapter 4). Polyadenylation has been 
shown to promote translation, as in the case of bicoid transcripts (Benoit et al., 2008). With these 
numbers taken together, we have a broad view of the fates of stored transcripts upon egg 
activation. 
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The specific mechanism regulating each transcript may require more work. Previous 
studies have shown that approximately two-thirds of the transcripts destined for degradation are 
targets of SMG, a conserved posttranscriptional regulator (Tadros et al., 2007). SMG targets 
have sequence elements in the 3’UTR that recruit SMG (Smaug Repressive Element, SRE), 
which promotes deadenylation and degradation if repression is not relieved (Vardy and Orr-
Weaver, 2007a). There are a handful of other repressive elements that may lie in the 3’UTR, 
signaling repression by other translational inhibitors such as PUMILIO and BRUNO (Vardy and 
Orr-Weaver, 2007a). These may regulate the other one-third of degraded transcripts that are 
SMG-independent. 
We were unable to find a sequence element that signals for WISP-dependent cytoplasmic 
polyadenylation. Like other Gld-2 family members, WISP does not have RNA-binding 
capabilities by itself and must pair with a binding partner (BIC-C, the Drosophila Gld-3 
homolog) in order to bind RNA (Wang et al., 2002). We searched for shared sequence motifs 
among the targets of WISP identified in our microarray data, but we were unable to find a 
consensus sequence using these methods. In frogs, for example, there is a known element in the 
3’UTR that binds CPEB (Drosophila ORB), and GLD-2 (Drosophila WISP) is a part of this 
complex (Kim and Richter, 2007). However, there are far fewer GLD-2 targets in other species 
(for example, 550 in worms (Kim et al., 2010)), so finding statistical significance for a single 
consensus sequence may be less confounding. Better computational methods will be required to 
identify a sequence element for WISP-dependent polyadenylation in Drosophila. 
The prg and wisp mutations were both identified in a screen for X-linked mutations that 
caused failure of egg activation and particularly failure to degrade key transcripts at egg 
activation (Tadros et al., 2003). Jun Cui mapped wisp to a poly(A) polymerase and classified its 
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action at egg activation (Cui et al., 2008), and mapped prg to a predicted exonuclease with no 
known function (Chapter 3). I had originally hypothesized that PRG might be responsible for 
destabilization of repressed transcripts at egg activation through its predicted exonuclease 
activity. To this end, I ran RNA-seq to detect differences in stored transcript abundance prior to 
zygotic genome activation (ZGA) in activated eggs (Chapter 3). Unfortunately, my data did not 
reveal any large-scale changes in transcript abundance between wild-type and prg mutant 
samples. However, Hsp83 was among the significant hits returned by the data analysis; this is an 
important internal control, since prg was first identified using Hsp83 degradation as a diagnostic 
marker (Tadros et al., 2003). Therefore, I believe that the data are reliable, but using an FDR 
cutoff of 0.05 I may be obtaining a large number of false negatives. My data lack biological 
replicates, which may drive the P-values to non-significant levels. Ideally, we would run more 
replicates to get a more accurate view of the true positives; however, we will likely get a close 
approximation by doing a simpler screening of the data returned by this RNA-seq experiment. I 
propose running qPCR on a range of hits by either P-value or fold-change (similar to what was 
done to conform the WISP microarray data, Chapter 4) to narrow down (or in this case, to 
broaden) our window of how many transcripts change abundance in a PRG-dependent manner. 
The egg activation phenotype of eggs from prg mutant mothers is also questionable. 
When prg was originally identified, the authors claimed that vitelline membrane reorganization 
occurred normally but meiosis failed to complete (Tadros et al., 2003). They used the same 
bleach-resistance assay as I have used and found that prg eggs did not lyse during incubation 
with bleach. On the contrary, I found that prg eggs are extremely fragile. While the eggs did not 
completely dissolve in bleach in the same way unactivated eggs do, eggs from prg mutant 
mothers were markedly different from their wild-type counterparts after bleach incubation 
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(Chapter 3). Additionally, I attempted manual chorion removal using double-sided tape, which is 
possible with activated eggs that have undergone proper VM crosslinking; I found that the prg 
eggs were extremely fragile. I often destroyed the eggs, and in the few instances in which I was 
able to remove the outer chorion, I could not touch the egg or it would burst. This indicates that 
the VM is especially fragile, but the “empty bag” appearance they take on after bleach incubation 
suggests that some crosslinking may have occurred. I believe it is likely that there is some role 
for PRG during oogenesis, possibly in the somatic cells that synthesize the eggshell components. 
It might be useful to separate somatic and germline functions (i.e., knockout prg everywhere 
except the germline or ectopically express prg in somatic cells of a prg mutant) in order to 
narrow down the precise egg activation defects in eggs from prg mutant mothers. 
Cytoplasmic polyadenylation during spermatogenesis 
In our lab’s original wispy study, Jun Cui noticed that the Drosophila genome encoded a 
gene closely related to wispy: CG5732, now called Gld2 (Cui et al., 2008). As a rotation project, 
I studied the role of this gene as a cytoplasmic poly(A) polymerase similar to wispy (Chapter 5). 
Unexpectedly, Gld2 played no role in female gametogenesis, but instead had roles in 
spermatogenesis. Unlike eggs, sperm do not need to contribute many nutrients to embryogenesis; 
instead, sperm cells should be compact and nimble, essentially a nucleus with a propeller. During 
spermatogenesis in Drosophila and other organisms, some transcripts are synthesized early, 
during premeiotic spermatocyte growth phases, but are not translated until after meiosis has 
completed. This is likely where GLD2 is required, but I was unable to provide direct evidence of 
any transcript that undergoes GLD2-dependent polyadenylation. Whatever the targets of GLD2 
in spermatogenesis, they are essential to this process: without GLD2, males cannot complete 
proper spermatogenesis and thus are completely sterile. Ideally, I would like to perform a high-
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throughput experiment in order to identify all the targets of GLD2 during spermatogenesis. 
Though we were able to successfully globally identify WISP targets using microarrays, I would 
recommend RIP-chip for future studies of this kind, since this single experiment allows 
identification of an RNA directly bound within the GLD-2 protein complex, whereas our 
microarray is a more indirect measure that we must assume is GLD-2 dependent. However, we 
did not perform this experiment on the sperm GLD2 because of issues obtaining great enough 
amounts of material from the Drosophila testes. Additionally, because we are traditionally not a 
spermatogenesis lab, such a time-consuming experiment is not a high priority for us at this point.  
It is interesting that Drosophila has independently developed two GLD-2 homologs with 
separate functions, whereas most GLD-2 homologs studied act solely in the female germline 
(with the exception of hermaphroditic worms). In collaboration with Richard Meisel in Andy 
Clark’s lab, I found that wisp and Gld2 are paralogous genes that have uniquely arisen in the 
Drosophila genus. Gld2 appears to be the derived copy while wisp lies in the ancestral 
chromosomal location. However, because in Drosophila the original GLD-2 homolog was on the 
X chromosome, it may have required duplication to an autosome in order to maintain expression 
during meiosis (MSCI avoidance, Chapter 5). It would be interesting to explore the requirement 
of GLD-2 homologs in males of other species to see if the same GLD-2 is required in both male 
and female germlines, or if this is a unique property of Drosophila GLD2. 
Summary 
My work has tied up some outstanding questions in Drosophila egg activation, and also 
opens doors to new research questions. I have made significant advances in examining calcium 
dynamics. Using the flies generated by the Aigaki lab, I have developed a method for 
successfully imaging calcium waves in Drosophila eggs, and have for the first time shown that a 
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calcium influx occurs in eggs of this species. This work pushes Drosophila forward as an 
important and useful model system for this process. I have also further classified the defects in 
eggs of wisp and prg mutant mothers, allowing for a more comprehensive view of RNA 
regulation during egg activation.
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   APPENDIX A. 
SUMMARY AND RESULTS OF CALCIUM DRUGS TESTED 
 To aid in future investigations of Ca2+ dynamics during egg activation in Drosophila 
melanogaster, I have compiled a list of all pharmacological inhibitors tested on activating 
oocytes to date (Table A1). Many of the inhibitors tested prior to January 2013 were only tested 
for their ability to inhibit vitelline membrane crosslinking using the bleach assay (described in 
Chapter 3 of this dissertation). I believe the bleach assay to be a less reliable assay for testing 
various aspects of the calcium influx; these reagents should be retested using the treatment and 
microscopy methods described in Chapter 2 instead. 
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Table A1. Pharmacological agents tested on activating oocytes. 
Drug Function Method Result Who Date 
U-73122 PLC inhibitor 10-20µM in bleach assays No effect VLH May-03 
    10-20µM GCaMP microscopy  No effect CVS Mar-13 
wortmannin PI3K inhibitor 1-5µM GCamP microscopy No effect CVS Mar-13 
GdCl3 SA channel blocker 100µM in bleach assays Inhibits VLH Oct-03 
    100-400µM GCaMP microscopy Inhibits CVS Mar-13 
    10µM GCaMP microscopy No effect CVS Jul-13 
Amiloride Blocks Na/H exchanger 10-100µM in bleach assays No effect VLH Nov-03 
Ryanodine Receptor channel on ER 50µM in bleach assays no effect VLH Dec-04 
Ruthenium Red Blocks RyR, some TRP 10µM in bleach assays, meiosis no effect VLH Dec-04 
    10µM GCaMP microscopy No effect CVS Jul-13 
XestosponginC Blocks IP3 350nM in bleach assays no effect VLH Dec-04 
thapsigargin Blocks SERCA pump 100-400µM in bleach assays inconsistent CVS 2012 
verapamil L-type blocker 50µM in bleach assays poor controls YWL Jan-10 
NiCl2 R-type blocker 1-5mM in bleach assays trend YWL Jan-10 
CdCl2 channel blocker 10mM in bleach assays Inhibits YWL Jan-10 
SNX-482 Block R-type channel 30nM in bleach assays poor controls YWL Dec-09 
w-conotoxin channel blocker 3µM in bleach assays no effect YWL Jan-10 
nifedipine L-type blocker 10µM in bleach assays no effect YWL Jan-10 
MRS-1845 SOC inhibitor 5µM in bleach assays poor controls MO/CVS Aug-12 
Calmidazolium CaM inhibitor 10µM in bleach assays moderate MO/CVS Aug-12 
ACA TRP blocker, broad 20µM in bleach assays No effect MO/CVS Aug-12 
    10-20µM GCaMP microscopy Inhibits CVS May-13 
BAPTA Ca2+ chelator Chelate Ca in buffer to <50nM       
    GCaMP microscopy assays inhibits CVS May-13 
    Bleach assay inhibits VLH 2008 
VLH = Vanessa Horner 
CVS = Caroline Sartain 
YWL = Yun Wei Lai 
MO = Misato Okajima (Tokyo Metropolitan University) 
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APPENDIX B 
DAVID ANALYSIS OF WISPY MICROARRAYS 
The following tables are the full results of gene ontology analysis using the program 
DAVID on subsets of genes identified in our WISPY microarray study (Chapter 4).  
 
Table B1. Oocyte DAVID analysis, transcripts ≥2-fold higher in control than wisp 
Term Count P value Bonferroni 
Biological process    
GO:0051276~chromosome organization 133 2.76E-30 7.46E-27 
GO:0006259~DNA metabolic process 105 3.03E-24 8.19E-21 
GO:0007049~cell cycle 209 1.46E-23 3.94E-20 
GO:0000278~mitotic cell cycle 141 1.50E-22 4.06E-19 
GO:0022402~cell cycle process 181 4.63E-19 1.25E-15 
GO:0048285~organelle fission 76 4.41E-19 1.19E-15 
GO:0007010~cytoskeleton organization 161 4.37E-19 1.18E-15 
GO:0000087~M phase of mitotic cell cycle 74 8.43E-19 2.28E-15 
GO:0007067~mitosis 73 1.49E-18 4.01E-15 
GO:0008104~protein localization 141 2.20E-18 5.94E-15 
GO:0000280~nuclear division 73 3.88E-18 1.05E-14 
GO:0006260~DNA replication 55 1.74E-17 4.69E-14 
GO:0007059~chromosome segregation 62 2.06E-17 5.57E-14 
GO:0051301~cell division 86 1.07E-15 3.00E-12 
GO:0000226~microtubule cytoskeleton organization 111 1.27E-15 3.30E-12 
GO:0043933~macromolecular complex subunit organization 106 2.25E-15 6.00E-12 
GO:0022403~cell cycle phase 157 1.98E-14 5.37E-11 
GO:0051726~regulation of cell cycle 71 1.38E-13 3.73E-10 
GO:0033043~regulation of organelle organization 54 1.36E-13 3.67E-10 
GO:0006325~chromatin organization 72 1.64E-13 4.44E-10 
GO:0000279~M phase 149 4.09E-13 1.11E-09 
GO:0034621~cellular macromolecular complex subunit organization 80 6.37E-13 1.72E-09 
GO:0007017~microtubule-based process 131 8.67E-13 2.34E-09 
GO:0046907~intracellular transport 108 1.09E-12 2.96E-09 
GO:0006261~DNA-dependent DNA replication 35 1.91E-12 5.16E-09 
GO:0007051~spindle organization 84 4.80E-12 1.30E-08 
GO:0045184~establishment of protein localization 99 6.98E-12 1.89E-08 
GO:0048610~reproductive cellular process 149 1.95E-11 5.28E-08 
GO:0065003~macromolecular complex assembly 88 2.04E-11 5.51E-08 
GO:0015031~protein transport 96 2.22E-11 6.00E-08 
 167 
GO:0044265~cellular macromolecule catabolic process 82 3.70E-11 9.99E-08 
GO:0007242~intracellular signaling cascade 99 1.03E-10 2.77E-07 
GO:0016568~chromatin modification 50 1.40E-10 3.79E-07 
GO:0000819~sister chromatid segregation 29 1.84E-10 4.97E-07 
GO:0009057~macromolecule catabolic process 93 2.66E-10 7.19E-07 
GO:0007052~mitotic spindle organization 72 2.64E-10 7.13E-07 
GO:0032989~cellular component morphogenesis 149 3.37E-10 9.11E-07 
GO:0048477~oogenesis 153 5.44E-10 1.47E-06 
GO:0000070~mitotic sister chromatid segregation 28 6.25E-10 1.69E-06 
GO:0007292~female gamete generation 154 7.84E-10 2.12E-06 
GO:0000902~cell morphogenesis 130 1.18E-09 3.20E-06 
GO:0003006~reproductive developmental process 144 1.59E-09 4.30E-06 
GO:0033554~cellular response to stress 65 2.75E-09 7.44E-06 
GO:0019953~sexual reproduction 193 2.71E-09 7.32E-06 
GO:0007346~regulation of mitotic cell cycle 43 6.22E-09 1.68E-05 
GO:0006323~DNA packaging 33 6.64E-09 1.79E-05 
GO:0007276~gamete generation 187 7.09E-09 1.91E-05 
GO:0006281~DNA repair 44 7.53E-09 2.03E-05 
GO:0051656~establishment of organelle localization 36 7.84E-09 2.12E-05 
GO:0034622~cellular macromolecular complex assembly 61 8.66E-09 2.34E-05 
GO:0051640~organelle localization 38 9.22E-09 2.49E-05 
GO:0010605~negative regulation of macromolecule metabolic process 98 1.16E-08 3.13E-05 
GO:0030182~neuron differentiation 119 1.33E-08 3.59E-05 
GO:0006270~DNA replication initiation 14 1.31E-08 3.54E-05 
GO:0006350~transcription 130 1.56E-08 4.21E-05 
GO:0006974~response to DNA damage stimulus 47 1.66E-08 4.49E-05 
GO:0045449~regulation of transcription 203 1.79E-08 4.84E-05 
GO:0010564~regulation of cell cycle process 38 2.05E-08 5.54E-05 
GO:0048666~neuron development 104 2.39E-08 6.45E-05 
GO:0007264~small GTPase mediated signal transduction 45 2.46E-08 6.64E-05 
GO:0016192~vesicle-mediated transport 114 2.50E-08 6.75E-05 
GO:0070727~cellular macromolecule localization 79 4.23E-08 1.14E-04 
GO:0051225~spindle assembly 21 5.11E-08 1.38E-04 
GO:0030163~protein catabolic process 68 5.20E-08 1.40E-04 
GO:0019941~modification-dependent protein catabolic process 59 1.61E-07 4.36E-04 
GO:0010604~positive regulation of macromolecule metabolic process 52 1.79E-07 4.84E-04 
GO:0043632~modification-dependent macromolecule catabolic process 59 2.03E-07 5.49E-04 
GO:0016071~mRNA metabolic process 71 2.12E-07 5.72E-04 
GO:0007143~female meiosis 30 2.18E-07 5.89E-04 
GO:0031175~neuron projection development 87 2.26E-07 6.10E-04 
GO:0044257~cellular protein catabolic process 62 2.52E-07 6.81E-04 
GO:0051603~proteolysis involved in cellular protein catabolic process 62 2.52E-07 6.81E-04 
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GO:0045935~positive regulation of nucleobase, nucleoside, nucleotide 
and nucleic acid metabolic process 46 3.00E-07 8.10E-04 
GO:0051173~positive regulation of nitrogen compound metabolic 
process 46 3.00E-07 8.10E-04 
GO:0065004~protein-DNA complex assembly 25 3.60E-07 9.72E-04 
GO:0000904~cell morphogenesis involved in differentiation 90 3.71E-07 0.00100 
GO:0048812~neuron projection morphogenesis 86 3.93E-07 0.00106 
GO:0006357~regulation of transcription from RNA polymerase II 
promoter 63 7.08E-07 0.00191 
GO:0044087~regulation of cellular component biogenesis 34 7.63E-07 0.00206 
GO:0009968~negative regulation of signal transduction 40 8.11E-07 0.00219 
GO:0007281~germ cell development 75 8.08E-07 0.00218 
GO:0010557~positive regulation of macromolecule biosynthetic 
process 47 9.03E-07 0.00244 
GO:0031328~positive regulation of cellular biosynthetic process 53 9.89E-07 0.00267 
GO:0009891~positive regulation of biosynthetic process 53 9.89E-07 0.00267 
GO:0048667~cell morphogenesis involved in neuron differentiation 85 1.10E-06 0.00295 
GO:0010648~negative regulation of cell communication 40 1.08E-06 0.00293 
GO:0032504~multicellular organism reproduction 190 1.16E-06 0.00313 
GO:0048609~reproductive process in a multicellular organism 190 1.16E-06 0.00313 
GO:0043067~regulation of programmed cell death 42 1.23E-06 0.00333 
GO:0060284~regulation of cell development 47 1.49E-06 0.00400 
GO:0007088~regulation of mitosis 22 1.95E-06 0.00524 
GO:0051783~regulation of nuclear division 22 1.95E-06 0.00524 
GO:0030261~chromosome condensation 18 1.97E-06 0.00532 
GO:0007098~centrosome cycle 20 2.11E-06 0.00567 
GO:0016044~membrane organization 91 2.17E-06 0.00584 
GO:0010628~positive regulation of gene expression 43 2.19E-06 0.00591 
GO:0007293~germarium-derived egg chamber formation 28 3.20E-06 0.00860 
GO:0010629~negative regulation of gene expression 76 3.46E-06 0.00930 
GO:0010941~regulation of cell death 42 3.53E-06 0.00949 
GO:0030030~cell projection organization 100 4.57E-06 0.01227 
GO:0045941~positive regulation of transcription 42 4.53E-06 0.01218 
GO:0031023~microtubule organizing center organization 23 4.51E-06 0.01211 
GO:0006397~mRNA processing 61 5.16E-06 0.01384 
GO:0007444~imaginal disc development 110 5.22E-06 0.01400 
GO:0007163~establishment or maintenance of cell polarity 40 5.50E-06 0.01475 
GO:0051254~positive regulation of RNA metabolic process 35 5.57E-06 0.01495 
GO:0051960~regulation of nervous system development 35 5.57E-06 0.01495 
GO:0012501~programmed cell death 51 5.73E-06 0.01537 
GO:0006403~RNA localization 44 5.96E-06 0.01599 
GO:0008356~asymmetric cell division 26 6.51E-06 0.01743 
GO:0008219~cell death 53 6.73E-06 0.01803 
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GO:0034613~cellular protein localization 57 7.22E-06 0.01932 
GO:0070271~protein complex biogenesis 54 7.97E-06 0.02131 
GO:0006461~protein complex assembly 54 7.97E-06 0.02131 
GO:0016265~death 53 8.21E-06 0.02193 
GO:0009798~axis specification 62 8.44E-06 0.02254 
GO:0006644~phospholipid metabolic process 33 8.52E-06 0.02276 
GO:0045893~positive regulation of transcription, DNA-dependent 34 9.17E-06 0.02447 
GO:0022604~regulation of cell morphogenesis 42 9.35E-06 0.02495 
GO:0007062~sister chromatid cohesion 12 1.03E-05 0.02733 
GO:0035220~wing disc development 80 1.05E-05 0.02801 
GO:0051129~negative regulation of cellular component organization 25 1.12E-05 0.02979 
GO:0048469~cell maturation 44 1.18E-05 0.03140 
GO:0051252~regulation of RNA metabolic process 164 1.30E-05 0.03443 
GO:0019637~organophosphate metabolic process 36 1.33E-05 0.03539 
GO:0042981~regulation of apoptosis 36 1.33E-05 0.03539 
GO:0051297~centrosome organization 21 1.38E-05 0.03660 
GO:0030707~ovarian follicle cell development 62 1.41E-05 0.03736 
GO:0006277~DNA amplification 13 1.46E-05 0.03873 
GO:0045132~meiotic chromosome segregation 25 1.61E-05 0.04256 
GO:0006333~chromatin assembly or disassembly 25 1.61E-05 0.04256 
Cellular compartment    
GO:0005694~chromosome 134 1.96E-24 1.05E-21 
GO:0044427~chromosomal part 107 2.02E-19 1.09E-16 
GO:0005654~nucleoplasm 106 1.67E-15 8.98E-13 
GO:0044451~nucleoplasm part 95 1.35E-13 7.28E-11 
GO:0005819~spindle 40 2.53E-12 1.37E-09 
GO:0012505~endomembrane system 81 4.65E-10 2.51E-07 
GO:0031981~nuclear lumen 123 1.04E-09 5.63E-07 
GO:0031974~membrane-enclosed lumen 163 9.66E-09 5.21E-06 
GO:0043232~intracellular non-membrane-bounded organelle 245 1.17E-08 6.32E-06 
GO:0043228~non-membrane-bounded organelle 245 1.17E-08 6.32E-06 
GO:0043233~organelle lumen 158 2.48E-08 1.34E-05 
GO:0070013~intracellular organelle lumen 158 2.48E-08 1.34E-05 
GO:0005635~nuclear envelope 40 2.32E-08 1.25E-05 
GO:0000775~chromosome, centromeric region 27 1.83E-07 9.88E-05 
GO:0005700~polytene chromosome 40 2.17E-07 1.17E-04 
GO:0000228~nuclear chromosome 35 4.10E-07 2.21E-04 
GO:0044454~nuclear chromosome part 32 8.40E-07 4.53E-04 
GO:0032993~protein-DNA complex 22 1.34E-06 7.21E-04 
GO:0000785~chromatin 44 1.86E-06 0.00100 
GO:0005813~centrosome 26 2.12E-06 0.00114 
GO:0005876~spindle microtubule 14 3.88E-06 0.00209 
GO:0005815~microtubule organizing center 28 4.15E-06 0.00224 
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GO:0000922~spindle pole 15 1.23E-05 0.00663 
GO:0000932~cytoplasmic mRNA processing body 9 1.36E-05 0.00730 
GO:0005656~pre-replicative complex 9 1.36E-05 0.00730 
GO:0015630~microtubule cytoskeleton 69 1.45E-05 0.00779 
GO:0005856~cytoskeleton 98 4.34E-05 0.02312 
GO:0016585~chromatin remodeling complex 19 4.74E-05 0.02520 
GO:0005938~cell cortex 30 6.34E-05 0.03358 
GO:0000776~kinetochore 16 8.36E-05 0.04407 
GO:0046930~pore complex 22 8.14E-05 0.04295 
GO:0005643~nuclear pore 21 9.18E-05 0.04826 
Molecular function    
GO:0000166~nucleotide binding 341 5.41E-18 5.94E-15 
GO:0032553~ribonucleotide binding 274 2.95E-17 3.24E-14 
GO:0032555~purine ribonucleotide binding 274 2.95E-17 3.24E-14 
GO:0017076~purine nucleotide binding 282 6.42E-15 7.07E-12 
GO:0003677~DNA binding 244 1.74E-14 1.91E-11 
GO:0008270~zinc ion binding 287 4.96E-14 5.44E-11 
GO:0005524~ATP binding 221 2.35E-13 2.58E-10 
GO:0032559~adenyl ribonucleotide binding 221 3.08E-13 3.38E-10 
GO:0001883~purine nucleoside binding 231 9.20E-12 1.01E-08 
GO:0001882~nucleoside binding 231 2.33E-11 2.56E-08 
GO:0030554~adenyl nucleotide binding 228 2.76E-11 3.03E-08 
GO:0004386~helicase activity 51 1.07E-10 1.17E-07 
GO:0019899~enzyme binding 34 1.14E-08 1.25E-05 
GO:0003729~mRNA binding 68 2.38E-08 2.61E-05 
GO:0046914~transition metal ion binding 323 7.25E-07 7.96E-04 
GO:0008026~ATP-dependent helicase activity 34 1.59E-06 0.00174 
GO:0070035~purine NTP-dependent helicase activity 34 1.59E-06 0.00174 
GO:0015631~tubulin binding 30 5.58E-06 0.00611 
GO:0008094~DNA-dependent ATPase activity 20 5.41E-06 0.00592 
GO:0003678~DNA helicase activity 21 8.99E-06 0.00982 
GO:0016251~general RNA polymerase II transcription factor activity 35 1.64E-05 0.01783 
GO:0008017~microtubule binding 27 3.39E-05 0.03655 
GO:0046872~metal ion binding 385 4.03E-05 0.04332 
KEGG pathway    
dme04120:Ubiquitin mediated proteolysis 42 4.07E-06 4.11E-04 
dme03040:Spliceosome 44 3.35E-05 0.00338192 
dme03030:DNA replication 19 7.19E-05 0.00723181 
dme04144:Endocytosis 33 1.77E-04 0.01771768 
dme04914:Progesterone-mediated oocyte maturation 20 4.39E-04 0.04337785 
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Table B2. Oocyte DAVID analysis, transcripts ≥3-fold higher in control than wisp 
Term Count P-value Bonferroni 
Biological process    
GO:0007049~cell cycle 172 1.23E-22 2.84E-19 
GO:0051276~chromosome organization 117 8.61E-21 9.89E-18 
GO:0022402~cell cycle process 150 2.59E-20 1.98E-17 
GO:0022403~cell cycle phase 131 7.43E-18 4.27E-15 
GO:0000279~M phase 124 3.16E-17 1.45E-14 
GO:0000087~M phase of mitotic cell cycle 67 4.98E-16 1.70E-13 
GO:0007067~mitosis 66 5.61E-16 1.82E-13 
GO:0000280~nuclear division 66 2.47E-15 7.02E-13 
GO:0048285~organelle fission 68 3.70E-15 9.35E-13 
GO:0006259~DNA metabolic process 84 5.28E-15 1.22E-12 
GO:0000278~mitotic cell cycle 119 5.44E-15 1.14E-12 
GO:0010605~negative regulation of macromolecule metabolic 
process 83 7.87E-12 1.51E-09 
GO:0007059~chromosome segregation 53 9.97E-11 1.76E-08 
GO:0051726~regulation of cell cycle 62 5.82E-10 9.55E-08 
GO:0006260~DNA replication 43 1.38E-09 2.12E-07 
GO:0051301~cell division 71 1.45E-09 2.08E-07 
GO:0048610~reproductive cellular process 117 7.84E-09 1.06E-06 
GO:0006325~chromatin organization 62 1.40E-08 1.79E-06 
GO:0006974~response to DNA damage stimulus 44 2.39E-08 2.89E-06 
GO:0065004~protein-DNA complex assembly 24 2.71E-08 3.12E-06 
GO:0019953~sexual reproduction 147 2.85E-08 3.11E-06 
GO:0051327~M phase of meiotic cell cycle 43 2.99E-08 3.13E-06 
GO:0007126~meiosis 43 2.99E-08 3.13E-06 
GO:0051321~meiotic cell cycle 44 4.15E-08 4.14E-06 
GO:0000226~microtubule cytoskeleton organization 87 5.80E-08 5.56E-06 
GO:0048477~oogenesis 118 7.58E-08 6.97E-06 
GO:0010558~negative regulation of macromolecule biosynthetic 
process 56 9.57E-08 8.46E-06 
GO:0031327~negative regulation of cellular biosynthetic process 56 9.57E-08 8.46E-06 
GO:0009890~negative regulation of biosynthetic process 56 9.57E-08 8.46E-06 
GO:0010629~negative regulation of gene expression 61 1.33E-07 1.13E-05 
GO:0000070~mitotic sister chromatid segregation 27 1.58E-07 1.30E-05 
GO:0007276~gamete generation 142 1.61E-07 1.27E-05 
GO:0007292~female gamete generation 118 1.92E-07 1.47E-05 
GO:0007017~microtubule-based process 103 2.18E-07 1.62E-05 
GO:0032504~multicellular organism reproduction 144 2.33E-07 1.67E-05 
GO:0048609~reproductive process in a multicellular organism 144 2.33E-07 1.67E-05 
GO:0007346~regulation of mitotic cell cycle 37 3.50E-07 2.44E-05 
GO:0000819~sister chromatid segregation 27 3.51E-07 2.37E-05 
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GO:0006281~DNA repair 39 3.81E-07 2.50E-05 
GO:0051172~negative regulation of nitrogen compound metabolic 
process 50 6.45E-07 4.12E-05 
GO:0045934~negative regulation of nucleobase, nucleoside, 
nucleotide and nucleic acid metabolic process 50 6.45E-07 4.12E-05 
GO:0006323~DNA packaging 30 8.54E-07 5.30E-05 
GO:0007051~spindle organization 67 9.31E-07 5.63E-05 
GO:0051253~negative regulation of RNA metabolic process 43 1.02E-06 5.99E-05 
GO:0045449~regulation of transcription 154 1.21E-06 6.94E-05 
GO:0045892~negative regulation of transcription, DNA-dependent 41 1.66E-06 9.30E-05 
GO:0003006~reproductive developmental process 109 1.78E-06 9.72E-05 
GO:0051252~regulation of RNA metabolic process 131 2.44E-06 1.30E-04 
GO:0009798~axis specification 51 4.82E-06 2.52E-04 
GO:0006261~DNA-dependent DNA replication 27 5.49E-06 2.80E-04 
GO:0045132~meiotic chromosome segregation 23 6.09E-06 3.04E-04 
GO:0007143~female meiosis 25 8.25E-06 4.03E-04 
GO:0007281~germ cell development 60 9.37E-06 4.49E-04 
GO:0007052~mitotic spindle organization 58 1.13E-05 5.30E-04 
GO:0016481~negative regulation of transcription 43 1.19E-05 5.48E-04 
GO:0003002~regionalization 86 1.62E-05 7.27E-04 
GO:0031328~positive regulation of cellular biosynthetic process 44 1.92E-05 8.50E-04 
GO:0009891~positive regulation of biosynthetic process 44 1.92E-05 8.50E-04 
GO:0007010~cytoskeleton organization 116 2.03E-05 8.79E-04 
GO:0009994~oocyte differentiation 39 2.21E-05 9.39E-04 
GO:0006350~transcription 99 2.24E-05 9.36E-04 
GO:0006333~chromatin assembly or disassembly 23 2.32E-05 9.53E-04 
GO:0010564~regulation of cell cycle process 29 3.06E-05 0.00123 
GO:0006403~RNA localization 36 3.15E-05 0.00125 
GO:0016071~mRNA metabolic process 57 3.38E-05 0.00132 
GO:0010604~positive regulation of macromolecule metabolic 
process 44 3.82E-05 0.00146 
GO:0034621~cellular macromolecular complex subunit 
organization 57 4.45E-05 0.00167 
GO:0008356~asymmetric cell division 25 4.75E-05 0.00176 
GO:0032989~cellular component morphogenesis 111 5.38E-05 0.00196 
GO:0007389~pattern specification process 90 5.42E-05 0.00195 
GO:0033043~regulation of organelle organization 38 5.97E-05 0.00211 
GO:0033554~cellular response to stress 53 6.59E-05 0.00229 
GO:0034728~nucleosome organization 17 6.97E-05 0.00239 
GO:0043933~macromolecular complex subunit organization 72 7.30E-05 0.00246 
GO:0000904~cell morphogenesis involved in differentiation 71 9.07E-05 0.00302 
GO:0006397~mRNA processing 49 9.71E-05 0.00318 
GO:0006270~DNA replication initiation 12 1.02E-04 0.00329 
GO:0006277~DNA amplification 12 1.02E-04 0.00329 
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GO:0016458~gene silencing 34 1.12E-04 0.00357 
GO:0016568~chromatin modification 39 1.30E-04 0.00410 
GO:0046822~regulation of nucleocytoplasmic transport 16 1.72E-04 0.00534 
GO:0048666~neuron development 79 1.95E-04 0.00597 
GO:0007293~germarium-derived egg chamber formation 23 2.12E-04 0.00638 
GO:0031023~microtubule organizing center organization 20 2.59E-04 0.00769 
GO:0034622~cellular macromolecular complex assembly 46 2.59E-04 0.00761 
GO:0048812~neuron projection morphogenesis 66 2.64E-04 0.00764 
GO:0006357~regulation of transcription from RNA polymerase II 
promoter 47 2.68E-04 0.00768 
GO:0009948~anterior/posterior axis specification 36 2.72E-04 0.00769 
GO:0006275~regulation of DNA replication 10 2.77E-04 0.00774 
GO:0007098~centrosome cycle 17 2.80E-04 0.00773 
GO:0007062~sister chromatid cohesion 11 2.95E-04 0.00804 
GO:0010557~positive regulation of macromolecule biosynthetic 
process 38 3.13E-04 0.00843 
GO:0031175~neuron projection development 66 3.24E-04 0.00863 
GO:0048024~regulation of nuclear mRNA splicing, via 
spliceosome 23 3.40E-04 0.00893 
GO:0050684~regulation of mRNA processing 23 3.40E-04 0.00893 
GO:0032386~regulation of intracellular transport 16 3.43E-04 0.00893 
GO:0048469~cell maturation 35 3.48E-04 0.00894 
GO:0048667~cell morphogenesis involved in neuron differentiation 66 3.97E-04 0.01009 
GO:0000122~negative regulation of transcription from RNA 
polymerase II promoter 18 4.10E-04 0.01030 
GO:0048599~oocyte development 33 4.10E-04 0.01020 
GO:0043484~regulation of RNA splicing 24 4.13E-04 0.01016 
GO:0033157~regulation of intracellular protein transport 15 4.17E-04 0.01015 
GO:0042306~regulation of protein import into nucleus 15 4.17E-04 0.01015 
GO:0007127~meiosis I 15 4.17E-04 0.01015 
GO:0030030~cell projection organization 77 4.22E-04 0.01015 
GO:0006355~regulation of transcription, DNA-dependent 107 4.63E-04 0.01104 
GO:0065003~macromolecular complex assembly 61 4.99E-04 0.01175 
GO:0051173~positive regulation of nitrogen compound metabolic 
process 36 5.08E-04 0.01184 
GO:0045935~positive regulation of nucleobase, nucleoside, 
nucleotide and nucleic acid metabolic process 36 5.08E-04 0.01184 
GO:0030261~chromosome condensation 17 5.14E-04 0.01186 
GO:0007088~regulation of mitosis 17 5.14E-04 0.01186 
GO:0051783~regulation of nuclear division 17 5.14E-04 0.01186 
GO:0048858~cell projection morphogenesis 68 5.75E-04 0.01314 
GO:0009952~anterior/posterior pattern formation 39 5.90E-04 0.01335 
GO:0030707~ovarian follicle cell development 49 5.93E-04 0.01326 
GO:0000075~cell cycle checkpoint 13 5.95E-04 0.01318 
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GO:0000578~embryonic axis specification 34 6.08E-04 0.01334 
GO:0021700~developmental maturation 36 6.82E-04 0.01483 
GO:0007140~male meiosis 12 6.90E-04 0.01486 
GO:0006334~nucleosome assembly 12 6.90E-04 0.01486 
GO:0051297~centrosome organization 18 7.06E-04 0.01505 
GO:0008298~intracellular mRNA localization 20 7.12E-04 0.01505 
GO:0007308~oocyte construction 32 7.24E-04 0.01516 
GO:0008595~determination of anterior/posterior axis, embryo 33 7.75E-04 0.01606 
GO:0007351~tripartite regional subdivision 33 7.75E-04 0.01606 
GO:0051052~regulation of DNA metabolic process 11 7.78E-04 0.01599 
GO:0032990~cell part morphogenesis 69 8.21E-04 0.01672 
GO:0007307~eggshell chorion gene amplification 10 8.38E-04 0.01690 
GO:0030182~neuron differentiation 88 9.02E-04 0.01803 
GO:0007350~blastoderm segmentation 46 9.12E-04 0.01807 
GO:0008380~RNA splicing 34 0.00110 0.02158 
GO:0051225~spindle assembly 16 0.00113 0.02206 
GO:0035282~segmentation 48 0.00117 0.02246 
GO:0009880~embryonic pattern specification 48 0.00117 0.02246 
GO:0060341~regulation of cellular localization 24 0.00136 0.02599 
GO:0070201~regulation of establishment of protein localization 15 0.00144 0.02713 
GO:0051223~regulation of protein transport 15 0.00144 0.02713 
GO:0009953~dorsal/ventral pattern formation 34 0.00146 0.02732 
GO:0000375~RNA splicing, via transesterification reactions 29 0.00151 0.02803 
GO:0000902~cell morphogenesis 94 0.00159 0.02923 
GO:0007309~oocyte axis specification 30 0.00160 0.02931 
GO:0031497~chromatin assembly 14 0.00181 0.03278 
GO:0010628~positive regulation of gene expression 33 0.00185 0.03313 
GO:0051248~negative regulation of protein metabolic process 16 0.00191 0.03403 
GO:0006267~pre-replicative complex assembly 7 0.00231 0.04066 
GO:0048134~germ-line cyst formation 9 0.00232 0.04060 
GO:0000398~nuclear mRNA splicing, via spliceosome 28 0.00260 0.04502 
GO:0000377~RNA splicing, via transesterification reactions with 
bulged adenosine as nucleophile 28 0.00260 0.04502 
Cellular compartment    
GO:0005694~chromosome 111 9.68E-22 4.54E-19 
GO:0044427~chromosomal part 91 2.21E-18 1.04E-15 
GO:0005654~nucleoplasm 82 6.55E-10 3.07E-07 
GO:0044451~nucleoplasm part 71 1.95E-08 9.13E-06 
GO:0043228~non-membrane-bounded organelle 193 3.52E-08 1.65E-05 
GO:0043232~intracellular non-membrane-bounded organelle 193 3.52E-08 1.65E-05 
GO:0000785~chromatin 39 4.47E-08 2.10E-05 
GO:0031981~nuclear lumen 93 1.34E-06 6.28E-04 
GO:0000228~nuclear chromosome 29 1.42E-06 6.66E-04 
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GO:0032993~protein-DNA complex 19 8.77E-06 0.00410 
GO:0044454~nuclear chromosome part 26 9.41E-06 0.00440 
GO:0000775~chromosome, centromeric region 23 9.53E-06 0.00446 
GO:0005700~polytene chromosome 31 3.49E-05 0.01625 
Molecular function    
GO:0003677~DNA binding 196 3.71E-17 3.16E-14 
GO:0008270~zinc ion binding 220 2.75E-11 2.35E-08 
GO:0003682~chromatin binding 29 8.92E-08 7.61E-05 
GO:0046914~transition metal ion binding 241 1.41E-06 0.00120 
GO:0043169~cation binding 288 1.72E-05 0.01457 
GO:0003702~RNA polymerase II transcription factor activity 57 1.80E-05 0.01529 
GO:0046872~metal ion binding 283 1.87E-05 0.01581 
GO:0043167~ion binding 288 2.10E-05 0.01778 
KEGG pathway    
dme04120:Ubiquitin mediated proteolysis 36 1.57E-07 1.38E-05 
dme04914:Progesterone-mediated oocyte maturation 17 1.16E-04 0.01015 
dme03030:DNA replication 15 1.25E-04 0.01092 
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Table B3. Oocyte DAVID analysis, total RNA transcripts downregulated in wisp 
Term Count P-value Bonferroni 
Biological process    
GO:0006260~DNA replication 18 1.00E-09 1.26E-06 
GO:0006261~DNA-dependent DNA replication 14 3.93E-09 4.95E-06 
GO:0006259~DNA metabolic process 24 4.93E-08 6.20E-05 
GO:0006270~DNA replication initiation 8 6.69E-08 8.41E-05 
GO:0007059~chromosome segregation 16 8.34E-07 0.00105 
GO:0051276~chromosome organization 25 1.09E-06 0.00137 
GO:0030261~chromosome condensation 8 1.48E-05 0.01839 
GO:0007049~cell cycle 37 1.75E-05 0.02183 
GO:0006267~pre-replicative complex assembly 5 1.99E-05 0.02469 
GO:0034984~cellular response to DNA damage stimulus 12 2.31E-05 0.02859 
Cellular compartment    
GO:0044451~nucleoplasm part 25 3.63E-07 9.43E-05 
GO:0005654~nucleoplasm 26 6.16E-07 1.60E-04 
GO:0032993~protein-DNA complex 10 2.43E-06 6.32E-04 
GO:0005656~pre-replicative complex 6 3.44E-06 8.94E-04 
GO:0031974~membrane-enclosed lumen 39 4.52E-06 0.00117 
GO:0044427~chromosomal part 23 6.27E-06 0.00163 
GO:0070013~intracellular organelle lumen 38 6.29E-06 0.00163 
GO:0043233~organelle lumen 38 6.29E-06 0.00163 
GO:0005694~chromosome 26 7.75E-06 0.00201 
GO:0031981~nuclear lumen 29 2.38E-05 0.00618 
Molecular function    
GO:0001882~nucleoside binding 57 1.96E-09 7.84E-07 
GO:0030554~adenyl nucleotide binding 55 8.97E-09 3.59E-06 
GO:0001883~purine nucleoside binding 55 1.11E-08 4.45E-06 
GO:0005524~ATP binding 50 8.41E-08 3.36E-05 
GO:0032559~adenyl ribonucleotide binding 50 9.14E-08 3.66E-05 
GO:0003677~DNA binding 53 1.32E-07 5.28E-05 
GO:0017076~purine nucleotide binding 58 4.93E-07 1.97E-04 
GO:0000166~nucleotide binding 66 7.03E-07 2.81E-04 
GO:0032555~purine ribonucleotide binding 53 3.59E-06 0.00143 
GO:0032553~ribonucleotide binding 53 3.59E-06 0.00143 
KEGG pathway    
dme03030:DNA replication 9 7.08E-05 0.00459 
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Table B4. Embryo DAVID analysis, transcripts ≥2-fold higher in control than wisp 
Term Count P value Bonferroni 
Biological process    
GO:0008104~protein localization 226 8.11E-33 2.57E-29 
GO:0051276~chromosome organization 167 4.89E-26 1.55E-22 
GO:0045184~establishment of protein localization 161 3.84E-22 1.22E-18 
GO:0015031~protein transport 156 4.42E-21 1.40E-17 
GO:0046907~intracellular transport 164 3.55E-18 1.13E-14 
GO:0007242~intracellular signaling cascade 156 1.89E-17 5.97E-14 
GO:0007010~cytoskeleton organization 219 5.97E-17 3.52E-13 
GO:0006259~DNA metabolic process 123 3.23E-16 1.06E-12 
GO:0051301~cell division 116 4.33E-16 1.41E-12 
GO:0016192~vesicle-mediated transport 189 7.46E-16 2.46E-12 
GO:0006325~chromatin organization 99 6.82E-15 2.15E-11 
GO:0007059~chromosome segregation 75 1.83E-14 5.81E-11 
GO:0007264~small GTPase mediated signal transduction 71 3.03E-14 9.60E-11 
GO:0043933~macromolecular complex subunit organization 142 5.50E-14 1.74E-10 
GO:0051726~regulation of cell cycle 95 1.10E-13 3.48E-10 
GO:0000902~cell morphogenesis 200 3.86E-13 1.22E-09 
GO:0016568~chromatin modification 70 9.05E-13 2.87E-09 
GO:0000278~mitotic cell cycle 168 9.11E-13 2.89E-09 
GO:0007049~cell cycle 260 1.37E-12 4.34E-09 
GO:0030182~neuron differentiation 186 1.67E-12 5.28E-09 
GO:0032989~cellular component morphogenesis 225 1.93E-12 6.12E-09 
GO:0051656~establishment of organelle localization 52 3.76E-12 1.19E-08 
GO:0051640~organelle localization 55 6.23E-12 1.98E-08 
GO:0016044~membrane organization 151 6.53E-12 2.07E-08 
GO:0006260~DNA replication 61 1.17E-11 3.71E-08 
GO:0048285~organelle fission 85 2.13E-11 6.75E-08 
GO:0033554~cellular response to stress 94 3.18E-11 1.01E-07 
GO:0044087~regulation of cellular component biogenesis 53 3.24E-11 1.03E-07 
GO:0033043~regulation of organelle organization 66 3.30E-11 1.05E-07 
GO:0048610~reproductive cellular process 214 3.96E-11 1.26E-07 
GO:0048666~neuron development 159 4.15E-11 1.31E-07 
GO:0000087~M phase of mitotic cell cycle 82 6.03E-11 1.91E-07 
GO:0034621~cellular macromolecular complex subunit 
organization 104 6.58E-11 2.08E-07 
GO:0007067~mitosis 81 7.33E-11 2.32E-07 
GO:0006350~transcription 198 1.05E-10 3.33E-07 
GO:0065003~macromolecular complex assembly 120 1.15E-10 3.65E-07 
GO:0060284~regulation of cell development 74 1.77E-10 5.60E-07 
GO:0000280~nuclear division 81 1.80E-10 5.70E-07 
GO:0006396~RNA processing 144 2.06E-10 6.53E-07 
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GO:0006468~protein amino acid phosphorylation 124 2.51E-10 7.96E-07 
GO:0051960~regulation of nervous system development 56 2.94E-10 9.33E-07 
GO:0070727~cellular macromolecule localization 118 3.31E-10 1.05E-06 
GO:0032940~secretion by cell 68 3.34E-10 1.06E-06 
GO:0007163~establishment or maintenance of cell polarity 64 4.14E-10 1.31E-06 
GO:0030029~actin filament-based process 78 7.78E-10 2.46E-06 
GO:0048477~oogenesis 222 1.16E-09 3.67E-06 
GO:0030036~actin cytoskeleton organization 77 1.45E-09 4.60E-06 
GO:0022604~regulation of cell morphogenesis 67 1.73E-09 5.49E-06 
GO:0006796~phosphate metabolic process 225 2.19E-09 6.94E-06 
GO:0006793~phosphorus metabolic process 225 2.19E-09 6.94E-06 
GO:0003001~generation of a signal involved in cell-cell signaling 60 2.40E-09 7.62E-06 
GO:0040008~regulation of growth 60 2.40E-09 7.62E-06 
GO:0006974~response to DNA damage stimulus 65 2.54E-09 8.04E-06 
GO:0007292~female gamete generation 223 2.56E-09 8.12E-06 
GO:0060429~epithelium development 112 2.84E-09 9.00E-06 
GO:0046903~secretion 69 2.95E-09 9.36E-06 
GO:0000904~cell morphogenesis involved in differentiation 137 3.18E-09 1.01E-05 
GO:0031175~neuron projection development 131 3.56E-09 1.13E-05 
GO:0048489~synaptic vesicle transport 54 4.09E-09 1.30E-05 
GO:0007269~neurotransmitter secretion 59 4.79E-09 1.52E-05 
GO:0003006~reproductive developmental process 208 5.12E-09 1.62E-05 
GO:0006261~DNA-dependent DNA replication 39 5.15E-09 1.63E-05 
GO:0048812~neuron projection morphogenesis 130 5.66E-09 1.79E-05 
GO:0000226~microtubule cytoskeleton organization 134 7.40E-09 2.34E-05 
GO:0045449~regulation of transcription 306 7.52E-09 2.38E-05 
GO:0048667~cell morphogenesis involved in neuron differentiation 130 9.58E-09 3.03E-05 
GO:0006897~endocytosis 119 9.62E-09 3.05E-05 
GO:0010324~membrane invagination 119 9.62E-09 3.05E-05 
GO:0006928~cell motion 136 1.08E-08 3.42E-05 
GO:0034613~cellular protein localization 89 1.20E-08 3.79E-05 
GO:0006281~DNA repair 58 1.54E-08 4.89E-05 
GO:0022402~cell cycle process 220 1.57E-08 4.97E-05 
GO:0007143~female meiosis 41 1.69E-08 5.35E-05 
GO:0002009~morphogenesis of an epithelium 106 1.72E-08 5.46E-05 
GO:0007346~regulation of mitotic cell cycle 56 2.25E-08 7.13E-05 
GO:0012501~programmed cell death 78 2.73E-08 8.66E-05 
GO:0044265~cellular macromolecule catabolic process 105 3.75E-08 1.19E-04 
GO:0007243~protein kinase cascade 39 4.26E-08 1.35E-04 
GO:0008219~cell death 81 4.31E-08 1.36E-04 
GO:0016265~death 81 6.07E-08 1.92E-04 
GO:0007017~microtubule-based process 169 6.23E-08 1.98E-04 
GO:0016071~mRNA metabolic process 102 6.80E-08 2.15E-04 
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GO:0006886~intracellular protein transport 85 7.31E-08 2.32E-04 
GO:0007276~gamete generation 273 7.93E-08 2.51E-04 
GO:0032535~regulation of cellular component size 55 1.11E-07 3.52E-04 
GO:0034622~cellular macromolecular complex assembly 81 1.18E-07 3.75E-04 
GO:0019953~sexual reproduction 278 1.60E-07 5.05E-04 
GO:0007391~dorsal closure 53 1.64E-07 5.19E-04 
GO:0001505~regulation of neurotransmitter levels 59 1.84E-07 5.83E-04 
GO:0008360~regulation of cell shape 54 2.11E-07 6.69E-04 
GO:0007267~cell-cell signaling 97 3.17E-07 0.00100 
GO:0048729~tissue morphogenesis 110 3.47E-07 0.00110 
GO:0008283~cell proliferation 65 3.81E-07 0.00121 
GO:0009968~negative regulation of signal transduction 55 4.09E-07 0.00129 
GO:0016569~covalent chromatin modification 35 5.11E-07 0.00162 
GO:0016570~histone modification 35 5.11E-07 0.00162 
GO:0070271~protein complex biogenesis 80 5.14E-07 0.00163 
GO:0006461~protein complex assembly 80 5.14E-07 0.00163 
GO:0010648~negative regulation of cell communication 55 6.17E-07 0.00195 
GO:0010605~negative regulation of macromolecule metabolic 
process 134 6.23E-07 0.00197 
GO:0006357~regulation of transcription from RNA polymerase II 
promoter 89 6.64E-07 0.00210 
GO:0010608~posttranscriptional regulation of gene expression 64 6.70E-07 0.00212 
GO:0016333~morphogenesis of follicular epithelium 22 7.20E-07 0.00228 
GO:0043067~regulation of programmed cell death 58 7.43E-07 0.00235 
GO:0010604~positive regulation of macromolecule metabolic 
process 70 7.86E-07 0.00249 
GO:0008356~asymmetric cell division 36 7.97E-07 0.00252 
GO:0000819~sister chromatid segregation 31 8.96E-07 0.00283 
GO:0019226~transmission of nerve impulse 90 9.47E-07 0.00300 
GO:0007293~germarium-derived egg chamber formation 38 1.00E-06 0.00316 
GO:0007444~imaginal disc development 166 1.02E-06 0.00322 
GO:0048813~dendrite morphogenesis 60 1.05E-06 0.00332 
GO:0016358~dendrite development 60 1.05E-06 0.00332 
GO:0016477~cell migration 82 1.13E-06 0.00357 
GO:0016331~morphogenesis of embryonic epithelium 61 1.23E-06 0.00389 
GO:0007268~synaptic transmission 87 1.29E-06 0.00409 
GO:0009886~post-embryonic morphogenesis 145 1.51E-06 0.00476 
GO:0030030~cell projection organization 149 1.62E-06 0.00514 
GO:0006836~neurotransmitter transport 63 1.65E-06 0.00522 
GO:0007281~germ cell development 106 1.92E-06 0.00607 
GO:0051674~localization of cell 89 1.96E-06 0.00618 
GO:0000070~mitotic sister chromatid segregation 30 1.98E-06 0.00627 
GO:0009057~macromolecule catabolic process 118 2.00E-06 0.00632 
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GO:0007167~enzyme linked receptor protein signaling pathway 70 2.06E-06 0.00649 
GO:0000165~MAPKKK cascade 29 2.27E-06 0.00718 
GO:0050767~regulation of neurogenesis 39 2.37E-06 0.00748 
GO:0035220~wing disc development 119 2.56E-06 0.00808 
GO:0017145~stem cell division 32 2.73E-06 0.00863 
GO:0009994~oocyte differentiation 67 2.74E-06 0.00866 
GO:0006403~RNA localization 62 2.84E-06 0.00895 
GO:0006323~DNA packaging 38 2.85E-06 0.00900 
GO:0043087~regulation of GTPase activity 27 2.92E-06 0.00922 
GO:0010941~regulation of cell death 58 3.22E-06 0.01016 
GO:0048870~cell motility 85 3.26E-06 0.01027 
GO:0051129~negative regulation of cellular component 
organization 34 3.47E-06 0.01092 
GO:0048858~cell projection morphogenesis 132 3.63E-06 0.01143 
GO:0007098~centrosome cycle 25 3.63E-06 0.01144 
GO:0030707~ovarian follicle cell development 91 3.70E-06 0.01165 
GO:0060341~regulation of cellular localization 39 3.86E-06 0.01217 
GO:0016321~female meiosis chromosome segregation 24 3.98E-06 0.01253 
GO:0045664~regulation of neuron differentiation 33 4.12E-06 0.01297 
GO:0045935~positive regulation of nucleobase, nucleoside, 
nucleotide and nucleic acid metabolic process 60 4.25E-06 0.01339 
GO:0051173~positive regulation of nitrogen compound metabolic 
process 60 4.25E-06 0.01339 
GO:0031047~gene silencing by RNA 29 4.34E-06 0.01366 
GO:0007015~actin filament organization 45 4.56E-06 0.01436 
GO:0051130~positive regulation of cellular component 
organization 20 4.78E-06 0.01503 
GO:0006397~mRNA processing 87 4.80E-06 0.01509 
GO:0021700~developmental maturation 65 5.60E-06 0.01758 
GO:0032990~cell part morphogenesis 135 5.62E-06 0.01764 
GO:0051236~establishment of RNA localization 37 5.65E-06 0.01774 
GO:0006605~protein targeting 55 5.92E-06 0.01859 
GO:0045132~meiotic chromosome segregation 34 5.93E-06 0.01862 
GO:0051056~regulation of small GTPase mediated signal 
transduction 49 6.73E-06 0.02110 
GO:0010564~regulation of cell cycle process 45 6.89E-06 0.02161 
GO:0006644~phospholipid metabolic process 45 6.89E-06 0.02161 
GO:0048707~instar larval or pupal morphogenesis 140 7.29E-06 0.02282 
GO:0042981~regulation of apoptosis 50 7.98E-06 0.02498 
GO:0019637~organophosphate metabolic process 50 7.98E-06 0.02498 
GO:0006915~apoptosis 42 8.31E-06 0.02599 
GO:0032318~regulation of Ras GTPase activity 24 8.39E-06 0.02625 
GO:0016310~phosphorylation 166 9.06E-06 0.02832 
GO:0051225~spindle assembly 23 9.33E-06 0.02913 
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GO:0010629~negative regulation of gene expression 108 9.63E-06 0.03005 
GO:0007051~spindle organization 97 1.00E-05 0.03126 
GO:0000910~cytokinesis 43 1.03E-05 0.03214 
GO:0050807~regulation of synapse organization 21 1.10E-05 0.03441 
GO:0050657~nucleic acid transport 36 1.11E-05 0.03443 
GO:0050658~RNA transport 36 1.11E-05 0.03443 
GO:0051963~regulation of synaptogenesis 18 1.21E-05 0.03758 
GO:0002165~instar larval or pupal development 163 1.23E-05 0.03819 
GO:0022403~cell cycle phase 189 1.24E-05 0.03858 
GO:0050803~regulation of synapse structure and activity 26 1.27E-05 0.03946 
GO:0035194~posttranscriptional gene silencing by RNA 26 1.27E-05 0.03946 
GO:0016441~posttranscriptional gene silencing 26 1.27E-05 0.03946 
GO:0007409~axonogenesis 87 1.27E-05 0.03948 
GO:0007552~metamorphosis 144 1.28E-05 0.03988 
GO:0045995~regulation of embryonic development 32 1.44E-05 0.04451 
GO:0007298~border follicle cell migration 37 1.45E-05 0.04477 
GO:0032880~regulation of protein localization 25 1.47E-05 0.04541 
GO:0006730~one-carbon metabolic process 41 1.54E-05 0.04768 
Cellular compartment    
GO:0005694~chromosome 163 4.46E-17 2.77E-14 
GO:0005654~nucleoplasm 145 5.42E-16 3.45E-13 
GO:0031974~membrane-enclosed lumen 258 5.20E-14 3.23E-11 
GO:0044427~chromosomal part 131 7.34E-14 4.56E-11 
GO:0070013~intracellular organelle lumen 250 2.91E-13 1.81E-10 
GO:0043233~organelle lumen 250 2.91E-13 1.81E-10 
GO:0044451~nucleoplasm part 127 1.12E-12 6.93E-10 
GO:0031981~nuclear lumen 184 2.19E-12 1.36E-09 
GO:0043232~intracellular non-membrane-bounded organelle 378 4.76E-11 2.96E-08 
GO:0043228~non-membrane-bounded organelle 378 4.76E-11 2.96E-08 
GO:0005938~cell cortex 49 3.27E-09 2.03E-06 
GO:0012505~endomembrane system 107 2.17E-08 1.35E-05 
GO:0005700~polytene chromosome 53 2.90E-07 1.80E-04 
GO:0005813~centrosome 35 3.15E-07 1.95E-04 
GO:0005819~spindle 42 5.11E-07 3.17E-04 
GO:0000785~chromatin 60 1.78E-06 0.00110 
GO:0005856~cytoskeleton 150 1.87E-06 0.00116 
GO:0005815~microtubule organizing center 37 3.00E-06 0.00186 
GO:0005635~nuclear envelope 47 1.07E-05 0.00665 
GO:0000775~chromosome, centromeric region 31 2.02E-05 0.01247 
GO:0044454~nuclear chromosome part 39 2.63E-05 0.01618 
GO:0005768~endosome 22 2.72E-05 0.01675 
GO:0000228~nuclear chromosome 42 3.71E-05 0.02281 
GO:0044430~cytoskeletal part 121 4.61E-05 0.02823 
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Molecular function    
GO:0032555~purine ribonucleotide binding 434 1.22E-26 1.77E-23 
GO:0032553~ribonucleotide binding 434 1.22E-26 1.77E-23 
GO:0000166~nucleotide binding 538 2.19E-26 3.18E-23 
GO:0017076~purine nucleotide binding 455 1.95E-25 2.82E-22 
GO:0032559~adenyl ribonucleotide binding 356 1.51E-22 2.20E-19 
GO:0005524~ATP binding 354 3.87E-22 5.61E-19 
GO:0001883~purine nucleoside binding 379 8.67E-22 1.26E-18 
GO:0001882~nucleoside binding 381 1.36E-21 1.97E-18 
GO:0030554~adenyl nucleotide binding 375 3.95E-21 5.73E-18 
GO:0003677~DNA binding 351 1.64E-12 2.38E-09 
GO:0004386~helicase activity 70 4.33E-12 6.29E-09 
GO:0008270~zinc ion binding 417 9.76E-12 1.42E-08 
GO:0070035~purine NTP-dependent helicase activity 51 2.10E-09 3.05E-06 
GO:0008026~ATP-dependent helicase activity 51 2.10E-09 3.05E-06 
GO:0019899~enzyme binding 45 3.17E-09 4.61E-06 
GO:0003729~mRNA binding 96 1.05E-08 1.52E-05 
GO:0008092~cytoskeletal protein binding 108 2.05E-08 2.98E-05 
GO:0004672~protein kinase activity 132 5.15E-08 7.48E-05 
GO:0060589~nucleoside-triphosphatase regulator activity 77 7.77E-08 1.13E-04 
GO:0004674~protein serine/threonine kinase activity 100 1.04E-07 1.51E-04 
GO:0030695~GTPase regulator activity 75 1.56E-07 2.27E-04 
GO:0003779~actin binding 65 7.88E-07 0.00114 
GO:0005096~GTPase activator activity 44 9.03E-07 0.00131 
GO:0005083~small GTPase regulator activity 59 9.40E-07 0.00136 
GO:0008134~transcription factor binding 50 2.53E-06 0.00366 
GO:0015631~tubulin binding 40 7.15E-06 0.01032 
GO:0003682~chromatin binding 38 9.51E-06 0.01370 
GO:0004004~ATP-dependent RNA helicase activity 27 1.12E-05 0.01613 
GO:0008186~RNA-dependent ATPase activity 27 1.12E-05 0.01613 
GO:0030528~transcription regulator activity 264 1.38E-05 0.01988 
GO:0008047~enzyme activator activity 49 1.53E-05 0.02194 
GO:0008017~microtubule binding 37 1.79E-05 0.02565 
GO:0042802~identical protein binding 70 2.49E-05 0.03552 
GO:0016879~ligase activity, forming carbon-nitrogen bonds 68 2.59E-05 0.03686 
GO:0016779~nucleotidyltransferase activity 48 2.63E-05 0.03748 
GO:0004518~nuclease activity 50 2.75E-05 0.03908 
GO:0035091~phosphoinositide binding 18 3.17E-05 0.04499 
KEGG pathway    
dme04144:Endocytosis 51 1.10E-06 1.21E-04 
dme04330:Notch signaling pathway 18 9.98E-05 1.09E-02 
dme04120:Ubiquitin mediated proteolysis 53 2.78E-04 3.01E-02 
 
 183 
Table B5. Embryo DAVID analysis, transcripts ≥3-fold higher in control than wisp 
Term Count P value Bonferroni 
Biological process    
GO:0048610~reproductive cellular process 224 4.32E-10 1.36E-06 
GO:0003006~reproductive developmental process 220 2.30E-09 7.23E-06 
GO:0019953~sexual reproduction 291 1.87E-08 5.88E-05 
GO:0051276~chromosome organization 177 1.97E-08 6.21E-05 
GO:0048477~oogenesis 230 3.37E-08 1.06E-04 
GO:0007276~gamete generation 284 3.99E-08 1.26E-04 
GO:0007292~female gamete generation 231 5.20E-08 1.63E-04 
GO:0045449~regulation of transcription 306 5.29E-08 1.66E-04 
GO:0010605~negative regulation of macromolecule metabolic process 141 5.67E-08 1.78E-04 
GO:0006396~RNA processing 161 7.44E-08 2.34E-04 
GO:0006350~transcription 206 1.84E-07 5.77E-04 
GO:0007444~imaginal disc development 170 2.05E-07 6.45E-04 
GO:0060429~epithelium development 117 2.32E-07 7.28E-04 
GO:0032504~multicellular organism reproduction 286 2.36E-07 7.42E-04 
GO:0048609~reproductive process in a multicellular organism 286 2.36E-07 7.42E-04 
GO:0010629~negative regulation of gene expression 112 3.18E-07 1.00E-03 
GO:0032989~cellular component morphogenesis 224 3.80E-07 0.00119 
GO:0006468~protein amino acid phosphorylation 131 6.36E-07 0.00200 
GO:0048598~embryonic morphogenesis 97 7.91E-07 0.00248 
GO:0030707~ovarian follicle cell development 97 7.91E-07 0.00248 
GO:0007423~sensory organ development 139 1.10E-06 0.00344 
GO:0048729~tissue morphogenesis 113 1.58E-06 0.00494 
GO:0002009~morphogenesis of an epithelium 109 1.73E-06 0.00542 
GO:0001700~embryonic development via the syncytial blastoderm 94 1.75E-06 0.00548 
GO:0016071~mRNA metabolic process 116 1.81E-06 0.00568 
GO:0051301~cell division 122 2.31E-06 0.00724 
GO:0006928~cell motion 138 2.89E-06 0.00905 
GO:0035282~segmentation 95 3.60E-06 0.01124 
GO:0009880~embryonic pattern specification 95 3.60E-06 0.01124 
GO:0035220~wing disc development 119 4.62E-06 0.01442 
GO:0048569~post-embryonic organ development 118 5.80E-06 0.01808 
GO:0000902~cell morphogenesis 197 6.19E-06 0.01927 
GO:0007389~pattern specification process 178 7.23E-06 0.02247 
GO:0010648~negative regulation of cell communication 60 7.47E-06 0.02322 
GO:0009968~negative regulation of signal transduction 60 7.47E-06 0.02322 
GO:0006397~mRNA processing 99 8.21E-06 0.02549 
GO:0045934~negative regulation of nucleobase, nucleoside, 
nucleotide and nucleic acid metabolic process 88 8.22E-06 0.02552 
GO:0051172~negative regulation of nitrogen compound metabolic 88 8.22E-06 0.02552 
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process 
GO:0009792~embryonic development ending in birth or egg hatching 95 9.03E-06 0.02798 
GO:0007560~imaginal disc morphogenesis 116 9.12E-06 0.02827 
GO:0048563~post-embryonic organ morphogenesis 116 9.12E-06 0.02827 
GO:0048749~compound eye development 105 1.06E-05 0.03282 
GO:0001709~cell fate determination 63 1.12E-05 0.03466 
GO:0016481~negative regulation of transcription 79 1.18E-05 0.03643 
GO:0001654~eye development 108 1.18E-05 0.03653 
GO:0010558~negative regulation of macromolecule biosynthetic 
process 97 1.33E-05 0.04089 
GO:0009890~negative regulation of biosynthetic process 97 1.33E-05 0.04089 
GO:0031327~negative regulation of cellular biosynthetic process 97 1.33E-05 0.04089 
GO:0007472~wing disc morphogenesis 93 1.47E-05 0.04515 
GO:0003002~regionalization 165 1.49E-05 0.04566 
GO:0051253~negative regulation of RNA metabolic process 74 1.58E-05 0.04860 
Cellular compartment    
GO:0005694~chromosome 181 1.36E-14 8.29E-12 
GO:0044427~chromosomal part 142 2.14E-10 1.31E-07 
GO:0031981~nuclear lumen 199 6.04E-09 3.69E-06 
GO:0005654~nucleoplasm 151 7.67E-07 4.69E-04 
GO:0031974~membrane-enclosed lumen 274 8.10E-07 4.96E-04 
GO:0070013~intracellular organelle lumen 265 4.06E-06 0.00248 
GO:0043233~organelle lumen 265 4.06E-06 0.00248 
GO:0005886~plasma membrane 231 1.60E-05 0.00975 
GO:0005700~polytene chromosome 57 2.50E-05 0.01519 
GO:0044451~nucleoplasm part 129 5.00E-05 0.03011 
Molecular function    
GO:0003677~DNA binding 368 3.97E-16 6.34E-13 
GO:0008270~zinc ion binding 463 7.16E-14 1.02E-10 
GO:0046872~metal ion binding 637 1.46E-09 2.09E-06 
GO:0043169~cation binding 646 6.87E-09 9.81E-06 
GO:0043167~ion binding 646 9.79E-09 1.40E-05 
GO:0004672~protein kinase activity 139 2.41E-08 3.43E-05 
GO:0030528~transcription regulator activity 261 1.12E-07 1.59E-04 
GO:0004674~protein serine/threonine kinase activity 107 1.90E-07 2.72E-04 
GO:0046914~transition metal ion binding 520 2.92E-07 4.16E-04 
KEGG pathway    
dme00564:Glycerophospholipid metabolism 31 5.79E-05 0.00618 
dme03040:Spliceosome 62 5.92E-05 0.00631 
dme04120:Ubiquitin mediated proteolysis 54 1.85E-04 0.01963 
dme04144:Endocytosis 48 2.95E-04 0.03106 
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Table B6. Embryo poly(A) downregulated minus embryo total RNA downregulated 
Term Count P-value Bonferroni 
Biological process 
   GO:0008104~protein localization 260 1.16E-35 3.86E-32 
GO:0051276~chromosome organization 190 2.49E-27 8.29E-24 
GO:0045184~establishment of protein localization 182 3.72E-22 1.24E-18 
GO:0015031~protein transport 178 7.27E-22 2.42E-18 
GO:0007010~cytoskeleton organization 264 4.65E-21 1.55E-17 
GO:0046907~intracellular transport 193 6.65E-21 2.22E-17 
GO:0016192~vesicle-mediated transport 228 3.45E-20 1.15E-16 
GO:0000278~mitotic cell cycle 210 4.76E-19 1.59E-15 
GO:0006259~DNA metabolic process 141 2.89E-17 9.61E-14 
GO:0051301~cell division 132 1.09E-16 3.70E-13 
GO:0007059~chromosome segregation 86 4.49E-16 1.48E-12 
GO:0006325~chromatin organization 113 1.08E-15 3.70E-12 
GO:0007049~cell cycle 314 2.58E-15 8.51E-12 
GO:0048285~organelle fission 103 6.17E-15 2.07E-11 
GO:0016044~membrane organization 181 2.19E-14 7.29E-11 
GO:0006396~RNA processing 176 1.07E-13 3.57E-10 
GO:0051726~regulation of cell cycle 107 1.40E-13 4.66E-10 
GO:0000280~nuclear division 98 1.45E-13 4.82E-10 
GO:0016568~chromatin modification 79 2.91E-13 9.69E-10 
GO:0033554~cellular response to stress 111 3.97E-13 1.32E-09 
GO:0006350~transcription 239 4.96E-13 1.65E-09 
GO:0007067~mitosis 96 4.99E-13 1.66E-09 
GO:0000087~M phase of mitotic cell cycle 97 4.99E-13 1.66E-09 
GO:0043933~macromolecular complex subunit organization 160 5.63E-13 1.87E-09 
GO:0070727~cellular macromolecule localization 142 1.39E-12 4.63E-09 
GO:0007242~intracellular signaling cascade 165 3.88E-12 1.29E-08 
GO:0000226~microtubule cytoskeleton organization 165 5.63E-12 1.87E-08 
GO:0000902~cell morphogenesis 228 6.33E-12 2.11E-08 
GO:0006260~DNA replication 68 1.21E-11 4.02E-08 
GO:0034613~cellular protein localization 109 1.63E-11 5.43E-08 
GO:0051640~organelle localization 60 2.77E-11 9.21E-08 
GO:0010324~membrane invagination 145 2.91E-11 9.69E-08 
GO:0006897~endocytosis 145 2.91E-11 9.69E-08 
GO:0022402~cell cycle process 270 3.22E-11 1.07E-07 
GO:0033043~regulation of organelle organization 74 3.31E-11 1.10E-07 
GO:0022604~regulation of cell morphogenesis 79 3.61E-11 1.20E-07 
GO:0051656~establishment of organelle localization 56 3.85E-11 1.28E-07 
GO:0032989~cellular component morphogenesis 257 5.30E-11 1.76E-07 
GO:0030182~neuron differentiation 210 8.37E-11 2.79E-07 
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GO:0006468~protein amino acid phosphorylation 144 9.85E-11 3.28E-07 
GO:0006974~response to DNA damage stimulus 76 1.24E-10 4.12E-07 
GO:0044265~cellular macromolecule catabolic process 128 1.63E-10 5.42E-07 
GO:0010604~positive regulation of macromolecule metabolic 
process 89 1.75E-10 5.84E-07 
GO:0016071~mRNA metabolic process 125 2.04E-10 6.80E-07 
GO:0006281~DNA repair 69 2.14E-10 7.13E-07 
GO:0006886~intracellular protein transport 104 2.32E-10 7.74E-07 
GO:0007017~microtubule-based process 207 2.60E-10 8.67E-07 
GO:0007163~establishment or maintenance of cell polarity 72 4.21E-10 1.40E-06 
GO:0030029~actin filament-based process 89 4.98E-10 1.66E-06 
GO:0044087~regulation of cellular component biogenesis 57 4.98E-10 1.66E-06 
GO:0065003~macromolecular complex assembly 136 5.78E-10 1.92E-06 
GO:0048610~reproductive cellular process 245 7.44E-10 2.48E-06 
GO:0048666~neuron development 180 7.83E-10 2.61E-06 
GO:0030036~actin cytoskeleton organization 88 8.63E-10 2.87E-06 
GO:0060284~regulation of cell development 82 1.10E-09 3.65E-06 
GO:0007264~small GTPase mediated signal transduction 71 1.41E-09 4.71E-06 
GO:0032940~secretion by cell 75 2.33E-09 7.76E-06 
GO:0051960~regulation of nervous system development 61 2.49E-09 8.29E-06 
GO:0008360~regulation of cell shape 65 2.63E-09 8.75E-06 
GO:0010557~positive regulation of macromolecule biosynthetic 
process 80 3.35E-09 1.12E-05 
GO:0008283~cell proliferation 79 3.48E-09 1.16E-05 
GO:0045935~positive regulation of nucleobase, nucleoside, 
nucleotide and nucleic acid metabolic process 76 3.88E-09 1.29E-05 
GO:0051173~positive regulation of nitrogen compound metabolic 
process 76 3.88E-09 1.29E-05 
GO:0040008~regulation of growth 67 4.78E-09 1.59E-05 
GO:0045449~regulation of transcription 362 8.62E-09 2.87E-05 
GO:0007143~female meiosis 46 9.34E-09 3.11E-05 
GO:0007051~spindle organization 123 1.03E-08 3.44E-05 
GO:0034621~cellular macromolecular complex subunit 
organization 113 1.16E-08 3.86E-05 
GO:0048477~oogenesis 256 1.26E-08 4.18E-05 
GO:0000819~sister chromatid segregation 37 1.39E-08 4.62E-05 
GO:0003001~generation of a signal involved in cell-cell signaling 66 1.53E-08 5.10E-05 
GO:0010608~posttranscriptional regulation of gene expression 77 1.73E-08 5.75E-05 
GO:0007292~female gamete generation 258 1.96E-08 6.54E-05 
GO:0007052~mitotic spindle organization 108 2.52E-08 8.40E-05 
GO:0003006~reproductive developmental process 241 2.65E-08 8.82E-05 
GO:0007269~neurotransmitter secretion 65 2.74E-08 9.11E-05 
GO:0007346~regulation of mitotic cell cycle 63 2.86E-08 9.54E-05 
GO:0046903~secretion 76 2.95E-08 9.83E-05 
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GO:0000070~mitotic sister chromatid segregation 36 2.99E-08 9.96E-05 
GO:0051254~positive regulation of RNA metabolic process 59 3.02E-08 1.01E-04 
GO:0048489~synaptic vesicle transport 59 3.02E-08 1.01E-04 
GO:0006261~DNA-dependent DNA replication 42 3.10E-08 1.03E-04 
GO:0031328~positive regulation of cellular biosynthetic process 89 3.28E-08 1.09E-04 
GO:0012501~programmed cell death 89 3.28E-08 1.09E-04 
GO:0009891~positive regulation of biosynthetic process 89 3.28E-08 1.09E-04 
GO:0010628~positive regulation of gene expression 72 3.58E-08 1.19E-04 
GO:0009057~macromolecule catabolic process 144 3.93E-08 1.31E-04 
GO:0031175~neuron projection development 148 4.87E-08 1.62E-04 
GO:0006796~phosphate metabolic process 258 5.46E-08 1.82E-04 
GO:0006793~phosphorus metabolic process 258 5.46E-08 1.82E-04 
GO:0006397~mRNA processing 107 5.68E-08 1.89E-04 
GO:0045941~positive regulation of transcription 71 6.16E-08 2.05E-04 
GO:0060429~epithelium development 125 6.45E-08 2.15E-04 
GO:0048812~neuron projection morphogenesis 147 7.11E-08 2.37E-04 
GO:0046486~glycerolipid metabolic process 43 7.51E-08 2.50E-04 
GO:0008219~cell death 92 8.95E-08 2.98E-04 
GO:0032774~RNA biosynthetic process 80 9.23E-08 3.07E-04 
GO:0045893~positive regulation of transcription, DNA-dependent 57 9.99E-08 3.33E-04 
GO:0030261~chromosome condensation 26 1.25E-07 4.15E-04 
GO:0016265~death 92 1.32E-07 4.39E-04 
GO:0006366~transcription from RNA polymerase II promoter 62 1.51E-07 5.02E-04 
GO:0000904~cell morphogenesis involved in differentiation 153 1.61E-07 5.37E-04 
GO:0006351~transcription, DNA-dependent 78 1.63E-07 5.41E-04 
GO:0022403~cell cycle phase 233 1.92E-07 6.40E-04 
GO:0048667~cell morphogenesis involved in neuron 
differentiation 146 2.36E-07 7.86E-04 
GO:0006461~protein complex assembly 93 2.59E-07 8.62E-04 
GO:0070271~protein complex biogenesis 93 2.59E-07 8.62E-04 
GO:0006928~cell motion 153 2.73E-07 9.08E-04 
GO:0006357~regulation of transcription from RNA polymerase II 
promoter 104 2.95E-07 9.82E-04 
GO:0007243~protein kinase cascade 42 3.06E-07 0.0010201 
GO:0019953~sexual reproduction 328 3.17E-07 0.0010555 
GO:0007276~gamete generation 320 3.28E-07 0.0010913 
GO:0006644~phospholipid metabolic process 54 3.30E-07 0.0010971 
GO:0043632~modification-dependent macromolecule catabolic 
process 94 3.43E-07 0.0011423 
GO:0032535~regulation of cellular component size 61 4.35E-07 0.0014489 
GO:0019941~modification-dependent protein catabolic process 93 5.33E-07 0.0017739 
GO:0001505~regulation of neurotransmitter levels 66 5.39E-07 0.0017944 
GO:0006323~DNA packaging 44 6.38E-07 0.0021241 
GO:0050767~regulation of neurogenesis 45 6.45E-07 0.0021478 
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GO:0009968~negative regulation of signal transduction 62 6.74E-07 0.0022429 
GO:0007267~cell-cell signaling 111 7.89E-07 0.002626 
GO:0002009~morphogenesis of an epithelium 117 8.34E-07 0.0027758 
GO:0034660~ncRNA metabolic process 76 9.84E-07 0.0032717 
GO:0007268~synaptic transmission 101 1.03E-06 0.0034254 
GO:0051329~interphase of mitotic cell cycle 22 1.05E-06 0.003481 
GO:0051325~interphase 22 1.05E-06 0.003481 
GO:0006650~glycerophospholipid metabolic process 38 1.05E-06 0.0034871 
GO:0010648~negative regulation of cell communication 62 1.08E-06 0.0035875 
GO:0019226~transmission of nerve impulse 104 1.08E-06 0.0036064 
GO:0043067~regulation of programmed cell death 65 2.17E-06 0.007207 
GO:0006605~protein targeting 64 2.32E-06 0.0077101 
GO:0016197~endosome transport 21 2.47E-06 0.008195 
GO:0050803~regulation of synapse structure and activity 30 2.60E-06 0.0086159 
GO:0051603~proteolysis involved in cellular protein catabolic 
process 97 2.77E-06 0.0091862 
GO:0044257~cellular protein catabolic process 97 2.77E-06 0.0091862 
GO:0051252~regulation of RNA metabolic process 300 2.77E-06 0.0091924 
GO:0000910~cytokinesis 50 3.21E-06 0.0106329 
GO:0019637~organophosphate metabolic process 58 3.42E-06 0.0113221 
GO:0007391~dorsal closure 57 3.63E-06 0.0120227 
GO:0030163~protein catabolic process 104 3.65E-06 0.0120809 
GO:0051493~regulation of cytoskeleton organization 35 3.76E-06 0.01246 
GO:0002165~instar larval or pupal development 195 3.85E-06 0.012743 
GO:0032268~regulation of cellular protein metabolic process 73 3.96E-06 0.0130961 
GO:0008356~asymmetric cell division 39 4.09E-06 0.0135277 
GO:0048488~synaptic vesicle endocytosis 27 4.11E-06 0.0136079 
GO:0007281~germ cell development 122 4.78E-06 0.0157932 
GO:0022613~ribonucleoprotein complex biogenesis 56 6.07E-06 0.0200038 
GO:0034622~cellular macromolecular complex assembly 88 6.17E-06 0.0203413 
GO:0000279~M phase 218 6.94E-06 0.0228405 
GO:0030030~cell projection organization 172 7.39E-06 0.0243003 
GO:0009791~post-embryonic development 200 7.73E-06 0.0254133 
GO:0010564~regulation of cell cycle process 51 8.17E-06 0.0268461 
GO:0008105~asymmetric protein localization 26 8.62E-06 0.0282897 
GO:0010941~regulation of cell death 65 1.09E-05 0.0356807 
GO:0030707~ovarian follicle cell development 104 1.13E-05 0.0369022 
GO:0060341~regulation of cellular localization 43 1.19E-05 0.0390012 
GO:0007298~border follicle cell migration 42 1.24E-05 0.0403818 
GO:0043484~regulation of RNA splicing 42 1.24E-05 0.0403818 
GO:0032990~cell part morphogenesis 157 1.24E-05 0.0404863 
GO:0048729~tissue morphogenesis 122 1.30E-05 0.04242 
GO:0032970~regulation of actin filament-based process 23 1.32E-05 0.0430347 
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GO:0032956~regulation of actin cytoskeleton organization 23 1.32E-05 0.0430347 
GO:0048585~negative regulation of response to stimulus 19 1.34E-05 0.0437617 
GO:0030384~phosphoinositide metabolic process 32 1.34E-05 0.0437991 
GO:0006338~chromatin remodeling 32 1.34E-05 0.0437991 
GO:0008654~phospholipid biosynthetic process 33 1.38E-05 0.044825 
GO:0007015~actin filament organization 50 1.38E-05 0.0448669 
GO:0009994~oocyte differentiation 75 1.39E-05 0.045229 
GO:0051129~negative regulation of cellular component 
organization 37 1.39E-05 0.0452828 
GO:0045664~regulation of neuron differentiation 36 1.40E-05 0.0456419 
Cellular Compartment 
   GO:0031974~membrane-enclosed lumen 319 9.42E-19 6.13E-16 
GO:0005694~chromosome 191 2.82E-18 1.84E-15 
GO:0043233~organelle lumen 310 4.93E-18 3.21E-15 
GO:0070013~intracellular organelle lumen 310 4.93E-18 3.21E-15 
GO:0005654~nucleoplasm 170 1.39E-17 9.03E-15 
GO:0031981~nuclear lumen 223 8.23E-15 5.35E-12 
GO:0043232~intracellular non-membrane-bounded organelle 467 6.49E-14 4.23E-11 
GO:0043228~non-membrane-bounded organelle 467 6.49E-14 4.23E-11 
GO:0044427~chromosomal part 151 8.92E-14 5.81E-11 
GO:0044451~nucleoplasm part 149 1.49E-13 9.71E-11 
GO:0012505~endomembrane system 137 4.38E-13 2.85E-10 
GO:0005938~cell cortex 56 9.46E-10 6.16E-07 
GO:0005813~centrosome 41 1.99E-08 1.29E-05 
GO:0005819~spindle 50 2.08E-08 1.36E-05 
GO:0005856~cytoskeleton 185 4.64E-08 3.02E-05 
GO:0005794~Golgi apparatus 96 3.29E-07 2.14E-04 
GO:0005815~microtubule organizing center 43 7.94E-07 5.17E-04 
GO:0005635~nuclear envelope 56 1.61E-06 0.0010466 
GO:0005700~polytene chromosome 59 1.67E-06 0.0010888 
GO:0000228~nuclear chromosome 51 2.49E-06 0.0016183 
GO:0044454~nuclear chromosome part 46 6.69E-06 0.0043448 
GO:0005789~endoplasmic reticulum membrane 49 7.23E-06 0.0046934 
GO:0042175~nuclear envelope-endoplasmic reticulum network 50 7.35E-06 0.0047719 
GO:0005768~endosome 25 1.26E-05 0.0081665 
GO:0005681~spliceosome 46 2.02E-05 0.013064 
GO:0044430~cytoskeletal part 145 3.26E-05 0.0209702 
GO:0016327~apicolateral plasma membrane 32 3.76E-05 0.0241983 
GO:0000785~chromatin 65 7.30E-05 0.0464249 
Molecular function 
   GO:0000166~nucleotide binding 645 1.11E-30 1.77E-27 
GO:0032553~ribonucleotide binding 511 1.65E-28 2.64E-25 
GO:0032555~purine ribonucleotide binding 511 1.65E-28 2.64E-25 
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GO:0017076~purine nucleotide binding 535 1.35E-26 2.15E-23 
GO:0032559~adenyl ribonucleotide binding 421 6.87E-25 1.10E-21 
GO:0005524~ATP binding 419 1.60E-24 2.56E-21 
GO:0001883~purine nucleoside binding 446 4.96E-23 7.92E-20 
GO:0001882~nucleoside binding 448 1.16E-22 1.85E-19 
GO:0030554~adenyl nucleotide binding 442 1.74E-22 2.77E-19 
GO:0008270~zinc ion binding 508 1.41E-14 2.25E-11 
GO:0003677~DNA binding 416 6.46E-13 1.03E-09 
GO:0004386~helicase activity 78 7.33E-12 1.17E-08 
GO:0003729~mRNA binding 118 8.09E-12 1.29E-08 
GO:0019899~enzyme binding 53 2.28E-11 3.64E-08 
GO:0008026~ATP-dependent helicase activity 58 4.85E-10 7.73E-07 
GO:0070035~purine NTP-dependent helicase activity 58 4.85E-10 7.73E-07 
GO:0008092~cytoskeletal protein binding 128 1.62E-09 2.59E-06 
GO:0016779~nucleotidyltransferase activity 62 1.45E-08 2.31E-05 
GO:0008134~transcription factor binding 61 2.59E-08 4.14E-05 
GO:0004674~protein serine/threonine kinase activity 116 8.25E-08 1.32E-04 
GO:0003779~actin binding 76 1.87E-07 2.99E-04 
GO:0015631~tubulin binding 48 2.69E-07 4.29E-04 
GO:0004672~protein kinase activity 151 3.13E-07 4.99E-04 
GO:0008017~microtubule binding 44 1.49E-06 0.0023681 
GO:0060589~nucleoside-triphosphatase regulator activity 83 6.49E-06 0.0103107 
GO:0046914~transition metal ion binding 593 8.39E-06 0.0133079 
GO:0003682~chromatin binding 43 9.26E-06 0.0146667 
GO:0030695~GTPase regulator activity 81 1.02E-05 0.0161191 
GO:0043566~structure-specific DNA binding 25 1.12E-05 0.0177629 
GO:0004004~ATP-dependent RNA helicase activity 30 1.26E-05 0.0198994 
GO:0008186~RNA-dependent ATPase activity 30 1.26E-05 0.0198994 
GO:0003712~transcription cofactor activity 42 1.60E-05 0.0252827 
GO:0005083~small GTPase regulator activity 64 2.03E-05 0.0318264 
GO:0003924~GTPase activity 74 2.86E-05 0.044638 
GO:0042802~identical protein binding 81 2.86E-05 0.0446407 
KEGG pathway 
   dme03040:Spliceosome 71 1.05E-04 0.0116223 
dme04320:Dorso-ventral axis formation 22 2.41E-04 0.0263651 
dme04144:Endocytosis 53 2.83E-04 0.0309255 
dme03018:RNA degradation 35 3.05E-04 0.033305 
dme04120:Ubiquitin mediated proteolysis 62 3.34E-04 0.0363751 
dme00970:Aminoacyl-tRNA biosynthesis 27 0.006009 0.4877783 
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Table B7. Oocyte poly(A) downregulated minus oocyte total downregulated 
Term Count P-value Bonferroni 
Biological process 
   GO:0007049~cell cycle 212 5.61E-16 1.50E-12 
GO:0022402~cell cycle process 181 3.87E-13 5.23E-10 
GO:0022403~cell cycle phase 159 4.55E-12 4.09E-09 
GO:0007067~mitosis 76 5.49E-12 3.70E-09 
GO:0000279~M phase 150 1.30E-11 7.01E-09 
GO:0000087~M phase of mitotic cell cycle 76 1.34E-11 6.00E-09 
GO:0000280~nuclear division 76 3.15E-11 1.21E-08 
GO:0048285~organelle fission 78 1.12E-10 3.79E-08 
GO:0051276~chromosome organization 129 3.84E-10 1.15E-07 
GO:0000278~mitotic cell cycle 145 4.57E-10 1.23E-07 
GO:0006259~DNA metabolic process 95 1.33E-08 3.25E-06 
GO:0006974~response to DNA damage stimulus 54 3.62E-07 8.13E-05 
GO:0019953~sexual reproduction 199 5.42E-07 1.12E-04 
GO:0007010~cytoskeleton organization 168 9.72E-07 1.87E-04 
GO:0007276~gamete generation 194 1.35E-06 2.43E-04 
GO:0000226~microtubule cytoskeleton organization 113 1.98E-06 3.34E-04 
GO:0048477~oogenesis 157 2.07E-06 3.28E-04 
GO:0032504~multicellular organism reproduction 197 2.12E-06 3.17E-04 
GO:0048609~reproductive process in a multicellular organism 197 2.12E-06 3.17E-04 
GO:0048610~reproductive cellular process 151 2.25E-06 3.20E-04 
GO:0007292~female gamete generation 158 3.63E-06 4.89E-04 
GO:0016071~mRNA metabolic process 79 5.27E-06 6.76E-04 
GO:0043933~macromolecular complex subunit organization 103 5.55E-06 6.80E-04 
GO:0051726~regulation of cell cycle 71 5.96E-06 6.99E-04 
GO:0033554~cellular response to stress 74 6.82E-06 7.66E-04 
GO:0007059~chromosome segregation 58 7.18E-06 7.75E-04 
GO:0006397~mRNA processing 68 1.32E-05 1.37E-03 
GO:0006281~DNA repair 47 1.38E-05 1.38E-03 
GO:0051321~meiotic cell cycle 51 2.08E-05 2.00E-03 
GO:0003006~reproductive developmental process 146 2.34E-05 2.18E-03 
GO:0007017~microtubule-based process 134 2.92E-05 2.62E-03 
GO:0008380~RNA splicing 49 5.25E-05 4.55E-03 
GO:0006350~transcription 137 7.94E-05 6.67E-03 
GO:0006325~chromatin organization 72 8.02E-05 6.53E-03 
GO:0007126~meiosis 48 8.26E-05 6.53E-03 
GO:0051327~M phase of meiotic cell cycle 48 8.26E-05 6.53E-03 
GO:0051301~cell division 80 8.66E-05 6.65E-03 
GO:0010605~negative regulation of macromolecule metabolic 
process 90 8.72E-05 6.51E-03 
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GO:0065003~macromolecular complex assembly 87 8.77E-05 6.37E-03 
GO:0033043~regulation of organelle organization 50 9.37E-05 6.63E-03 
GO:0009057~macromolecule catabolic process 106 1.04E-04 7.15E-03 
GO:0006260~DNA replication 45 1.13E-04 7.57E-03 
GO:0044265~cellular macromolecule catabolic process 94 1.17E-04 7.70E-03 
GO:0000375~RNA splicing, via transesterification reactions 41 1.41E-04 9.00E-03 
GO:0007051~spindle organization 83 1.72E-04 1.07E-02 
GO:0046907~intracellular transport 114 2.09E-04 1.28E-02 
GO:0000819~sister chromatid segregation 29 2.14E-04 1.27E-02 
GO:0000398~nuclear mRNA splicing, via spliceosome 40 2.24E-04 1.31E-02 
GO:0000377~RNA splicing, via transesterification reactions with 
bulged adenosine as nucleophile 40 2.24E-04 1.31E-02 
GO:0051028~mRNA transport 17 2.49E-04 1.42E-02 
GO:0008104~protein localization 145 2.73E-04 1.52E-02 
GO:0007281~germ cell development 76 3.38E-04 1.84E-02 
GO:0034621~cellular macromolecular complex subunit 
organization 74 3.39E-04 1.81E-02 
GO:0032989~cellular component morphogenesis 152 3.52E-04 1.84E-02 
GO:0000070~mitotic sister chromatid segregation 28 3.66E-04 1.88E-02 
GO:0006323~DNA packaging 33 3.68E-04 1.86E-02 
GO:0007346~regulation of mitotic cell cycle 41 4.04E-04 2.00E-02 
GO:0006468~protein amino acid phosphorylation 88 4.16E-04 2.02E-02 
GO:0009891~positive regulation of biosynthetic process 55 4.27E-04 2.03E-02 
GO:0031328~positive regulation of cellular biosynthetic process 55 4.27E-04 2.03E-02 
GO:0035220~wing disc development 84 4.35E-04 2.04E-02 
GO:0010564~regulation of cell cycle process 35 4.46E-04 2.05E-02 
GO:0010629~negative regulation of gene expression 71 4.75E-04 2.15E-02 
GO:0045449~regulation of transcription 205 5.20E-04 2.31E-02 
GO:0030182~neuron differentiation 126 5.46E-04 2.39E-02 
GO:0000902~cell morphogenesis 136 6.60E-04 2.83E-02 
GO:0045184~establishment of protein localization 106 6.79E-04 2.87E-02 
GO:0007143~female meiosis 28 7.09E-04 2.94E-02 
GO:0009968~negative regulation of signal transduction 43 7.13E-04 2.92E-02 
GO:0010648~negative regulation of cell communication 43 7.13E-04 2.92E-02 
GO:0003002~regionalization 111 7.75E-04 3.12E-02 
GO:0018130~heterocycle biosynthetic process 25 9.10E-04 3.60E-02 
GO:0007389~pattern specification process 119 1.01E-03 3.94E-02 
GO:0007242~intracellular signaling cascade 105 1.12E-03 4.30E-02 
GO:0015031~protein transport 103 1.17E-03 4.43E-02 
GO:0051252~regulation of RNA metabolic process 171 1.18E-03 4.38E-02 
GO:0010941~regulation of cell death 46 1.19E-03 4.36E-02 
GO:0043067~regulation of programmed cell death 46 1.19E-03 4.36E-02 
GO:0031175~neuron projection development 89 1.22E-03 4.43E-02 
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GO:0006396~RNA processing 97 1.34E-03 4.76E-02 
GO:0030030~cell projection organization 105 1.42E-03 4.97E-02 
GO:0006928~cell motion 94 1.43E-03 4.94E-02 
GO:0030163~protein catabolic process 80 1.43E-03 4.90E-02 
GO:0000904~cell morphogenesis involved in differentiation 93 1.46E-03 4.91E-02 
Cellular compartment 
   GO:0005694~chromosome 130 1.12E-14 6.08E-12 
GO:0044427~chromosomal part 102 1.59E-10 8.61E-08 
GO:0005654~nucleoplasm 105 4.46E-08 2.42E-05 
GO:0044451~nucleoplasm part 92 2.68E-07 1.45E-04 
GO:0005700~polytene chromosome 43 2.12E-06 1.15E-03 
GO:0031981~nuclear lumen 124 4.01E-05 2.15E-02 
Molecular function 
   GO:0003677~DNA binding 240 5.36E-08 6.18E-05 
GO:0008270~zinc ion binding 291 1.15E-06 1.33E-03 
GO:0003729~mRNA binding 75 4.49E-06 5.16E-03 
GO:0000166~nucleotide binding 370 8.91E-06 1.02E-02 
GO:0019899~enzyme binding 38 2.44E-05 2.77E-02 
GO:0016251~general RNA polymerase II transcription factor 
activity 36 3.70E-05 4.18E-02 
GO:0004672~protein kinase activity 95 3.89E-05 4.39E-02 
KEGG pathway 
   dme04120:Ubiquitin mediated proteolysis 50 9.32E-09 9.32E-07 
dme03040:Spliceosome 52 7.18E-08 7.18E-06 
dme04914:Progesterone-mediated oocyte maturation 23 5.21E-05 5.20E-03 
dme03030:DNA replication 19 2.94E-04 2.89E-02 
dme04144:Endocytosis 37 3.01E-04 2.97E-02 
 
Table B8. Embryo poly(A) downregulated minus Embryo total downregulated 
Term Count P-value Bonferroni 
Biological process 
   GO:0008104~protein localization 260 1.16E-35 3.86E-32 
GO:0051276~chromosome organization 190 2.49E-27 8.29E-24 
GO:0045184~establishment of protein localization 182 3.72E-22 1.24E-18 
GO:0015031~protein transport 178 7.27E-22 2.42E-18 
GO:0007010~cytoskeleton organization 264 4.65E-21 1.55E-17 
GO:0046907~intracellular transport 193 6.65E-21 2.22E-17 
GO:0016192~vesicle-mediated transport 228 3.45E-20 1.15E-16 
GO:0000278~mitotic cell cycle 210 4.76E-19 1.59E-15 
GO:0006259~DNA metabolic process 141 2.89E-17 9.61E-14 
GO:0051301~cell division 132 1.09E-16 3.70E-13 
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GO:0007059~chromosome segregation 86 4.49E-16 1.48E-12 
GO:0006325~chromatin organization 113 1.08E-15 3.70E-12 
GO:0007049~cell cycle 314 2.58E-15 8.51E-12 
GO:0048285~organelle fission 103 6.17E-15 2.07E-11 
GO:0016044~membrane organization 181 2.19E-14 7.29E-11 
GO:0006396~RNA processing 176 1.07E-13 3.57E-10 
GO:0051726~regulation of cell cycle 107 1.40E-13 4.66E-10 
GO:0000280~nuclear division 98 1.45E-13 4.82E-10 
GO:0016568~chromatin modification 79 2.91E-13 9.69E-10 
GO:0033554~cellular response to stress 111 3.97E-13 1.32E-09 
GO:0006350~transcription 239 4.96E-13 1.65E-09 
GO:0007067~mitosis 96 4.99E-13 1.66E-09 
GO:0000087~M phase of mitotic cell cycle 97 4.99E-13 1.66E-09 
GO:0043933~macromolecular complex subunit organization 160 5.63E-13 1.87E-09 
GO:0070727~cellular macromolecule localization 142 1.39E-12 4.63E-09 
GO:0007242~intracellular signaling cascade 165 3.88E-12 1.29E-08 
GO:0000226~microtubule cytoskeleton organization 165 5.63E-12 1.87E-08 
GO:0000902~cell morphogenesis 228 6.33E-12 2.11E-08 
GO:0006260~DNA replication 68 1.21E-11 4.02E-08 
GO:0034613~cellular protein localization 109 1.63E-11 5.43E-08 
GO:0051640~organelle localization 60 2.77E-11 9.21E-08 
GO:0010324~membrane invagination 145 2.91E-11 9.69E-08 
GO:0006897~endocytosis 145 2.91E-11 9.69E-08 
GO:0022402~cell cycle process 270 3.22E-11 1.07E-07 
GO:0033043~regulation of organelle organization 74 3.31E-11 1.10E-07 
GO:0022604~regulation of cell morphogenesis 79 3.61E-11 1.20E-07 
GO:0051656~establishment of organelle localization 56 3.85E-11 1.28E-07 
GO:0032989~cellular component morphogenesis 257 5.30E-11 1.76E-07 
GO:0030182~neuron differentiation 210 8.37E-11 2.79E-07 
GO:0006468~protein amino acid phosphorylation 144 9.85E-11 3.28E-07 
GO:0006974~response to DNA damage stimulus 76 1.24E-10 4.12E-07 
GO:0044265~cellular macromolecule catabolic process 128 1.63E-10 5.42E-07 
GO:0010604~positive regulation of macromolecule metabolic 
process 89 1.75E-10 5.84E-07 
GO:0016071~mRNA metabolic process 125 2.04E-10 6.80E-07 
GO:0006281~DNA repair 69 2.14E-10 7.13E-07 
GO:0006886~intracellular protein transport 104 2.32E-10 7.74E-07 
GO:0007017~microtubule-based process 207 2.60E-10 8.67E-07 
GO:0007163~establishment or maintenance of cell polarity 72 4.21E-10 1.40E-06 
GO:0030029~actin filament-based process 89 4.98E-10 1.66E-06 
GO:0044087~regulation of cellular component biogenesis 57 4.98E-10 1.66E-06 
GO:0065003~macromolecular complex assembly 136 5.78E-10 1.92E-06 
GO:0048610~reproductive cellular process 245 7.44E-10 2.48E-06 
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GO:0048666~neuron development 180 7.83E-10 2.61E-06 
GO:0030036~actin cytoskeleton organization 88 8.63E-10 2.87E-06 
GO:0060284~regulation of cell development 82 1.10E-09 3.65E-06 
GO:0007264~small GTPase mediated signal transduction 71 1.41E-09 4.71E-06 
GO:0032940~secretion by cell 75 2.33E-09 7.76E-06 
GO:0051960~regulation of nervous system development 61 2.49E-09 8.29E-06 
GO:0008360~regulation of cell shape 65 2.63E-09 8.75E-06 
GO:0010557~positive regulation of macromolecule biosynthetic 
process 80 3.35E-09 1.12E-05 
GO:0008283~cell proliferation 79 3.48E-09 1.16E-05 
GO:0045935~positive regulation of nucleobase, nucleoside, 
nucleotide and nucleic acid metabolic process 76 3.88E-09 1.29E-05 
GO:0051173~positive regulation of nitrogen compound metabolic 
process 76 3.88E-09 1.29E-05 
GO:0040008~regulation of growth 67 4.78E-09 1.59E-05 
GO:0045449~regulation of transcription 362 8.62E-09 2.87E-05 
GO:0007143~female meiosis 46 9.34E-09 3.11E-05 
GO:0007051~spindle organization 123 1.03E-08 3.44E-05 
GO:0034621~cellular macromolecular complex subunit 
organization 113 1.16E-08 3.86E-05 
GO:0048477~oogenesis 256 1.26E-08 4.18E-05 
GO:0000819~sister chromatid segregation 37 1.39E-08 4.62E-05 
GO:0003001~generation of a signal involved in cell-cell signaling 66 1.53E-08 5.10E-05 
GO:0010608~posttranscriptional regulation of gene expression 77 1.73E-08 5.75E-05 
GO:0007292~female gamete generation 258 1.96E-08 6.54E-05 
GO:0007052~mitotic spindle organization 108 2.52E-08 8.40E-05 
GO:0003006~reproductive developmental process 241 2.65E-08 8.82E-05 
GO:0007269~neurotransmitter secretion 65 2.74E-08 9.11E-05 
GO:0007346~regulation of mitotic cell cycle 63 2.86E-08 9.54E-05 
GO:0046903~secretion 76 2.95E-08 9.83E-05 
GO:0000070~mitotic sister chromatid segregation 36 2.99E-08 9.96E-05 
GO:0051254~positive regulation of RNA metabolic process 59 3.02E-08 1.01E-04 
GO:0048489~synaptic vesicle transport 59 3.02E-08 1.01E-04 
GO:0006261~DNA-dependent DNA replication 42 3.10E-08 1.03E-04 
GO:0031328~positive regulation of cellular biosynthetic process 89 3.28E-08 1.09E-04 
GO:0012501~programmed cell death 89 3.28E-08 1.09E-04 
GO:0009891~positive regulation of biosynthetic process 89 3.28E-08 1.09E-04 
GO:0010628~positive regulation of gene expression 72 3.58E-08 1.19E-04 
GO:0009057~macromolecule catabolic process 144 3.93E-08 1.31E-04 
GO:0031175~neuron projection development 148 4.87E-08 1.62E-04 
GO:0006796~phosphate metabolic process 258 5.46E-08 1.82E-04 
GO:0006793~phosphorus metabolic process 258 5.46E-08 1.82E-04 
GO:0006397~mRNA processing 107 5.68E-08 1.89E-04 
GO:0045941~positive regulation of transcription 71 6.16E-08 2.05E-04 
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GO:0060429~epithelium development 125 6.45E-08 2.15E-04 
GO:0048812~neuron projection morphogenesis 147 7.11E-08 2.37E-04 
GO:0046486~glycerolipid metabolic process 43 7.51E-08 2.50E-04 
GO:0008219~cell death 92 8.95E-08 2.98E-04 
GO:0032774~RNA biosynthetic process 80 9.23E-08 3.07E-04 
GO:0045893~positive regulation of transcription, DNA-dependent 57 9.99E-08 3.33E-04 
GO:0030261~chromosome condensation 26 1.25E-07 4.15E-04 
GO:0016265~death 92 1.32E-07 4.39E-04 
GO:0006366~transcription from RNA polymerase II promoter 62 1.51E-07 5.02E-04 
GO:0000904~cell morphogenesis involved in differentiation 153 1.61E-07 5.37E-04 
GO:0006351~transcription, DNA-dependent 78 1.63E-07 5.41E-04 
GO:0022403~cell cycle phase 233 1.92E-07 6.40E-04 
GO:0048667~cell morphogenesis involved in neuron 
differentiation 146 2.36E-07 7.86E-04 
GO:0006461~protein complex assembly 93 2.59E-07 8.62E-04 
GO:0070271~protein complex biogenesis 93 2.59E-07 8.62E-04 
GO:0006928~cell motion 153 2.73E-07 9.08E-04 
GO:0006357~regulation of transcription from RNA polymerase II 
promoter 104 2.95E-07 9.82E-04 
GO:0007243~protein kinase cascade 42 3.06E-07 0.0010201 
GO:0019953~sexual reproduction 328 3.17E-07 0.0010555 
GO:0007276~gamete generation 320 3.28E-07 0.0010913 
GO:0006644~phospholipid metabolic process 54 3.30E-07 0.0010971 
GO:0043632~modification-dependent macromolecule catabolic 
process 94 3.43E-07 0.0011423 
GO:0032535~regulation of cellular component size 61 4.35E-07 0.0014489 
GO:0019941~modification-dependent protein catabolic process 93 5.33E-07 0.0017739 
GO:0001505~regulation of neurotransmitter levels 66 5.39E-07 0.0017944 
GO:0006323~DNA packaging 44 6.38E-07 0.0021241 
GO:0050767~regulation of neurogenesis 45 6.45E-07 0.0021478 
GO:0009968~negative regulation of signal transduction 62 6.74E-07 0.0022429 
GO:0007267~cell-cell signaling 111 7.89E-07 0.002626 
GO:0002009~morphogenesis of an epithelium 117 8.34E-07 0.0027758 
GO:0034660~ncRNA metabolic process 76 9.84E-07 0.0032717 
GO:0007268~synaptic transmission 101 1.03E-06 0.0034254 
GO:0051329~interphase of mitotic cell cycle 22 1.05E-06 0.003481 
GO:0051325~interphase 22 1.05E-06 0.003481 
GO:0006650~glycerophospholipid metabolic process 38 1.05E-06 0.0034871 
GO:0010648~negative regulation of cell communication 62 1.08E-06 0.0035875 
GO:0019226~transmission of nerve impulse 104 1.08E-06 0.0036064 
GO:0043067~regulation of programmed cell death 65 2.17E-06 0.007207 
GO:0006605~protein targeting 64 2.32E-06 0.0077101 
GO:0016197~endosome transport 21 2.47E-06 0.008195 
GO:0050803~regulation of synapse structure and activity 30 2.60E-06 0.0086159 
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GO:0051603~proteolysis involved in cellular protein catabolic 
process 97 2.77E-06 0.0091862 
GO:0044257~cellular protein catabolic process 97 2.77E-06 0.0091862 
GO:0051252~regulation of RNA metabolic process 300 2.77E-06 0.0091924 
GO:0000910~cytokinesis 50 3.21E-06 0.0106329 
GO:0019637~organophosphate metabolic process 58 3.42E-06 0.0113221 
GO:0007391~dorsal closure 57 3.63E-06 0.0120227 
GO:0030163~protein catabolic process 104 3.65E-06 0.0120809 
GO:0051493~regulation of cytoskeleton organization 35 3.76E-06 0.01246 
GO:0002165~instar larval or pupal development 195 3.85E-06 0.012743 
GO:0032268~regulation of cellular protein metabolic process 73 3.96E-06 0.0130961 
GO:0008356~asymmetric cell division 39 4.09E-06 0.0135277 
GO:0048488~synaptic vesicle endocytosis 27 4.11E-06 0.0136079 
GO:0007281~germ cell development 122 4.78E-06 0.0157932 
GO:0022613~ribonucleoprotein complex biogenesis 56 6.07E-06 0.0200038 
GO:0034622~cellular macromolecular complex assembly 88 6.17E-06 0.0203413 
GO:0000279~M phase 218 6.94E-06 0.0228405 
GO:0030030~cell projection organization 172 7.39E-06 0.0243003 
GO:0009791~post-embryonic development 200 7.73E-06 0.0254133 
GO:0010564~regulation of cell cycle process 51 8.17E-06 0.0268461 
GO:0008105~asymmetric protein localization 26 8.62E-06 0.0282897 
GO:0010941~regulation of cell death 65 1.09E-05 0.0356807 
GO:0030707~ovarian follicle cell development 104 1.13E-05 0.0369022 
GO:0060341~regulation of cellular localization 43 1.19E-05 0.0390012 
GO:0007298~border follicle cell migration 42 1.24E-05 0.0403818 
GO:0043484~regulation of RNA splicing 42 1.24E-05 0.0403818 
GO:0032990~cell part morphogenesis 157 1.24E-05 0.0404863 
GO:0048729~tissue morphogenesis 122 1.30E-05 0.04242 
GO:0032970~regulation of actin filament-based process 23 1.32E-05 0.0430347 
GO:0032956~regulation of actin cytoskeleton organization 23 1.32E-05 0.0430347 
GO:0048585~negative regulation of response to stimulus 19 1.34E-05 0.0437617 
GO:0030384~phosphoinositide metabolic process 32 1.34E-05 0.0437991 
GO:0006338~chromatin remodeling 32 1.34E-05 0.0437991 
GO:0008654~phospholipid biosynthetic process 33 1.38E-05 0.044825 
GO:0007015~actin filament organization 50 1.38E-05 0.0448669 
GO:0009994~oocyte differentiation 75 1.39E-05 0.045229 
GO:0051129~negative regulation of cellular component 
organization 37 1.39E-05 0.0452828 
GO:0045664~regulation of neuron differentiation 36 1.40E-05 0.0456419 
Cellular Compartment 
   GO:0031974~membrane-enclosed lumen 319 9.42E-19 6.13E-16 
GO:0005694~chromosome 191 2.82E-18 1.84E-15 
GO:0043233~organelle lumen 310 4.93E-18 3.21E-15 
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GO:0070013~intracellular organelle lumen 310 4.93E-18 3.21E-15 
GO:0005654~nucleoplasm 170 1.39E-17 9.03E-15 
GO:0031981~nuclear lumen 223 8.23E-15 5.35E-12 
GO:0043232~intracellular non-membrane-bounded organelle 467 6.49E-14 4.23E-11 
GO:0043228~non-membrane-bounded organelle 467 6.49E-14 4.23E-11 
GO:0044427~chromosomal part 151 8.92E-14 5.81E-11 
GO:0044451~nucleoplasm part 149 1.49E-13 9.71E-11 
GO:0012505~endomembrane system 137 4.38E-13 2.85E-10 
GO:0005938~cell cortex 56 9.46E-10 6.16E-07 
GO:0005813~centrosome 41 1.99E-08 1.29E-05 
GO:0005819~spindle 50 2.08E-08 1.36E-05 
GO:0005856~cytoskeleton 185 4.64E-08 3.02E-05 
GO:0005794~Golgi apparatus 96 3.29E-07 2.14E-04 
GO:0005815~microtubule organizing center 43 7.94E-07 5.17E-04 
GO:0005635~nuclear envelope 56 1.61E-06 0.0010466 
GO:0005700~polytene chromosome 59 1.67E-06 0.0010888 
GO:0000228~nuclear chromosome 51 2.49E-06 0.0016183 
GO:0044454~nuclear chromosome part 46 6.69E-06 0.0043448 
GO:0005789~endoplasmic reticulum membrane 49 7.23E-06 0.0046934 
GO:0042175~nuclear envelope-endoplasmic reticulum network 50 7.35E-06 0.0047719 
GO:0005768~endosome 25 1.26E-05 0.0081665 
GO:0005681~spliceosome 46 2.02E-05 0.013064 
GO:0044430~cytoskeletal part 145 3.26E-05 0.0209702 
GO:0016327~apicolateral plasma membrane 32 3.76E-05 0.0241983 
GO:0000785~chromatin 65 7.30E-05 0.0464249 
Molecular function 
   GO:0000166~nucleotide binding 645 1.11E-30 1.77E-27 
GO:0032553~ribonucleotide binding 511 1.65E-28 2.64E-25 
GO:0032555~purine ribonucleotide binding 511 1.65E-28 2.64E-25 
GO:0017076~purine nucleotide binding 535 1.35E-26 2.15E-23 
GO:0032559~adenyl ribonucleotide binding 421 6.87E-25 1.10E-21 
GO:0005524~ATP binding 419 1.60E-24 2.56E-21 
GO:0001883~purine nucleoside binding 446 4.96E-23 7.92E-20 
GO:0001882~nucleoside binding 448 1.16E-22 1.85E-19 
GO:0030554~adenyl nucleotide binding 442 1.74E-22 2.77E-19 
GO:0008270~zinc ion binding 508 1.41E-14 2.25E-11 
GO:0003677~DNA binding 416 6.46E-13 1.03E-09 
GO:0004386~helicase activity 78 7.33E-12 1.17E-08 
GO:0003729~mRNA binding 118 8.09E-12 1.29E-08 
GO:0019899~enzyme binding 53 2.28E-11 3.64E-08 
GO:0008026~ATP-dependent helicase activity 58 4.85E-10 7.73E-07 
GO:0070035~purine NTP-dependent helicase activity 58 4.85E-10 7.73E-07 
GO:0008092~cytoskeletal protein binding 128 1.62E-09 2.59E-06 
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GO:0016779~nucleotidyltransferase activity 62 1.45E-08 2.31E-05 
GO:0008134~transcription factor binding 61 2.59E-08 4.14E-05 
GO:0004674~protein serine/threonine kinase activity 116 8.25E-08 1.32E-04 
GO:0003779~actin binding 76 1.87E-07 2.99E-04 
GO:0015631~tubulin binding 48 2.69E-07 4.29E-04 
GO:0004672~protein kinase activity 151 3.13E-07 4.99E-04 
GO:0008017~microtubule binding 44 1.49E-06 0.0023681 
GO:0060589~nucleoside-triphosphatase regulator activity 83 6.49E-06 0.0103107 
GO:0046914~transition metal ion binding 593 8.39E-06 0.0133079 
GO:0003682~chromatin binding 43 9.26E-06 0.0146667 
GO:0030695~GTPase regulator activity 81 1.02E-05 0.0161191 
GO:0043566~structure-specific DNA binding 25 1.12E-05 0.0177629 
GO:0004004~ATP-dependent RNA helicase activity 30 1.26E-05 0.0198994 
GO:0008186~RNA-dependent ATPase activity 30 1.26E-05 0.0198994 
GO:0003712~transcription cofactor activity 42 1.60E-05 0.0252827 
GO:0005083~small GTPase regulator activity 64 2.03E-05 0.0318264 
GO:0003924~GTPase activity 74 2.86E-05 0.044638 
GO:0042802~identical protein binding 81 2.86E-05 0.0446407 
KEGG pathway 
   dme03040:Spliceosome 71 1.05E-04 0.0116223 
dme04320:Dorso-ventral axis formation 22 2.41E-04 0.0263651 
dme04144:Endocytosis 53 2.83E-04 0.0309255 
dme03018:RNA degradation 35 3.05E-04 0.033305 
dme04120:Ubiquitin mediated proteolysis 62 3.34E-04 0.0363751 
dme00970:Aminoacyl-tRNA biosynthesis 27 
0.00600
9 0.4877783 
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